data_2m6o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6o _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 109.82 -0.437 . . . . 1.14 109.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 42' ' ' MET . 14.3 m -81.43 147.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.962 -0.384 . . . . 1.12 109.962 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 57.6 tt0 -121.05 121.44 37.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.246 0.546 . . . . 1.99 110.937 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 80.4 m-85 -112.61 141.18 46.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.564 -0.743 . . . . 0.94 110.075 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.97 118.74 28.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 0.92 110.503 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 28.3 p -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.899 0.38 . . . . 1.55 110.498 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 0.14 15.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 1.99 110.894 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.71 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 69.5 mmtt -75.9 -21.85 56.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.227 -0.657 . . . . 2.23 109.227 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.08 5.05 41.23 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.282 -0.872 . . . . 0.75 112.303 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -103.79 143.8 32.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 3.22 110.701 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 55.5 mtt180 -113.61 144.51 42.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.288 -0.414 . . . . 2.37 109.914 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.95 153.41 41.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.244 -0.435 . . . . 0.22 110.659 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 11.1 pt-20 -110.84 143.64 41.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 1.7 110.351 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.627 ' O ' HG21 ' A' ' 30' ' ' VAL . 63.1 mtm -137.37 151.63 71.73 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.227 -0.442 . . . . 1.31 109.82 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.75 122.86 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.039 1.826 . . . . 0.74 112.688 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' HG22 ' A' ' 30' ' ' VAL . 11.3 m-85 -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.798 -0.637 . . . . 0.46 109.33 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 21.9 t -84.36 137.87 33.18 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.29 -0.633 . . . . 1.71 109.29 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.01 -5.75 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.285 0.564 . . . . 1.58 110.618 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.69 13.85 19.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.572 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 45' ' ' SER . . . -98.91 160.21 14.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 1.22 110.767 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.65 91.83 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.734 -0.839 . . . . 2.59 108.734 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.3 120.89 47.83 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 1.12 111.08 -172.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 56.1 Cg_exo -52.51 129.05 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.385 2.723 . . . . 0.68 112.215 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 22.9 Cg_exo -64.56 -17.28 59.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.154 2.569 . . . . 0.29 113.112 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.23 148.88 33.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.885 0.374 . . . . 1.74 110.353 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 32.4 t-105 -146.25 159.25 43.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.745 -0.835 . . . . 2.04 108.745 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.58 142.43 56.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.82 0.343 . . . . 0.67 110.194 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -77.79 109.04 11.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.31 110.645 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -14.4 60.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.854 -0.612 . . . . 1.41 111.315 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.54 -60.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.096 0.406 . . . . 1.17 112.096 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.522 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 43.6 t -125.15 -42.62 2.0 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.31 -0.556 . . . . 0.5 112.228 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.77 92.85 0.38 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.003 -1.094 . . . . 0.59 112.266 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.75 -177.7 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.847 -0.427 . . . . 1.09 109.847 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -98.0 123.19 41.89 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.63 -0.878 . . . . 2.02 108.63 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -102.33 129.21 48.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.138 -0.483 . . . . 1.02 110.819 -176.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.52 136.61 33.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.991 -0.549 . . . . 1.13 110.141 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 31' ' ' GLU . 3.3 tm? -78.98 131.77 36.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.512 -0.767 . . . . 1.15 109.123 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 116.496 -0.32 . . . . 1.59 110.27 -179.511 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.903 -0.406 . . . . 1.14 109.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 42' ' ' MET . 3.2 m -87.86 144.65 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.167 -0.679 . . . . 1.12 109.167 176.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 37.8 tt0 -119.59 128.09 53.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.312 0.577 . . . . 1.99 110.673 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 61.1 m-85 -113.83 139.26 49.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.436 -0.802 . . . . 0.94 109.844 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 119.54 35.48 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.315 -0.254 . . . . 0.92 110.315 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 21.1 p -80.51 172.07 14.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.462 . . . . 1.55 111.967 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 41.6 mt-10 -64.81 -21.41 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.705 . . . . 1.99 110.994 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.15 0.03 54.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 2.23 111.037 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.31 31.1 43.1 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.862 -0.685 . . . . 0.75 112.589 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -113.42 127.46 56.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 3.22 109.545 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 49.5 mtt180 -99.51 141.34 32.43 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.661 -0.496 . . . . 2.37 109.661 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -142.51 153.4 43.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.868 -0.605 . . . . 0.22 110.385 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.83 135.81 41.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 1.7 110.057 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.541 ' O ' HG22 ' A' ' 30' ' ' VAL . 65.4 mmm -125.73 146.64 55.73 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.714 -0.675 . . . . 1.31 110.188 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.57 122.46 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.036 1.824 . . . . 0.74 112.775 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -143.25 -177.42 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.656 -0.702 . . . . 0.46 109.276 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.484 ' HB3' ' CB ' ' A' ' 48' ' ' ALA . 24.0 t -93.2 143.21 26.48 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.654 -0.498 . . . . 1.71 109.654 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.24 -1.28 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.937 -0.574 . . . . 1.58 110.751 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -127.17 21.11 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.766 -0.652 . . . . 1.25 110.761 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 45' ' ' SER . . . -109.77 172.02 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 1.22 110.078 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 33.8 tt0 -76.05 118.23 18.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 2.59 109.181 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.412 HG23 ' HG ' ' A' ' 65' ' ' LEU . 23.8 mm -89.79 106.03 12.91 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.164 -0.68 . . . . 1.12 109.164 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 49' ' ' GLU . 63.9 Cg_exo -51.99 124.95 15.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.232 2.621 . . . . 0.68 112.449 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.3 20.76 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.634 2.889 . . . . 0.29 113.429 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.65 152.86 38.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.74 110.551 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 34.7 t-105 -149.05 160.72 43.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.949 -0.759 . . . . 2.04 108.949 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -75.89 143.68 41.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.4 . . . . 0.67 110.412 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.4 t -83.58 97.76 9.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.307 0.575 . . . . 0.31 110.357 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 9.8 mmpt? -77.07 11.0 1.99 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.347 -0.842 . . . . 1.41 111.694 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.85 -60.71 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.623 0.249 . . . . 1.17 111.102 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t -108.9 -45.76 3.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.913 -0.315 . . . . 0.5 111.282 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.72 55.67 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.445 -0.883 . . . . 0.59 112.156 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -149.29 -167.21 2.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.985 -0.376 . . . . 1.09 109.985 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 tt0 -99.55 148.4 24.33 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.493 -0.558 . . . . 2.02 109.493 171.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -124.86 147.43 48.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.966 0.412 . . . . 1.02 111.293 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.0 mt -104.0 137.03 42.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 1.13 109.976 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.4 tm? -73.18 132.08 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.513 -0.767 . . . . 1.15 109.629 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 66' ' ' VAL . 33.9 m . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 1.59 110.91 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.3 -0.259 . . . . 1.14 110.3 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 42' ' ' MET . 15.2 m -80.0 154.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.18 -0.304 . . . . 1.12 110.18 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 6.7 tp10 -116.37 135.87 53.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 1.99 110.724 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' HE3' ' A' ' 42' ' ' MET . 64.4 m-85 -129.77 136.4 49.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.384 -0.371 . . . . 0.94 110.028 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.38 121.98 35.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.272 -0.422 . . . . 0.92 110.505 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.3 p -86.58 159.77 19.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.091 0.472 . . . . 1.55 110.219 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.86 4.74 5.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 1.99 110.515 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mmmt -91.71 -16.9 26.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 2.23 109.437 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.11 -3.66 22.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.672 -0.775 . . . . 0.75 113.711 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -100.54 143.33 30.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.408 0.604 . . . . 3.22 111.974 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -113.31 148.25 36.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.402 -0.817 . . . . 2.37 108.977 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.82 152.26 30.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.945 0.402 . . . . 0.22 111.011 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.42 138.14 45.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.818 -0.628 . . . . 1.7 110.158 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.652 ' HE1' ' CD1' ' A' ' 54' ' ' TRP . 37.5 mtm -130.7 152.64 80.83 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.601 -0.272 . . . . 1.31 110.572 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.52 122.91 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.198 1.932 . . . . 0.74 113.069 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.54 -175.89 4.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.261 -0.881 . . . . 0.46 109.368 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB3' ' HB1' ' A' ' 48' ' ' ALA . 33.9 t -86.95 144.05 27.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.41 -0.589 . . . . 1.71 109.41 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.72 2.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.494 0.664 . . . . 1.58 110.426 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.8 5.89 7.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.101 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 45' ' ' SER . . . -97.03 147.33 24.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.805 0.336 . . . . 1.22 110.959 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.73 89.5 1.35 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.386 0.612 . . . . 2.59 109.814 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.65 124.26 71.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.182 -0.917 . . . . 1.12 110.691 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.58 129.64 36.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.056 2.504 . . . . 0.68 112.295 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.68 -16.28 36.1 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.509 2.806 . . . . 0.29 113.626 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 151.04 36.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.995 -0.372 . . . . 1.74 109.995 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.652 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 34.7 t-105 -146.52 159.66 43.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.31 -0.626 . . . . 2.04 109.31 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 139.3 57.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.962 0.41 . . . . 0.67 110.653 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.8 t -79.04 110.07 13.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.006 0.431 . . . . 0.31 111.098 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 1.1 mpmm? -76.68 -5.94 50.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 1.41 111.642 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -83.82 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.09 -0.244 . . . . 1.17 111.638 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.27 -44.45 2.58 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.589 -0.444 . . . . 0.5 112.081 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.12 75.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.252 -0.975 . . . . 0.59 112.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -165.85 -168.69 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.409 -0.589 . . . . 1.09 109.409 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -98.39 133.43 42.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 2.02 109.903 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -110.66 132.82 53.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 1.02 110.426 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.74 137.5 32.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.234 -0.439 . . . . 1.13 110.164 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.7 tm? -71.23 121.9 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 1.15 110.018 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 77.8 t . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.694 -0.685 . . . . 1.59 109.892 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.979 -0.378 . . . . 1.14 109.979 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 42' ' ' MET . 22.0 m -88.89 153.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 110.154 -0.313 . . . . 1.12 110.154 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' O ' HD22 ' A' ' 65' ' ' LEU . 37.5 mt-10 -114.68 120.11 39.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.425 -0.352 . . . . 1.99 111.207 -173.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.5 m-85 -112.94 141.05 47.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.474 -0.33 . . . . 0.94 110.488 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 126.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.92 110.446 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.719 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 19.5 p -89.39 -177.05 5.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.55 111.41 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.64 -14.18 62.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.668 . . . . 1.99 112.438 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.719 ' HE3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -87.64 -25.51 23.5 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.43 0.633 . . . . 2.23 110.3 176.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.39 5.35 40.01 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.283 -0.872 . . . . 0.75 111.331 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 39.0 m80 -68.39 102.24 1.38 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.746 -0.464 . . . . 3.22 109.746 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mtt180 -98.22 141.95 30.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.034 -0.53 . . . . 2.37 110.491 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -151.0 153.4 35.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.603 -0.726 . . . . 0.22 110.486 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.0 mt-10 -104.58 138.64 40.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 1.7 110.097 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.578 ' O ' HG21 ' A' ' 30' ' ' VAL . 42.8 mtm -135.25 146.16 56.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.773 -0.454 . . . . 1.31 109.773 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.91 121.83 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.029 1.819 . . . . 0.74 113.314 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.16 -175.87 3.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.221 -0.9 . . . . 0.46 108.945 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 29.0 t -81.0 135.77 35.9 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.3 -0.63 . . . . 1.71 109.3 171.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.58 -4.15 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.43 0.633 . . . . 1.58 110.579 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.6 19.96 11.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 1.25 110.402 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -108.32 161.23 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.075 0.464 . . . . 1.22 111.075 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.79 88.66 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 2.59 109.533 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.8 121.27 52.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.588 -0.733 . . . . 1.12 110.909 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.47 127.38 25.21 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.939 2.426 . . . . 0.68 111.802 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.9 -8.99 6.78 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.757 2.972 . . . . 0.29 114.314 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.48 148.22 27.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.711 0.291 . . . . 1.74 110.731 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.484 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 23.5 t-105 -151.7 158.18 43.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.716 -0.846 . . . . 2.04 108.716 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.24 142.71 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.117 0.484 . . . . 0.67 111.183 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 t -79.59 103.83 9.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.717 -0.674 . . . . 0.31 111.127 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 7.94 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 1.41 111.636 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.83 -59.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.114 0.413 . . . . 1.17 112.114 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -110.42 -45.28 3.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.203 0.446 . . . . 0.5 112.203 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.64 68.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.096 -1.05 . . . . 0.59 112.18 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -172.99 -166.04 0.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.139 -0.689 . . . . 1.09 109.139 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -99.43 146.77 25.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.66 -0.416 . . . . 2.02 109.987 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -119.62 148.33 43.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 1.02 110.306 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -102.88 140.55 37.01 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.044 0.45 . . . . 1.13 110.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.3 tm? -74.17 112.61 10.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.418 -0.81 . . . . 1.15 109.059 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 121.301 0.572 . . . . 1.59 112.041 -173.075 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.566 0.222 . . . . 1.14 111.02 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 42' ' ' MET . 19.6 m -96.65 141.63 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.295 -0.632 . . . . 1.12 109.295 172.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' HD23 ' A' ' 65' ' ' LEU . 34.8 tt0 -119.23 126.58 51.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.365 0.602 . . . . 1.99 111.15 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 94.4 m-85 -115.52 136.66 52.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.387 -0.824 . . . . 0.94 109.821 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.31 117.44 23.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.942 0.401 . . . . 0.92 110.755 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.529 ' SG ' ' HB1' ' A' ' 61' ' ' ALA . 15.8 t -82.93 156.24 23.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.55 109.702 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.22 -3.32 19.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.783 -0.644 . . . . 1.99 110.875 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -75.82 -21.27 57.47 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.373 -0.602 . . . . 2.23 109.373 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.36 -16.42 17.27 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.75 112.358 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -73.92 128.01 34.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 3.22 111.762 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -110.8 153.07 25.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.144 -0.688 . . . . 2.37 109.144 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 32.3 p90 -161.59 153.3 19.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.522 -0.308 . . . . 0.22 110.576 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 pt-20 -112.19 142.56 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.966 -0.561 . . . . 1.7 110.527 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.595 ' HE3' ' CD1' ' A' ' 54' ' ' TRP . 68.5 mtm -133.72 155.08 80.76 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.157 -0.474 . . . . 1.31 110.611 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.0 122.98 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.376 2.051 . . . . 0.74 112.941 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.3 -176.87 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.252 -0.885 . . . . 0.46 109.106 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 26.0 t -94.36 140.41 29.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.113 0.482 . . . . 1.71 110.04 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.24 -12.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.873 -0.603 . . . . 1.58 110.582 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.88 9.68 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 1.25 110.406 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' SER . . . -94.82 161.81 14.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 1.22 110.595 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.61 84.15 6.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.29 -0.633 . . . . 2.59 109.29 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.7 mm -57.75 117.29 18.1 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.514 -0.766 . . . . 1.12 110.697 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.5 132.59 40.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.544 2.829 . . . . 0.68 112.742 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.63 -18.73 56.71 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.334 2.689 . . . . 0.29 112.861 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 150.29 42.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.195 -0.298 . . . . 1.74 110.195 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 42' ' ' MET . 31.7 t-105 -149.86 155.4 39.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 2.04 109.377 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.65 140.69 58.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.087 0.47 . . . . 0.67 110.555 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 15.4 t -80.54 110.46 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.584 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.32 -2.98 30.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.681 -0.69 . . . . 1.41 111.329 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 -60.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.113 0.412 . . . . 1.17 112.113 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.0 t -105.6 -47.35 3.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.236 -0.586 . . . . 0.5 112.411 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 55.52 0.08 OUTLIER Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.942 -1.123 . . . . 0.59 112.596 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.529 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -154.33 -170.94 3.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.314 -0.625 . . . . 1.09 109.314 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -98.35 122.61 41.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 2.02 109.842 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -98.68 139.58 34.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 1.02 110.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.73 135.44 34.1 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.885 0.374 . . . . 1.13 110.163 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -68.99 117.37 10.56 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.913 -0.773 . . . . 1.15 108.913 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.215 0.531 . . . . 1.59 111.591 -174.605 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 110.338 -0.245 . . . . 1.14 110.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 42' ' ' MET . 10.7 m -91.09 147.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.726 -0.472 . . . . 1.12 109.726 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' HD21 ' A' ' 65' ' ' LEU . 46.8 mt-10 -118.27 124.04 46.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.051 0.453 . . . . 1.99 111.36 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CZ ' HD23 ' A' ' 65' ' ' LEU . 82.7 m-85 -113.06 138.13 50.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.94 110.039 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.67 121.21 37.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 0.92 110.191 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.1 p -83.24 166.23 18.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.085 -0.507 . . . . 1.55 110.888 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.63 3.03 10.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.471 -0.786 . . . . 1.99 110.595 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -99.28 -0.29 41.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.274 -0.421 . . . . 2.23 110.461 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.98 9.04 58.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.927 -0.654 . . . . 0.75 113.464 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -111.36 156.26 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.351 0.576 . . . . 3.22 110.764 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -122.9 147.82 46.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.879 -0.786 . . . . 2.37 108.879 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -146.86 153.99 40.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 0.22 111.178 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.33 138.17 47.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.55 -0.75 . . . . 1.7 110.371 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.642 ' O ' HG22 ' A' ' 30' ' ' VAL . 62.9 mtm -136.91 147.82 60.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.85 -0.426 . . . . 1.31 109.85 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.69 123.27 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.049 1.833 . . . . 0.74 112.746 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CD1' HG23 ' A' ' 30' ' ' VAL . 13.2 m-85 -125.28 -175.74 3.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.913 -0.773 . . . . 0.46 108.913 173.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.438 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 7.4 m -88.08 132.16 34.4 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.447 -0.575 . . . . 1.71 109.447 171.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.41 -12.06 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.429 0.633 . . . . 1.58 110.225 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.5 6.31 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.809 . . . . 1.25 110.357 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 45' ' ' SER . . . -102.23 160.37 14.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.907 -0.588 . . . . 1.22 110.777 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -77.45 95.67 4.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.845 -0.798 . . . . 2.59 108.845 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.77 117.72 23.15 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.41 -0.359 . . . . 1.12 110.763 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 54.4 Cg_exo -51.85 125.33 16.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.161 2.574 . . . . 0.68 112.179 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -62.3 -12.14 25.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.378 2.719 . . . . 0.29 113.217 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.58 143.51 16.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.451 -0.341 . . . . 1.74 110.418 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 30.6 t-105 -142.79 159.01 43.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.561 -0.903 . . . . 2.04 108.561 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.79 144.81 55.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.99 0.424 . . . . 0.67 110.656 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.17 107.84 16.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.09 -0.505 . . . . 0.31 110.794 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -4.37 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.957 -0.565 . . . . 1.41 111.249 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.46 -60.43 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 111.896 0.332 . . . . 1.17 111.896 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 53.1 t -108.51 -44.64 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.608 -0.437 . . . . 0.5 112.162 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 55.21 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.131 -1.033 . . . . 0.59 111.785 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.8 -165.46 2.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.282 -0.636 . . . . 1.09 109.282 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -99.71 149.56 23.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.485 -0.561 . . . . 2.02 109.485 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -123.99 147.0 48.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.994 0.426 . . . . 1.02 110.677 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.83 139.26 35.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.078 -0.51 . . . . 1.13 110.244 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -75.94 123.81 26.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 1.15 109.111 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 1.59 111.321 -176.618 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 CA-C-O 120.599 0.238 . . . . 1.14 111.011 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 42' ' ' MET . 11.5 m -102.69 157.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.709 -0.478 . . . . 1.12 109.709 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.511 ' O ' HD22 ' A' ' 65' ' ' LEU . 45.2 mt-10 -131.47 127.71 37.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.729 0.3 . . . . 1.99 111.218 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.98 144.08 46.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.454 -0.339 . . . . 0.94 110.438 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.97 127.6 43.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.92 110.449 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 30.9 p -90.34 168.32 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 1.55 110.978 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.97 -6.08 39.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.634 -0.712 . . . . 1.99 110.882 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 72.1 mmtt -84.57 -13.41 51.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 2.23 110.284 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.71 13.71 46.19 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.704 -0.68 . . . . 0.75 112.583 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -105.38 145.77 30.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 3.22 110.328 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -120.15 142.95 48.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.578 -0.527 . . . . 2.37 109.578 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -149.79 154.19 38.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.973 0.416 . . . . 0.22 111.271 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.22 143.24 42.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.668 -0.696 . . . . 1.7 109.955 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.621 ' HE2' ' CD1' ' A' ' 54' ' ' TRP . 64.2 mtm -136.41 150.28 70.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.445 -0.343 . . . . 1.31 110.078 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.247 1.965 . . . . 0.74 113.006 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CD2' HG21 ' A' ' 30' ' ' VAL . 33.7 m-85 -141.69 -177.09 5.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.623 -0.717 . . . . 0.46 109.604 177.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.5 t -104.17 144.55 31.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.232 0.539 . . . . 1.71 110.334 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -76.81 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 1.58 109.645 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.42 22.54 15.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.067 -0.97 . . . . 1.25 110.034 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.51 146.07 45.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.005 -0.543 . . . . 1.22 110.308 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.02 85.09 2.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.94 -0.763 . . . . 2.59 108.94 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.0 mm -58.68 117.43 20.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 1.12 110.45 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.72 130.37 38.64 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.066 2.511 . . . . 0.68 112.291 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.23 -11.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.151 2.567 . . . . 0.29 112.929 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.08 137.4 14.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.531 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CD1' ' HE2' ' A' ' 42' ' ' MET . 33.8 t-105 -137.21 158.74 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.939 -0.763 . . . . 2.04 108.939 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.25 141.04 56.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.924 0.393 . . . . 0.67 110.606 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.97 109.26 16.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.425 . . . . 0.31 110.842 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -14.05 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.792 -0.64 . . . . 1.41 111.403 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.03 -60.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.016 0.376 . . . . 1.17 112.016 -171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.513 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 42.5 t -110.91 -44.46 3.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.507 -0.477 . . . . 0.5 111.79 -172.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.67 55.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.215 -0.993 . . . . 0.59 112.239 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.02 -162.9 1.61 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.986 -0.375 . . . . 1.09 109.986 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -98.62 142.47 30.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.42 -0.585 . . . . 2.02 109.42 170.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -117.2 138.97 51.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.939 0.4 . . . . 1.02 110.568 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.08 134.28 35.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.131 -0.486 . . . . 1.13 110.192 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.4 tm? -68.69 118.59 11.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.667 -0.864 . . . . 1.15 108.667 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 C--N 1.322 -0.609 0 CA-C-O 121.252 0.549 . . . . 1.59 111.698 -175.24 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.563 0.22 . . . . 1.14 110.545 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 42' ' ' MET . 12.1 m -86.39 148.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.145 -0.687 . . . . 1.12 109.145 175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 34.8 tt0 -118.68 130.53 55.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.376 0.608 . . . . 1.99 111.431 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 76.5 m-85 -118.76 141.28 48.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.94 109.94 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.426 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -127.64 113.57 16.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 0.92 110.586 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.65 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.7 t -85.44 164.02 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.082 -0.508 . . . . 1.55 110.235 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.8 -11.66 56.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.213 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -72.38 -6.66 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 2.23 110.946 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.15 78.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.869 -0.682 . . . . 0.75 112.111 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -105.98 129.99 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.903 0.382 . . . . 3.22 110.661 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 62.1 mtt180 -105.91 153.23 22.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 2.37 109.803 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -154.91 153.04 30.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.936 0.398 . . . . 0.22 110.571 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.4 pt-20 -105.49 139.61 39.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.704 -0.68 . . . . 1.7 110.332 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.682 ' HE2' ' CD1' ' A' ' 54' ' ' TRP . 60.3 mtm -131.68 151.57 78.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.268 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.82 122.68 4.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.74 112.894 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CD1' HG21 ' A' ' 30' ' ' VAL . 16.2 m-85 -131.76 -176.78 4.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.231 -0.895 . . . . 0.46 108.862 172.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 15.0 m -87.07 137.52 32.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.723 -0.473 . . . . 1.71 109.723 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -73.98 -7.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.131 -0.486 . . . . 1.58 111.681 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.42 20.49 9.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.25 111.052 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 45' ' ' SER . . . -102.05 160.21 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 1.22 110.462 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.56 106.53 9.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.077 -0.712 . . . . 2.59 109.077 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mm -76.02 117.56 64.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.085 -0.339 . . . . 1.12 110.085 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.71 127.94 28.26 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.159 2.573 . . . . 0.68 112.614 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.78 -14.22 30.8 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.467 2.778 . . . . 0.29 113.217 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.56 140.95 25.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.116 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.682 ' CD1' ' HE2' ' A' ' 42' ' ' MET . 28.1 t-105 -147.76 159.16 44.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 2.04 109.363 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.68 142.4 58.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.67 110.996 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.53 112.4 19.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.31 110.944 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.15 -12.45 60.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 1.41 111.294 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.3 -59.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.184 0.439 . . . . 1.17 112.184 -172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.5 t -114.17 -45.48 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.5 112.266 -173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 68.62 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.163 -1.017 . . . . 0.59 111.696 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.65 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -163.52 -170.58 2.27 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.635 -0.505 . . . . 1.09 109.635 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -99.57 117.37 33.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.009 -0.367 . . . . 2.02 110.009 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -92.85 141.15 28.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.245 -0.434 . . . . 1.02 110.336 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.2 136.63 38.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.009 0.433 . . . . 1.13 110.268 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 3.3 tm? -69.93 120.01 15.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.375 -0.829 . . . . 1.15 109.543 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.376 -0.375 . . . . 1.59 111.303 -176.154 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.748 -0.093 . . . . 1.14 110.748 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 42' ' ' MET . 13.1 m -81.34 140.75 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.539 -0.541 . . . . 1.12 109.539 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -117.16 130.26 56.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 1.99 111.347 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 93.1 m-85 -116.61 142.1 47.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.757 -0.656 . . . . 0.94 109.793 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.4 122.47 42.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.8 0.333 . . . . 0.92 110.587 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 31.5 p -83.53 170.64 14.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 1.55 111.142 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.09 -5.71 43.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.743 -0.662 . . . . 1.99 110.808 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 66.0 mmtt -86.41 -13.4 46.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 2.23 110.117 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.85 34.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.98 -0.629 . . . . 0.75 112.463 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -113.17 131.6 55.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.919 0.39 . . . . 3.22 110.078 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -105.51 145.39 30.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 2.37 109.808 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.28 153.13 43.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.735 0.302 . . . . 0.22 110.937 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 13.1 pt-20 -106.43 144.26 33.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.188 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.541 ' HE1' ' CD1' ' A' ' 54' ' ' TRP . 52.8 mtm -139.38 148.52 57.0 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.342 -0.39 . . . . 1.31 110.059 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.5 122.24 6.85 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.441 2.094 . . . . 0.74 112.943 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -137.35 -176.19 4.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.359 -0.837 . . . . 0.46 109.025 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.27 146.77 23.46 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.392 -0.595 . . . . 1.71 109.392 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.28 -6.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 1.58 110.621 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.47 20.35 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 1.25 110.057 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -108.67 152.43 24.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.849 -0.614 . . . . 1.22 109.933 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -75.02 88.71 2.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.427 -0.583 . . . . 2.59 109.427 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.2 mm -58.81 116.08 14.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 1.12 110.725 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.8 131.42 41.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.42 2.747 . . . . 0.68 112.637 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.43 -22.44 74.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.491 2.794 . . . . 0.29 113.166 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.78 152.12 39.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.35 . . . . 1.74 110.16 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.541 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 30.4 t-105 -149.51 159.24 44.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.394 -0.595 . . . . 2.04 109.394 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.37 143.79 56.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.67 110.656 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.52 109.2 14.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.31 110.748 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.06 -10.16 59.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 1.41 111.251 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.03 -60.27 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.127 0.417 . . . . 1.17 112.127 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.6 t -112.47 -46.49 3.16 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.464 -0.495 . . . . 0.5 111.634 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 76.82 0.11 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.117 -1.039 . . . . 0.59 112.315 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -171.61 -167.42 0.51 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 1.09 109.347 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -98.56 140.34 32.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.142 -0.688 . . . . 2.02 109.142 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -118.71 147.98 43.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.391 -0.368 . . . . 1.02 110.551 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.8 mt -99.57 136.63 39.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.107 -0.497 . . . . 1.13 110.25 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 3.0 tm? -70.65 123.28 21.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.553 -0.749 . . . . 1.15 109.872 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 1.59 110.638 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.957 -0.386 . . . . 1.14 109.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 42' ' ' MET . 10.6 m -96.26 142.62 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.781 -0.451 . . . . 1.12 109.781 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.98 135.05 55.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.128 0.489 . . . . 1.99 111.069 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.701 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 79.9 m-85 -125.58 144.24 50.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.94 110.442 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -131.22 117.74 19.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.151 -0.477 . . . . 0.92 110.541 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.6 t -91.67 161.66 14.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.972 0.415 . . . . 1.55 110.258 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.29 -1.94 9.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 1.99 110.663 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HG2' ' SG ' ' A' ' 34' ' ' CYS . 74.7 mmtt -74.53 -15.18 60.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.598 . . . . 2.23 110.434 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.83 1.25 63.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.915 -0.66 . . . . 0.75 112.069 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -106.57 123.69 48.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.948 0.404 . . . . 3.22 110.766 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 61.4 mtt180 -99.12 155.15 17.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 2.37 109.67 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 34.0 p90 -156.02 156.23 34.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 0.22 111.176 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.32 144.69 32.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.272 -0.876 . . . . 1.7 109.506 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.55 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.7 mtm -137.66 148.93 63.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.637 0.256 . . . . 1.31 110.878 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.71 125.8 4.41 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.608 2.205 . . . . 0.74 112.578 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -140.94 -177.11 4.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.64 . . . . 0.46 110.236 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 140.5 29.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.859 -0.609 . . . . 1.71 110.056 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.94 -6.21 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.557 0.694 . . . . 1.58 110.216 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.39 8.48 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 1.25 110.948 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.67 142.9 33.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.757 0.313 . . . . 1.22 110.88 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.42 92.68 1.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.569 -0.53 . . . . 2.59 109.569 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mm -58.46 115.9 13.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.618 -0.719 . . . . 1.12 110.519 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.9 Cg_exo -55.05 134.93 66.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.062 2.508 . . . . 0.68 112.48 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 21.8 Cg_exo -66.78 -5.15 12.55 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.457 2.771 . . . . 0.29 112.836 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.67 137.22 16.83 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.365 -0.606 . . . . 1.74 109.365 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.701 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -148.4 159.84 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.755 0.312 . . . . 2.04 110.87 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.09 135.12 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 0.67 110.995 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.1 t -84.7 112.04 20.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.758 -0.655 . . . . 0.31 110.861 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.37 -14.37 60.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 1.41 110.981 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.86 -59.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.346 -0.388 . . . . 1.17 111.705 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.2 t -112.11 -46.35 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.418 -0.513 . . . . 0.5 112.001 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.9 56.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.871 -1.157 . . . . 0.59 112.662 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -150.67 -173.09 4.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.914 0.357 . . . . 1.09 110.361 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.75 105.17 17.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.795 -0.446 . . . . 2.02 109.795 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 142.83 30.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.852 -0.613 . . . . 1.02 110.745 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.1 mt -90.72 136.44 33.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.276 0.56 . . . . 1.13 110.249 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 2.5 tm? -66.89 130.0 41.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.11 -0.95 . . . . 1.15 109.888 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.975 0.417 . . . . 1.59 110.859 179.774 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.812 0.339 . . . . 2.26 110.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -141.4 140.87 33.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.82 -0.437 . . . . 1.14 109.82 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 42' ' ' MET . 14.3 m -81.43 147.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.962 -0.384 . . . . 1.12 109.962 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 57.6 tt0 -121.05 121.44 37.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.246 0.546 . . . . 1.99 110.937 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 80.4 m-85 -112.61 141.18 46.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.564 -0.743 . . . . 0.94 110.075 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.97 118.74 28.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 0.92 110.503 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 28.3 p -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.899 0.38 . . . . 1.55 110.498 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 0.14 15.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 1.99 110.894 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.71 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 69.5 mmtt -75.9 -21.85 56.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.227 -0.657 . . . . 2.23 109.227 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.08 5.05 41.23 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.282 -0.872 . . . . 0.75 112.303 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -103.79 143.8 32.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 3.22 110.701 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 55.5 mtt180 -113.61 144.51 42.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.288 -0.414 . . . . 2.37 109.914 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.95 153.41 41.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.244 -0.435 . . . . 0.22 110.659 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 11.1 pt-20 -110.84 143.64 41.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 1.7 110.351 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.627 ' O ' HG21 ' A' ' 30' ' ' VAL . 63.1 mtm -137.37 151.63 71.73 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.227 -0.442 . . . . 1.31 109.82 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.75 122.86 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.039 1.826 . . . . 0.74 112.688 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CD1' HG22 ' A' ' 30' ' ' VAL . 11.3 m-85 -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.798 -0.637 . . . . 0.46 109.33 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 21.9 t -84.36 137.87 33.18 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.29 -0.633 . . . . 1.71 109.29 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 3.8 p -81.01 -5.75 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.285 0.564 . . . . 1.58 110.618 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.69 13.85 19.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.572 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 45' ' ' SER . . . -98.91 160.21 14.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 1.22 110.767 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.65 91.83 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.734 -0.839 . . . . 2.59 108.734 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.3 120.89 47.83 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 1.12 111.08 -172.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 56.1 Cg_exo -52.51 129.05 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.385 2.723 . . . . 0.68 112.215 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 22.9 Cg_exo -64.56 -17.28 59.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.154 2.569 . . . . 0.29 113.112 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.23 148.88 33.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.885 0.374 . . . . 1.74 110.353 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 32.4 t-105 -146.25 159.25 43.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.745 -0.835 . . . . 2.04 108.745 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.58 142.43 56.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.82 0.343 . . . . 0.67 110.194 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -77.79 109.04 11.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.31 110.645 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -14.4 60.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.854 -0.612 . . . . 1.41 111.315 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.54 -60.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.096 0.406 . . . . 1.17 112.096 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.522 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 43.6 t -125.15 -42.62 2.0 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.31 -0.556 . . . . 0.5 112.228 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.77 92.85 0.38 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.003 -1.094 . . . . 0.59 112.266 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -178.75 -177.7 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.847 -0.427 . . . . 1.09 109.847 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -98.0 123.19 41.89 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.63 -0.878 . . . . 2.02 108.63 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -102.33 129.21 48.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.138 -0.483 . . . . 1.02 110.819 -176.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.52 136.61 33.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.991 -0.549 . . . . 1.13 110.141 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 31' ' ' GLU . 3.3 tm? -78.98 131.77 36.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.512 -0.767 . . . . 1.15 109.123 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.95 145.39 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.496 -0.32 . . . . 1.59 110.27 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' CG ' ' HG2' ' A' ' 75' ' ' LYS . 67.7 m-20 65.11 30.43 11.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.932 -0.576 . . . . 1.96 112.078 175.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.91 61.13 4.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.035 -0.602 . . . . 1.47 113.021 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.437 0.637 . . . . 3.25 110.301 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.17 -78.85 0.18 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.501 -1.04 . . . . 1.27 110.501 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.55 145.61 95.39 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.322 2.014 . . . . 1.52 111.302 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 40.8 mt-10 -46.47 -60.65 2.22 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.699 0.624 . . . . 1.92 112.654 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 30.9 tt0 -106.69 35.82 2.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 1.65 109.904 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -59.14 -56.33 23.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 2.92 109.675 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HG2' ' CG ' ' A' ' 67' ' ' ASP . 61.9 mttm . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.128 0.892 . . . . 5.47 111.415 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.018 0.437 . . . . 2.26 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.7 142.76 32.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.233 -0.439 . . . . 1.14 109.903 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 42' ' ' MET . 3.2 m -87.86 144.65 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.167 -0.679 . . . . 1.12 109.167 176.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 37.8 tt0 -119.59 128.09 53.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.312 0.577 . . . . 1.99 110.673 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 61.1 m-85 -113.83 139.26 49.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.436 -0.802 . . . . 0.94 109.844 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 119.54 35.48 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.315 -0.254 . . . . 0.92 110.315 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 21.1 p -80.51 172.07 14.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.462 . . . . 1.55 111.967 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 41.6 mt-10 -64.81 -21.41 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.705 . . . . 1.99 110.994 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.15 0.03 54.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 2.23 111.037 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.31 31.1 43.1 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.862 -0.685 . . . . 0.75 112.589 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -113.42 127.46 56.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 3.22 109.545 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 49.5 mtt180 -99.51 141.34 32.43 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.661 -0.496 . . . . 2.37 109.661 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -142.51 153.4 43.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.868 -0.605 . . . . 0.22 110.385 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.83 135.81 41.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 1.7 110.057 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.541 ' O ' HG22 ' A' ' 30' ' ' VAL . 65.4 mmm -125.73 146.64 55.73 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.714 -0.675 . . . . 1.31 110.188 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.57 122.46 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.036 1.824 . . . . 0.74 112.775 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -143.25 -177.42 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.656 -0.702 . . . . 0.46 109.276 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.484 ' HB3' ' CB ' ' A' ' 48' ' ' ALA . 24.0 t -93.2 143.21 26.48 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.654 -0.498 . . . . 1.71 109.654 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 4.4 p -79.24 -1.28 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.937 -0.574 . . . . 1.58 110.751 -178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -127.17 21.11 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.766 -0.652 . . . . 1.25 110.761 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 45' ' ' SER . . . -109.77 172.02 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 1.22 110.078 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 33.8 tt0 -76.05 118.23 18.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 2.59 109.181 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.412 HG23 ' HG ' ' A' ' 65' ' ' LEU . 23.8 mm -89.79 106.03 12.91 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.164 -0.68 . . . . 1.12 109.164 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 49' ' ' GLU . 63.9 Cg_exo -51.99 124.95 15.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.232 2.621 . . . . 0.68 112.449 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.3 20.76 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.634 2.889 . . . . 0.29 113.429 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.65 152.86 38.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.74 110.551 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 34.7 t-105 -149.05 160.72 43.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.949 -0.759 . . . . 2.04 108.949 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -75.89 143.68 41.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.4 . . . . 0.67 110.412 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.4 t -83.58 97.76 9.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.307 0.575 . . . . 0.31 110.357 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 9.8 mmpt? -77.07 11.0 1.99 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.347 -0.842 . . . . 1.41 111.694 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.85 -60.71 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.623 0.249 . . . . 1.17 111.102 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t -108.9 -45.76 3.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.913 -0.315 . . . . 0.5 111.282 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.72 55.67 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.445 -0.883 . . . . 0.59 112.156 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -149.29 -167.21 2.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.985 -0.376 . . . . 1.09 109.985 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 tt0 -99.55 148.4 24.33 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.493 -0.558 . . . . 2.02 109.493 171.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -124.86 147.43 48.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.966 0.412 . . . . 1.02 111.293 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.0 mt -104.0 137.03 42.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 1.13 109.976 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.4 tm? -73.18 132.08 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.513 -0.767 . . . . 1.15 109.629 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 66' ' ' VAL . 33.9 m -112.15 110.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 1.59 110.91 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 63.66 83.55 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.327 -0.851 . . . . 1.96 112.363 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.44 -92.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 1.47 112.386 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 69.71 -60.76 0.46 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.423 0.689 . . . . 3.25 111.668 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -129.81 -72.72 0.13 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.086 -0.578 . . . . 1.27 111.691 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.16 127.8 11.61 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.181 1.92 . . . . 1.52 111.536 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 34.0 mt-10 -56.72 -49.93 73.72 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.221 -0.899 . . . . 1.92 111.593 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -136.42 78.8 1.73 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.402 -0.817 . . . . 1.65 109.659 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -149.99 -36.7 0.15 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.198 -0.455 . . . . 2.92 110.71 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.802 -0.618 . . . . 5.47 110.403 -176.592 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.593 0.235 . . . . 2.26 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -142.24 136.86 30.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.3 -0.259 . . . . 1.14 110.3 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 42' ' ' MET . 15.2 m -80.0 154.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.18 -0.304 . . . . 1.12 110.18 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 6.7 tp10 -116.37 135.87 53.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 1.99 110.724 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' HE3' ' A' ' 42' ' ' MET . 64.4 m-85 -129.77 136.4 49.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.384 -0.371 . . . . 0.94 110.028 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.38 121.98 35.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.272 -0.422 . . . . 0.92 110.505 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.3 p -86.58 159.77 19.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.091 0.472 . . . . 1.55 110.219 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.86 4.74 5.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 1.99 110.515 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mmmt -91.71 -16.9 26.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 2.23 109.437 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.11 -3.66 22.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.672 -0.775 . . . . 0.75 113.711 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -100.54 143.33 30.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.408 0.604 . . . . 3.22 111.974 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -113.31 148.25 36.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.402 -0.817 . . . . 2.37 108.977 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.82 152.26 30.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.945 0.402 . . . . 0.22 111.011 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.42 138.14 45.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.818 -0.628 . . . . 1.7 110.158 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.652 ' HE1' ' CD1' ' A' ' 54' ' ' TRP . 37.5 mtm -130.7 152.64 80.83 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.601 -0.272 . . . . 1.31 110.572 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.52 122.91 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.198 1.932 . . . . 0.74 113.069 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.54 -175.89 4.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.261 -0.881 . . . . 0.46 109.368 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB3' ' HB1' ' A' ' 48' ' ' ALA . 33.9 t -86.95 144.05 27.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.41 -0.589 . . . . 1.71 109.41 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 6.8 p -80.72 2.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.494 0.664 . . . . 1.58 110.426 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.8 5.89 7.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.101 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 45' ' ' SER . . . -97.03 147.33 24.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.805 0.336 . . . . 1.22 110.959 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.73 89.5 1.35 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.386 0.612 . . . . 2.59 109.814 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' A' ' 68' ' ' GLY . 28.2 mm -58.65 124.26 71.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.182 -0.917 . . . . 1.12 110.691 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.58 129.64 36.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.056 2.504 . . . . 0.68 112.295 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.68 -16.28 36.1 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.509 2.806 . . . . 0.29 113.626 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 151.04 36.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.995 -0.372 . . . . 1.74 109.995 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.652 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 34.7 t-105 -146.52 159.66 43.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.31 -0.626 . . . . 2.04 109.31 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 139.3 57.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.962 0.41 . . . . 0.67 110.653 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.8 t -79.04 110.07 13.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.006 0.431 . . . . 0.31 111.098 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 1.1 mpmm? -76.68 -5.94 50.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 1.41 111.642 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -83.82 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.09 -0.244 . . . . 1.17 111.638 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.27 -44.45 2.58 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.589 -0.444 . . . . 0.5 112.081 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.12 75.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.252 -0.975 . . . . 0.59 112.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -165.85 -168.69 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.409 -0.589 . . . . 1.09 109.409 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -98.39 133.43 42.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 2.02 109.903 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -110.66 132.82 53.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 1.02 110.426 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.74 137.5 32.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.234 -0.439 . . . . 1.13 110.164 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.7 tm? -71.23 121.9 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 1.15 110.018 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 77.8 t -105.31 109.23 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.694 -0.685 . . . . 1.59 109.892 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.07 102.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.383 -0.826 . . . . 1.96 112.053 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 175.99 62.56 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.317 -0.856 . . . . 1.47 111.374 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.03 4.68 44.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.246 0.546 . . . . 3.25 110.176 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 48' ' ' ALA . . . 160.55 -74.09 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.031 -0.828 . . . . 1.27 111.031 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.93 128.83 16.42 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.329 2.02 . . . . 1.52 112.163 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 35.1 mt-10 -70.02 136.25 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 1.92 110.31 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 49.4 tt0 59.11 43.14 17.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.934 0.873 . . . . 1.65 110.467 175.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -74.51 -50.89 16.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.295 -0.866 . . . . 2.92 109.067 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 73' ' ' GLU . 61.4 mttm . . . . . 0 C--O 1.249 1.069 0 CA-C-N 114.614 -1.175 . . . . 5.47 111.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.75 0.31 . . . . 2.26 110.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.56 143.8 32.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.325 -0.398 . . . . 1.14 109.979 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 42' ' ' MET . 22.0 m -88.89 153.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 110.154 -0.313 . . . . 1.12 110.154 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' O ' HD22 ' A' ' 65' ' ' LEU . 37.5 mt-10 -114.68 120.11 39.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.425 -0.352 . . . . 1.99 111.207 -173.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.5 m-85 -112.94 141.05 47.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.474 -0.33 . . . . 0.94 110.488 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 126.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.92 110.446 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.719 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 19.5 p -89.39 -177.05 5.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.55 111.41 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.64 -14.18 62.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.668 . . . . 1.99 112.438 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.719 ' HE3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -87.64 -25.51 23.5 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.43 0.633 . . . . 2.23 110.3 176.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.39 5.35 40.01 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.283 -0.872 . . . . 0.75 111.331 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 39.0 m80 -68.39 102.24 1.38 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.746 -0.464 . . . . 3.22 109.746 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mtt180 -98.22 141.95 30.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.034 -0.53 . . . . 2.37 110.491 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -151.0 153.4 35.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.603 -0.726 . . . . 0.22 110.486 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.0 mt-10 -104.58 138.64 40.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 1.7 110.097 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.578 ' O ' HG21 ' A' ' 30' ' ' VAL . 42.8 mtm -135.25 146.16 56.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.773 -0.454 . . . . 1.31 109.773 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.91 121.83 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.029 1.819 . . . . 0.74 113.314 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.16 -175.87 3.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.221 -0.9 . . . . 0.46 108.945 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 29.0 t -81.0 135.77 35.9 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.3 -0.63 . . . . 1.71 109.3 171.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.58 -4.15 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.43 0.633 . . . . 1.58 110.579 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.6 19.96 11.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 1.25 110.402 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -108.32 161.23 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.075 0.464 . . . . 1.22 111.075 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.79 88.66 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 2.59 109.533 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.8 121.27 52.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.588 -0.733 . . . . 1.12 110.909 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.47 127.38 25.21 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.939 2.426 . . . . 0.68 111.802 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.9 -8.99 6.78 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.757 2.972 . . . . 0.29 114.314 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.48 148.22 27.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.711 0.291 . . . . 1.74 110.731 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.484 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 23.5 t-105 -151.7 158.18 43.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.716 -0.846 . . . . 2.04 108.716 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.24 142.71 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.117 0.484 . . . . 0.67 111.183 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 t -79.59 103.83 9.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.717 -0.674 . . . . 0.31 111.127 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 7.94 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 1.41 111.636 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.83 -59.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.114 0.413 . . . . 1.17 112.114 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -110.42 -45.28 3.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.203 0.446 . . . . 0.5 112.203 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.64 68.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.096 -1.05 . . . . 0.59 112.18 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -172.99 -166.04 0.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.139 -0.689 . . . . 1.09 109.139 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -99.43 146.77 25.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.66 -0.416 . . . . 2.02 109.987 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -119.62 148.33 43.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 1.02 110.306 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -102.88 140.55 37.01 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.044 0.45 . . . . 1.13 110.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.3 tm? -74.17 112.61 10.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.418 -0.81 . . . . 1.15 109.059 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -100.61 114.99 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.301 0.572 . . . . 1.59 112.041 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 75' ' ' LYS . 12.6 m-20 56.01 51.33 12.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.908 -1.042 . . . . 1.96 111.769 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.64 67.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.04 -0.824 . . . . 1.47 111.04 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.58 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 28.5 t70 -81.04 61.77 4.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.247 0.546 . . . . 3.25 110.456 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.13 -95.24 1.08 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.715 -0.675 . . . . 1.27 112.448 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 69' ' ' ASP . 10.3 Cg_endo -54.23 126.59 22.65 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.941 2.427 . . . . 1.52 112.95 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HG2' ' CG1' ' A' ' 30' ' ' VAL . 39.9 mt-10 -68.69 151.42 46.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.295 -0.866 . . . . 1.92 110.826 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 56.54 62.38 2.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.339 0.59 . . . . 1.65 110.743 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -136.36 -54.74 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.876 -0.602 . . . . 2.92 110.675 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 66.5 tttm . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.059 -0.972 . . . . 5.47 110.033 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' HA ' ' HB2' ' A' ' 73' ' ' GLU . 26.1 mt-30 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.063 -0.347 . . . . 2.26 110.063 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.18 141.41 32.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.293 -0.412 . . . . 1.14 111.02 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 42' ' ' MET . 19.6 m -96.65 141.63 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.295 -0.632 . . . . 1.12 109.295 172.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' HD23 ' A' ' 65' ' ' LEU . 34.8 tt0 -119.23 126.58 51.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.365 0.602 . . . . 1.99 111.15 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 94.4 m-85 -115.52 136.66 52.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.387 -0.824 . . . . 0.94 109.821 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.31 117.44 23.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.942 0.401 . . . . 0.92 110.755 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.529 ' SG ' ' HB1' ' A' ' 61' ' ' ALA . 15.8 t -82.93 156.24 23.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.55 109.702 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.22 -3.32 19.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.783 -0.644 . . . . 1.99 110.875 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -75.82 -21.27 57.47 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.373 -0.602 . . . . 2.23 109.373 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.36 -16.42 17.27 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.75 112.358 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -73.92 128.01 34.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 3.22 111.762 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -110.8 153.07 25.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.144 -0.688 . . . . 2.37 109.144 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 32.3 p90 -161.59 153.3 19.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.522 -0.308 . . . . 0.22 110.576 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 pt-20 -112.19 142.56 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.966 -0.561 . . . . 1.7 110.527 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.595 ' HE3' ' CD1' ' A' ' 54' ' ' TRP . 68.5 mtm -133.72 155.08 80.76 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.157 -0.474 . . . . 1.31 110.611 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.0 122.98 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.376 2.051 . . . . 0.74 112.941 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -142.3 -176.87 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.252 -0.885 . . . . 0.46 109.106 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 26.0 t -94.36 140.41 29.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.113 0.482 . . . . 1.71 110.04 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.402 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 4.9 p -76.24 -12.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.873 -0.603 . . . . 1.58 110.582 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.88 9.68 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 1.25 110.406 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' SER . . . -94.82 161.81 14.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 1.22 110.595 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.61 84.15 6.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.29 -0.633 . . . . 2.59 109.29 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.642 HG12 ' O ' ' A' ' 70' ' ' GLY . 32.7 mm -57.75 117.29 18.1 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.514 -0.766 . . . . 1.12 110.697 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.5 132.59 40.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.544 2.829 . . . . 0.68 112.742 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.63 -18.73 56.71 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.334 2.689 . . . . 0.29 112.861 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 150.29 42.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.195 -0.298 . . . . 1.74 110.195 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 42' ' ' MET . 31.7 t-105 -149.86 155.4 39.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 2.04 109.377 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.65 140.69 58.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.087 0.47 . . . . 0.67 110.555 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 15.4 t -80.54 110.46 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.584 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.32 -2.98 30.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.681 -0.69 . . . . 1.41 111.329 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 -60.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.113 0.412 . . . . 1.17 112.113 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.0 t -105.6 -47.35 3.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.236 -0.586 . . . . 0.5 112.411 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 55.52 0.08 OUTLIER Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.942 -1.123 . . . . 0.59 112.596 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.529 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -154.33 -170.94 3.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.314 -0.625 . . . . 1.09 109.314 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -98.35 122.61 41.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 2.02 109.842 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -98.68 139.58 34.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 1.02 110.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.73 135.44 34.1 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.885 0.374 . . . . 1.13 110.163 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -68.99 117.37 10.56 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.913 -0.773 . . . . 1.15 108.913 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.47 111.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.215 0.531 . . . . 1.59 111.591 -174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 5.5 m-20 67.97 90.11 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.159 -0.928 . . . . 1.96 111.928 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -82.88 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.124 -0.944 . . . . 1.47 111.209 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 48.24 44.07 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.864 0.84 . . . . 3.25 110.21 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.642 ' O ' HG12 ' A' ' 50' ' ' ILE . . . 153.61 -112.85 0.55 Allowed Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.006 -0.997 . . . . 1.27 110.988 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.09 124.47 11.39 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.086 1.858 . . . . 1.52 112.11 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 74' ' ' LYS . 15.9 pt-20 -72.12 157.88 36.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.962 -0.563 . . . . 1.92 110.015 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 28' ' ' GLN . 7.2 tp10 72.13 -41.03 0.49 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.747 0.654 . . . . 1.65 111.728 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 72' ' ' GLU . 39.2 ttmt -59.87 -43.41 94.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.146 -0.479 . . . . 2.92 111.088 -177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 67' ' ' ASP . 99.3 mttt . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.596 0.56 . . . . 5.47 111.132 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 52.8 mt-30 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.579 0.228 . . . . 2.26 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.74 137.17 29.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.338 -0.245 . . . . 1.14 110.338 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 42' ' ' MET . 10.7 m -91.09 147.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.726 -0.472 . . . . 1.12 109.726 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' HD21 ' A' ' 65' ' ' LEU . 46.8 mt-10 -118.27 124.04 46.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.051 0.453 . . . . 1.99 111.36 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' CZ ' HD23 ' A' ' 65' ' ' LEU . 82.7 m-85 -113.06 138.13 50.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.94 110.039 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.67 121.21 37.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 0.92 110.191 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.1 p -83.24 166.23 18.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.085 -0.507 . . . . 1.55 110.888 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.63 3.03 10.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.471 -0.786 . . . . 1.99 110.595 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -99.28 -0.29 41.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.274 -0.421 . . . . 2.23 110.461 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.98 9.04 58.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.927 -0.654 . . . . 0.75 113.464 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -111.36 156.26 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.351 0.576 . . . . 3.22 110.764 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -122.9 147.82 46.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.879 -0.786 . . . . 2.37 108.879 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -146.86 153.99 40.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 0.22 111.178 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.33 138.17 47.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.55 -0.75 . . . . 1.7 110.371 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.642 ' O ' HG22 ' A' ' 30' ' ' VAL . 62.9 mtm -136.91 147.82 60.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.85 -0.426 . . . . 1.31 109.85 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.69 123.27 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.049 1.833 . . . . 0.74 112.746 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CD1' HG23 ' A' ' 30' ' ' VAL . 13.2 m-85 -125.28 -175.74 3.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.913 -0.773 . . . . 0.46 108.913 173.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.438 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 7.4 m -88.08 132.16 34.4 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.447 -0.575 . . . . 1.71 109.447 171.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.462 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 2.7 p -76.41 -12.06 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.429 0.633 . . . . 1.58 110.225 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.5 6.31 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.809 . . . . 1.25 110.357 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 45' ' ' SER . . . -102.23 160.37 14.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.907 -0.588 . . . . 1.22 110.777 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -77.45 95.67 4.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.845 -0.798 . . . . 2.59 108.845 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.77 117.72 23.15 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.41 -0.359 . . . . 1.12 110.763 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 54.4 Cg_exo -51.85 125.33 16.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.161 2.574 . . . . 0.68 112.179 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -62.3 -12.14 25.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.378 2.719 . . . . 0.29 113.217 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.58 143.51 16.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.451 -0.341 . . . . 1.74 110.418 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 30.6 t-105 -142.79 159.01 43.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.561 -0.903 . . . . 2.04 108.561 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.79 144.81 55.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.99 0.424 . . . . 0.67 110.656 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.6 t -83.17 107.84 16.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.09 -0.505 . . . . 0.31 110.794 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -4.37 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.957 -0.565 . . . . 1.41 111.249 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.46 -60.43 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 111.896 0.332 . . . . 1.17 111.896 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 53.1 t -108.51 -44.64 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.608 -0.437 . . . . 0.5 112.162 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 55.21 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.131 -1.033 . . . . 0.59 111.785 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.8 -165.46 2.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.282 -0.636 . . . . 1.09 109.282 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -99.71 149.56 23.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.485 -0.561 . . . . 2.02 109.485 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -123.99 147.0 48.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.994 0.426 . . . . 1.02 110.677 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.83 139.26 35.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.078 -0.51 . . . . 1.13 110.244 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -75.94 123.81 26.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 1.15 109.111 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.05 110.62 28.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 1.59 111.321 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 64.06 80.9 0.22 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.224 -0.898 . . . . 1.96 112.114 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.524 ' O ' ' HD2' ' A' ' 71' ' ' PRO . . . -140.88 -106.39 0.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 1.47 112.391 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.12 26.17 12.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.942 0.401 . . . . 3.25 111.199 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.51 -66.61 0.44 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.501 -0.856 . . . . 1.27 112.728 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 74.0 Cg_endo -76.12 147.06 29.45 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.412 2.075 . . . . 1.52 111.833 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 44.2 mt-10 -88.41 -57.15 3.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.678 -0.692 . . . . 1.92 110.897 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -115.87 18.98 15.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.272 -0.877 . . . . 1.65 110.961 -166.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -79.81 -45.59 18.48 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.614 . . . . 2.92 109.704 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.0 tttp . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.953 -1.023 . . . . 5.47 111.274 -179.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 109.75 -0.463 . . . . 2.26 109.75 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.91 157.82 44.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 1.14 111.011 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 42' ' ' MET . 11.5 m -102.69 157.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.709 -0.478 . . . . 1.12 109.709 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' O ' HD22 ' A' ' 65' ' ' LEU . 45.2 mt-10 -131.47 127.71 37.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.729 0.3 . . . . 1.99 111.218 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.98 144.08 46.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.454 -0.339 . . . . 0.94 110.438 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.97 127.6 43.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.92 110.449 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 30.9 p -90.34 168.32 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 1.55 110.978 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.97 -6.08 39.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.634 -0.712 . . . . 1.99 110.882 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 72.1 mmtt -84.57 -13.41 51.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 2.23 110.284 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.71 13.71 46.19 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.704 -0.68 . . . . 0.75 112.583 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -105.38 145.77 30.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 3.22 110.328 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -120.15 142.95 48.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.578 -0.527 . . . . 2.37 109.578 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -149.79 154.19 38.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.973 0.416 . . . . 0.22 111.271 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.22 143.24 42.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.668 -0.696 . . . . 1.7 109.955 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.621 ' HE2' ' CD1' ' A' ' 54' ' ' TRP . 64.2 mtm -136.41 150.28 70.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.445 -0.343 . . . . 1.31 110.078 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.247 1.965 . . . . 0.74 113.006 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CD2' HG21 ' A' ' 30' ' ' VAL . 33.7 m-85 -141.69 -177.09 5.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.623 -0.717 . . . . 0.46 109.604 177.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.5 t -104.17 144.55 31.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.232 0.539 . . . . 1.71 110.334 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 4.3 p -76.81 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 1.58 109.645 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.42 22.54 15.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.067 -0.97 . . . . 1.25 110.034 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.51 146.07 45.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.005 -0.543 . . . . 1.22 110.308 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.02 85.09 2.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.94 -0.763 . . . . 2.59 108.94 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.0 mm -58.68 117.43 20.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 1.12 110.45 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.72 130.37 38.64 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.066 2.511 . . . . 0.68 112.291 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.23 -11.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.151 2.567 . . . . 0.29 112.929 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.08 137.4 14.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.531 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CD1' ' HE2' ' A' ' 42' ' ' MET . 33.8 t-105 -137.21 158.74 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.939 -0.763 . . . . 2.04 108.939 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.25 141.04 56.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.924 0.393 . . . . 0.67 110.606 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.97 109.26 16.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.425 . . . . 0.31 110.842 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -14.05 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.792 -0.64 . . . . 1.41 111.403 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.03 -60.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.016 0.376 . . . . 1.17 112.016 -171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.513 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 42.5 t -110.91 -44.46 3.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.507 -0.477 . . . . 0.5 111.79 -172.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.67 55.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.215 -0.993 . . . . 0.59 112.239 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.02 -162.9 1.61 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.986 -0.375 . . . . 1.09 109.986 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -98.62 142.47 30.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.42 -0.585 . . . . 2.02 109.42 170.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -117.2 138.97 51.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.939 0.4 . . . . 1.02 110.568 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.08 134.28 35.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.131 -0.486 . . . . 1.13 110.192 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.4 tm? -68.69 118.59 11.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.667 -0.864 . . . . 1.15 108.667 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -107.17 118.75 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.252 0.549 . . . . 1.59 111.698 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.423 ' OD2' ' HE2' ' A' ' 75' ' ' LYS . 6.2 m-20 57.19 61.09 2.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.023 -0.989 . . . . 1.96 112.31 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 65' ' ' LEU . . . -143.73 64.57 0.47 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.835 -0.906 . . . . 1.47 110.835 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -66.94 85.28 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.221 0.534 . . . . 3.25 110.353 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.44 -110.28 3.04 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.291 -0.868 . . . . 1.27 112.332 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.74 137.71 67.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.674 2.249 . . . . 1.52 112.028 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 46' ' ' VAL . 18.1 pt-20 -67.74 151.41 47.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.136 -0.484 . . . . 1.92 110.027 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 65.74 15.89 10.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.134 0.492 . . . . 1.65 110.851 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -90.79 -56.4 3.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 2.92 110.472 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HE2' ' OD2' ' A' ' 67' ' ' ASP . 62.8 tttm . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.047 -0.978 . . . . 5.47 110.264 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.726 0.298 . . . . 2.26 110.431 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -141.7 140.27 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 1.14 110.545 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 42' ' ' MET . 12.1 m -86.39 148.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.145 -0.687 . . . . 1.12 109.145 175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 34.8 tt0 -118.68 130.53 55.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.376 0.608 . . . . 1.99 111.431 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 76.5 m-85 -118.76 141.28 48.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.94 109.94 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.426 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -127.64 113.57 16.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 0.92 110.586 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.65 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.7 t -85.44 164.02 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.082 -0.508 . . . . 1.55 110.235 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.8 -11.66 56.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.213 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -72.38 -6.66 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 2.23 110.946 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.15 78.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.869 -0.682 . . . . 0.75 112.111 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -105.98 129.99 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.903 0.382 . . . . 3.22 110.661 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 62.1 mtt180 -105.91 153.23 22.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 2.37 109.803 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -154.91 153.04 30.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.936 0.398 . . . . 0.22 110.571 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.4 pt-20 -105.49 139.61 39.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.704 -0.68 . . . . 1.7 110.332 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.682 ' HE2' ' CD1' ' A' ' 54' ' ' TRP . 60.3 mtm -131.68 151.57 78.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.268 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.82 122.68 4.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.74 112.894 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CD1' HG21 ' A' ' 30' ' ' VAL . 16.2 m-85 -131.76 -176.78 4.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.231 -0.895 . . . . 0.46 108.862 172.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 15.0 m -87.07 137.52 32.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.723 -0.473 . . . . 1.71 109.723 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 3.2 p -73.98 -7.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.131 -0.486 . . . . 1.58 111.681 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.42 20.49 9.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.25 111.052 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 45' ' ' SER . . . -102.05 160.21 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 1.22 110.462 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.56 106.53 9.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.077 -0.712 . . . . 2.59 109.077 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mm -76.02 117.56 64.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.085 -0.339 . . . . 1.12 110.085 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.71 127.94 28.26 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.159 2.573 . . . . 0.68 112.614 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.78 -14.22 30.8 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.467 2.778 . . . . 0.29 113.217 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.56 140.95 25.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.116 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.682 ' CD1' ' HE2' ' A' ' 42' ' ' MET . 28.1 t-105 -147.76 159.16 44.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 2.04 109.363 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.68 142.4 58.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.67 110.996 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.7 t -83.53 112.4 19.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.31 110.944 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.15 -12.45 60.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 1.41 111.294 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.3 -59.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.184 0.439 . . . . 1.17 112.184 -172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.5 t -114.17 -45.48 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.5 112.266 -173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 68.62 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.163 -1.017 . . . . 0.59 111.696 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.65 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -163.52 -170.58 2.27 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.635 -0.505 . . . . 1.09 109.635 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -99.57 117.37 33.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.009 -0.367 . . . . 2.02 110.009 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -92.85 141.15 28.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.245 -0.434 . . . . 1.02 110.336 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.2 136.63 38.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.009 0.433 . . . . 1.13 110.268 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 3.3 tm? -69.93 120.01 15.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.375 -0.829 . . . . 1.15 109.543 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.59 139.31 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.376 -0.375 . . . . 1.59 111.303 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 6.2 m-20 51.74 48.29 23.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.593 -0.73 . . . . 1.96 112.332 176.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.62 -178.82 19.73 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.564 -0.827 . . . . 1.47 111.966 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -168.19 -61.04 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.305 -0.998 . . . . 3.25 108.305 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.07 -68.24 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.058 -0.974 . . . . 1.27 112.126 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 18.5 Cg_endo -60.16 123.64 13.59 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.046 1.831 . . . . 1.52 111.729 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 36.5 mt-10 -64.39 134.46 54.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 1.92 110.276 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 27.7 tt0 67.27 22.81 9.52 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.604 0.565 . . . . 1.65 111.433 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.35 -36.03 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.3 0.572 . . . . 2.92 109.869 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 32.1 mmmt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.417 -0.802 . . . . 5.47 109.331 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.529 0.681 . . . . 2.26 110.234 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.71 135.08 27.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 1.14 110.748 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 42' ' ' MET . 13.1 m -81.34 140.75 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.539 -0.541 . . . . 1.12 109.539 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -117.16 130.26 56.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 1.99 111.347 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 93.1 m-85 -116.61 142.1 47.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.757 -0.656 . . . . 0.94 109.793 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.4 122.47 42.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.8 0.333 . . . . 0.92 110.587 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 31.5 p -83.53 170.64 14.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 1.55 111.142 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.09 -5.71 43.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.743 -0.662 . . . . 1.99 110.808 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 66.0 mmtt -86.41 -13.4 46.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 2.23 110.117 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.85 34.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.98 -0.629 . . . . 0.75 112.463 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -113.17 131.6 55.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.919 0.39 . . . . 3.22 110.078 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -105.51 145.39 30.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 2.37 109.808 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.28 153.13 43.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.735 0.302 . . . . 0.22 110.937 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 13.1 pt-20 -106.43 144.26 33.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.188 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.541 ' HE1' ' CD1' ' A' ' 54' ' ' TRP . 52.8 mtm -139.38 148.52 57.0 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.342 -0.39 . . . . 1.31 110.059 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.5 122.24 6.85 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.441 2.094 . . . . 0.74 112.943 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -137.35 -176.19 4.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.359 -0.837 . . . . 0.46 109.025 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.27 146.77 23.46 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.392 -0.595 . . . . 1.71 109.392 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.28 -6.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 1.58 110.621 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.47 20.35 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 1.25 110.057 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.479 ' O ' ' HA2' ' A' ' 70' ' ' GLY . . . -108.67 152.43 24.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.849 -0.614 . . . . 1.22 109.933 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -75.02 88.71 2.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.427 -0.583 . . . . 2.59 109.427 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.2 mm -58.81 116.08 14.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 1.12 110.725 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.8 131.42 41.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.42 2.747 . . . . 0.68 112.637 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.43 -22.44 74.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.491 2.794 . . . . 0.29 113.166 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.78 152.12 39.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.35 . . . . 1.74 110.16 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.541 ' CD1' ' HE1' ' A' ' 42' ' ' MET . 30.4 t-105 -149.51 159.24 44.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.394 -0.595 . . . . 2.04 109.394 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.37 143.79 56.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.67 110.656 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.52 109.2 14.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.31 110.748 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.06 -10.16 59.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 1.41 111.251 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.03 -60.27 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.127 0.417 . . . . 1.17 112.127 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.6 t -112.47 -46.49 3.16 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.464 -0.495 . . . . 0.5 111.634 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 76.82 0.11 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.117 -1.039 . . . . 0.59 112.315 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -171.61 -167.42 0.51 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 1.09 109.347 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -98.56 140.34 32.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.142 -0.688 . . . . 2.02 109.142 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -118.71 147.98 43.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.391 -0.368 . . . . 1.02 110.551 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.8 mt -99.57 136.63 39.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.107 -0.497 . . . . 1.13 110.25 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 3.0 tm? -70.65 123.28 21.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.553 -0.749 . . . . 1.15 109.872 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.09 110.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 1.59 110.638 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 66.64 93.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.522 -0.763 . . . . 1.96 111.581 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.473 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -174.5 -112.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.669 . . . . 1.47 112.366 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 55.57 39.41 30.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.565 0.698 . . . . 3.25 110.659 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 48' ' ' ALA . . . 147.73 -83.85 0.18 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.596 -0.729 . . . . 1.27 111.705 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.02 138.37 18.28 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.371 2.047 . . . . 1.52 111.209 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.0 -47.82 41.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.842 -0.617 . . . . 1.92 111.311 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -137.33 33.03 2.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.635 -0.711 . . . . 1.65 110.655 -168.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -100.96 -13.16 18.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.51 0.672 . . . . 2.92 110.161 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.541 -0.754 . . . . 5.47 109.799 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.583 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 26.0 mt-30 . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.951 0.405 . . . . 2.26 110.853 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.64 141.44 31.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 1.14 109.957 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 42' ' ' MET . 10.6 m -96.26 142.62 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.781 -0.451 . . . . 1.12 109.781 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.98 135.05 55.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.128 0.489 . . . . 1.99 111.069 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.701 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 79.9 m-85 -125.58 144.24 50.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.94 110.442 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -131.22 117.74 19.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.151 -0.477 . . . . 0.92 110.541 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.6 t -91.67 161.66 14.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.972 0.415 . . . . 1.55 110.258 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.29 -1.94 9.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 1.99 110.663 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HG2' ' SG ' ' A' ' 34' ' ' CYS . 74.7 mmtt -74.53 -15.18 60.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.598 . . . . 2.23 110.434 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.83 1.25 63.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.915 -0.66 . . . . 0.75 112.069 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -106.57 123.69 48.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.948 0.404 . . . . 3.22 110.766 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 61.4 mtt180 -99.12 155.15 17.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 2.37 109.67 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 34.0 p90 -156.02 156.23 34.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 0.22 111.176 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.32 144.69 32.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.272 -0.876 . . . . 1.7 109.506 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.55 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.7 mtm -137.66 148.93 63.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.637 0.256 . . . . 1.31 110.878 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.71 125.8 4.41 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.608 2.205 . . . . 0.74 112.578 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -140.94 -177.11 4.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.64 . . . . 0.46 110.236 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -89.06 140.5 29.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.859 -0.609 . . . . 1.71 110.056 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 6.2 p -78.94 -6.21 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.557 0.694 . . . . 1.58 110.216 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.39 8.48 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 1.25 110.948 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.67 142.9 33.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.757 0.313 . . . . 1.22 110.88 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.42 92.68 1.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.569 -0.53 . . . . 2.59 109.569 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mm -58.46 115.9 13.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.618 -0.719 . . . . 1.12 110.519 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.9 Cg_exo -55.05 134.93 66.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.062 2.508 . . . . 0.68 112.48 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 21.8 Cg_exo -66.78 -5.15 12.55 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.457 2.771 . . . . 0.29 112.836 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.67 137.22 16.83 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.365 -0.606 . . . . 1.74 109.365 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.701 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -148.4 159.84 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.755 0.312 . . . . 2.04 110.87 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.09 135.12 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 0.67 110.995 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.1 t -84.7 112.04 20.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.758 -0.655 . . . . 0.31 110.861 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.37 -14.37 60.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 1.41 110.981 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.86 -59.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.346 -0.388 . . . . 1.17 111.705 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.2 t -112.11 -46.35 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.418 -0.513 . . . . 0.5 112.001 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.9 56.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.871 -1.157 . . . . 0.59 112.662 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -150.67 -173.09 4.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.914 0.357 . . . . 1.09 110.361 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.75 105.17 17.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.795 -0.446 . . . . 2.02 109.795 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 142.83 30.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.852 -0.613 . . . . 1.02 110.745 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.1 mt -90.72 136.44 33.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.276 0.56 . . . . 1.13 110.249 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.472 HD11 ' CA ' ' A' ' 68' ' ' GLY . 2.5 tm? -66.89 130.0 41.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.11 -0.95 . . . . 1.15 109.888 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.3 113.23 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.975 0.417 . . . . 1.59 110.859 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 63.2 73.41 0.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.457 -0.792 . . . . 1.96 111.422 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.472 ' CA ' HD11 ' A' ' 65' ' ' LEU . . . -157.69 -103.52 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.679 -0.691 . . . . 1.47 111.52 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 71.54 -41.65 0.51 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.697 0.799 . . . . 3.25 111.894 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 68' ' ' GLY . . . -142.56 -67.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.488 -0.645 . . . . 1.27 111.488 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.24 152.9 45.41 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.218 1.945 . . . . 1.52 112.466 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.583 ' OE2' ' HB3' ' A' ' 28' ' ' GLN . 19.5 pt-20 -112.83 117.16 31.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 1.92 109.906 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 61.92 82.19 0.18 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.445 0.64 . . . . 1.65 110.264 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.91 -26.17 0.35 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 2.92 110.577 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.544 . . . . 5.47 110.357 179.192 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.55000000000000004 109.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 42' ' ' MET . 14.3 m -81.43 147.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.962 -0.384 . . . . 0.33000000000000002 109.962 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 57.6 tt0 -121.05 121.44 37.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.246 0.546 . . . . 1.74 110.937 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 80.4 m-85 -112.61 141.18 46.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.564 -0.743 . . . . 0.23000000000000001 110.075 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -122.97 118.74 28.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 0.34999999999999998 110.503 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 28.3 p -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.899 0.38 . . . . 1.55 110.498 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG3' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -74.36 0.14 15.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 1.99 110.894 178.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.717 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 69.5 mmtt -75.9 -21.85 56.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.227 -0.657 . . . . 1.74 109.227 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.08 5.05 41.23 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.282 -0.872 . . . . 0.62 112.303 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -103.79 143.8 32.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 2.52 110.701 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 55.5 mtt180 -113.61 144.51 42.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.288 -0.414 . . . . 1.99 109.914 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.95 153.41 41.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.244 -0.435 . . . . 0.17999999999999999 110.659 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 11.1 pt-20 -110.84 143.64 41.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 1.3799999999999999 110.351 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.639 ' O ' HG22 ' A' ' 30' ' ' VAL . 63.1 mtm -137.37 151.63 71.73 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.227 -0.442 . . . . 0.62 109.82 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.75 122.86 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.039 1.826 . . . . 0.54000000000000004 112.688 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 30' ' ' VAL . 11.3 m-85 -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.798 -0.637 . . . . 0.40000000000000002 109.33 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 21.9 t -84.36 137.87 33.18 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.29 -0.633 . . . . 1.3700000000000001 109.29 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.01 -5.75 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.285 0.564 . . . . 1.0 110.618 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.69 13.85 19.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.572 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -98.91 160.21 14.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.34999999999999998 110.767 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.65 91.83 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.734 -0.839 . . . . 2.5899999999999999 108.734 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.472 HG22 ' HG ' ' A' ' 65' ' ' LEU . 21.3 mm -58.3 120.89 47.83 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.35999999999999999 111.08 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 56.1 Cg_exo -52.51 129.05 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.385 2.723 . . . . 0.37 112.215 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 22.9 Cg_exo -64.56 -17.28 59.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.154 2.569 . . . . 0.23999999999999999 113.112 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.23 148.88 33.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.885 0.374 . . . . 1.74 110.353 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 32.4 t-105 -146.25 159.25 43.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.745 -0.835 . . . . 1.3999999999999999 108.745 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.58 142.43 56.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.82 0.343 . . . . 0.67000000000000004 110.194 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.7 t -77.79 109.04 11.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.31 110.645 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -14.4 60.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.854 -0.612 . . . . 0.81999999999999995 111.315 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.54 -60.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.096 0.406 . . . . 0.33000000000000002 112.096 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 43.6 t -125.15 -42.62 2.0 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.31 -0.556 . . . . 0.5 112.228 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.77 92.85 0.38 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.003 -1.094 . . . . 0.58999999999999997 112.266 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 35' ' ' GLU . . . -178.75 -177.7 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.847 -0.427 . . . . 0.33000000000000002 109.847 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -98.0 123.19 41.89 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.63 -0.878 . . . . 1.3400000000000001 108.63 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -102.33 129.21 48.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.138 -0.483 . . . . 0.22 110.819 -176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.52 136.61 33.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.991 -0.549 . . . . 0.27000000000000002 110.141 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.489 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.3 tm? -78.98 131.77 36.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.512 -0.767 . . . . 0.34000000000000002 109.123 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 116.496 -0.32 . . . . 0.91000000000000003 110.27 -179.511 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.903 -0.406 . . . . 0.55000000000000004 109.903 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 42' ' ' MET . 3.2 m -87.86 144.65 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.167 -0.679 . . . . 0.33000000000000002 109.167 176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 37.8 tt0 -119.59 128.09 53.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.312 0.577 . . . . 1.74 110.673 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 61.1 m-85 -113.83 139.26 49.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.436 -0.802 . . . . 0.23000000000000001 109.844 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 119.54 35.48 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.315 -0.254 . . . . 0.34999999999999998 110.315 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 21.1 p -80.51 172.07 14.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.462 . . . . 1.55 111.967 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 41.6 mt-10 -64.81 -21.41 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.705 . . . . 1.99 110.994 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.15 0.03 54.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 1.74 111.037 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.31 31.1 43.1 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.862 -0.685 . . . . 0.62 112.589 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -113.42 127.46 56.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 2.52 109.545 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 49.5 mtt180 -99.51 141.34 32.43 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.661 -0.496 . . . . 1.99 109.661 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -142.51 153.4 43.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.868 -0.605 . . . . 0.17999999999999999 110.385 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.83 135.81 41.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 1.3799999999999999 110.057 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 30' ' ' VAL . 65.4 mmm -125.73 146.64 55.73 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.714 -0.675 . . . . 0.62 110.188 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.57 122.46 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.036 1.824 . . . . 0.54000000000000004 112.775 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -143.25 -177.42 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.656 -0.702 . . . . 0.40000000000000002 109.276 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 24.0 t -93.2 143.21 26.48 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.654 -0.498 . . . . 1.3700000000000001 109.654 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.24 -1.28 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.751 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -127.17 21.11 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.766 -0.652 . . . . 1.25 110.761 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -109.77 172.02 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.34999999999999998 110.078 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 33.8 tt0 -76.05 118.23 18.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 2.5899999999999999 109.181 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.8 mm -89.79 106.03 12.91 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.164 -0.68 . . . . 0.35999999999999999 109.164 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 49' ' ' GLU . 63.9 Cg_exo -51.99 124.95 15.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.232 2.621 . . . . 0.37 112.449 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 51.1 Cg_exo -55.22 -19.3 20.76 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.634 2.889 . . . . 0.23999999999999999 113.429 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.65 152.86 38.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.74 110.551 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 34.7 t-105 -149.05 160.72 43.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.949 -0.759 . . . . 1.3999999999999999 108.949 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -75.89 143.68 41.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.4 . . . . 0.67000000000000004 110.412 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.4 t -83.58 97.76 9.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.307 0.575 . . . . 0.31 110.357 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 9.8 mmpt? -77.07 11.0 1.99 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.347 -0.842 . . . . 0.81999999999999995 111.694 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.85 -60.71 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.623 0.249 . . . . 0.33000000000000002 111.102 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t -108.9 -45.76 3.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.913 -0.315 . . . . 0.5 111.282 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.72 55.67 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.445 -0.883 . . . . 0.58999999999999997 112.156 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -149.29 -167.21 2.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.985 -0.376 . . . . 0.33000000000000002 109.985 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 tt0 -99.55 148.4 24.33 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.493 -0.558 . . . . 1.3400000000000001 109.493 171.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -124.86 147.43 48.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.966 0.412 . . . . 0.22 111.293 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.0 mt -104.0 137.03 42.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.27000000000000002 109.976 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.4 tm? -73.18 132.08 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.513 -0.767 . . . . 0.34000000000000002 109.629 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 33.9 m . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 0.91000000000000003 110.91 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.3 -0.259 . . . . 0.55000000000000004 110.3 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 42' ' ' MET . 15.2 m -80.0 154.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.18 -0.304 . . . . 0.33000000000000002 110.18 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 6.7 tp10 -116.37 135.87 53.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 1.74 110.724 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.77 136.4 49.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.384 -0.371 . . . . 0.23000000000000001 110.028 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.38 121.98 35.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.272 -0.422 . . . . 0.34999999999999998 110.505 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.3 p -86.58 159.77 19.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.091 0.472 . . . . 1.55 110.219 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.86 4.74 5.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 1.99 110.515 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mmmt -91.71 -16.9 26.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 1.74 109.437 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.11 -3.66 22.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.672 -0.775 . . . . 0.62 113.711 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -100.54 143.33 30.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.408 0.604 . . . . 2.52 111.974 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -113.31 148.25 36.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.402 -0.817 . . . . 1.99 108.977 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.82 152.26 30.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.945 0.402 . . . . 0.17999999999999999 111.011 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 10.1 pt-20 -108.42 138.14 45.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.818 -0.628 . . . . 1.3799999999999999 110.158 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 37.5 mtm -130.7 152.64 80.83 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.601 -0.272 . . . . 0.62 110.572 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.52 122.91 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.198 1.932 . . . . 0.54000000000000004 113.069 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HG21 ' A' ' 30' ' ' VAL . 23.8 m-85 -137.54 -175.89 4.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.261 -0.881 . . . . 0.40000000000000002 109.368 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 33.9 t -86.95 144.05 27.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.41 -0.589 . . . . 1.3700000000000001 109.41 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.72 2.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.494 0.664 . . . . 1.0 110.426 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.8 5.89 7.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.101 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -97.03 147.33 24.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.805 0.336 . . . . 0.34999999999999998 110.959 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.73 89.5 1.35 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.386 0.612 . . . . 2.5899999999999999 109.814 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.65 124.26 71.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.182 -0.917 . . . . 0.35999999999999999 110.691 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 11.4 Cg_endo -55.58 129.64 36.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.056 2.504 . . . . 0.37 112.295 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -59.68 -16.28 36.1 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.509 2.806 . . . . 0.23999999999999999 113.626 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 151.04 36.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.995 -0.372 . . . . 1.74 109.995 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -146.52 159.66 43.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.31 -0.626 . . . . 1.3999999999999999 109.31 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 139.3 57.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.962 0.41 . . . . 0.67000000000000004 110.653 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.8 t -79.04 110.07 13.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.006 0.431 . . . . 0.31 111.098 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 1.1 mpmm? -76.68 -5.94 50.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.81999999999999995 111.642 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -83.82 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.09 -0.244 . . . . 0.33000000000000002 111.638 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.27 -44.45 2.58 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.589 -0.444 . . . . 0.5 112.081 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.12 75.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.252 -0.975 . . . . 0.58999999999999997 112.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -165.85 -168.69 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.409 -0.589 . . . . 0.33000000000000002 109.409 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -98.39 133.43 42.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 1.3400000000000001 109.903 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -110.66 132.82 53.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 0.22 110.426 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.74 137.5 32.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.234 -0.439 . . . . 0.27000000000000002 110.164 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 31' ' ' GLU . 2.7 tm? -71.23 121.9 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 0.34000000000000002 110.018 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 77.8 t . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.694 -0.685 . . . . 0.91000000000000003 109.892 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.979 -0.378 . . . . 0.55000000000000004 109.979 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 42' ' ' MET . 22.0 m -88.89 153.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 110.154 -0.313 . . . . 0.33000000000000002 110.154 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 37.5 mt-10 -114.68 120.11 39.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.425 -0.352 . . . . 1.74 111.207 -173.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.5 m-85 -112.94 141.05 47.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.474 -0.33 . . . . 0.23000000000000001 110.488 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -135.37 126.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.34999999999999998 110.446 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 19.5 p -89.39 -177.05 5.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.55 111.41 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.64 -14.18 62.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.668 . . . . 1.99 112.438 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HE3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -87.64 -25.51 23.5 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.43 0.633 . . . . 1.74 110.3 176.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.39 5.35 40.01 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.283 -0.872 . . . . 0.62 111.331 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 39.0 m80 -68.39 102.24 1.38 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.746 -0.464 . . . . 2.52 109.746 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mtt180 -98.22 141.95 30.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.034 -0.53 . . . . 1.99 110.491 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -151.0 153.4 35.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.603 -0.726 . . . . 0.17999999999999999 110.486 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.0 mt-10 -104.58 138.64 40.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 1.3799999999999999 110.097 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 30' ' ' VAL . 42.8 mtm -135.25 146.16 56.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.773 -0.454 . . . . 0.62 109.773 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.91 121.83 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.029 1.819 . . . . 0.54000000000000004 113.314 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.16 -175.87 3.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.221 -0.9 . . . . 0.40000000000000002 108.945 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 29.0 t -81.0 135.77 35.9 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.3 -0.63 . . . . 1.3700000000000001 109.3 171.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.58 -4.15 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.43 0.633 . . . . 1.0 110.579 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.6 19.96 11.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 1.25 110.402 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -108.32 161.23 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.075 0.464 . . . . 0.34999999999999998 111.075 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.79 88.66 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 2.5899999999999999 109.533 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.1 mm -58.8 121.27 52.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.588 -0.733 . . . . 0.35999999999999999 110.909 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.47 127.38 25.21 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.939 2.426 . . . . 0.37 111.802 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 42.7 Cg_exo -58.9 -8.99 6.78 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.757 2.972 . . . . 0.23999999999999999 114.314 -176.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.48 148.22 27.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.711 0.291 . . . . 1.74 110.731 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 23.5 t-105 -151.7 158.18 43.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.716 -0.846 . . . . 1.3999999999999999 108.716 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.24 142.71 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.117 0.484 . . . . 0.67000000000000004 111.183 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 6.0 t -79.59 103.83 9.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.717 -0.674 . . . . 0.31 111.127 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 7.94 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.81999999999999995 111.636 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.83 -59.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.114 0.413 . . . . 0.33000000000000002 112.114 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -110.42 -45.28 3.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.203 0.446 . . . . 0.5 112.203 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.64 68.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.096 -1.05 . . . . 0.58999999999999997 112.18 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -172.99 -166.04 0.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.33000000000000002 109.139 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -99.43 146.77 25.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.66 -0.416 . . . . 1.3400000000000001 109.987 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -119.62 148.33 43.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.22 110.306 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -102.88 140.55 37.01 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.044 0.45 . . . . 0.27000000000000002 110.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.3 tm? -74.17 112.61 10.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.418 -0.81 . . . . 0.34000000000000002 109.059 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 121.301 0.572 . . . . 0.91000000000000003 112.041 -173.075 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.566 0.222 . . . . 0.55000000000000004 111.02 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 42' ' ' MET . 19.6 m -96.65 141.63 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.295 -0.632 . . . . 0.33000000000000002 109.295 172.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 34.8 tt0 -119.23 126.58 51.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.365 0.602 . . . . 1.74 111.15 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 94.4 m-85 -115.52 136.66 52.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.387 -0.824 . . . . 0.23000000000000001 109.821 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.31 117.44 23.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.942 0.401 . . . . 0.34999999999999998 110.755 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 15.8 t -82.93 156.24 23.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.55 109.702 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.22 -3.32 19.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.783 -0.644 . . . . 1.99 110.875 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -75.82 -21.27 57.47 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.373 -0.602 . . . . 1.74 109.373 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.36 -16.42 17.27 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.62 112.358 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -73.92 128.01 34.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 2.52 111.762 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -110.8 153.07 25.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.144 -0.688 . . . . 1.99 109.144 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 32.3 p90 -161.59 153.3 19.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.522 -0.308 . . . . 0.17999999999999999 110.576 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 pt-20 -112.19 142.56 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.966 -0.561 . . . . 1.3799999999999999 110.527 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 30' ' ' VAL . 68.5 mtm -133.72 155.08 80.76 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.611 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.0 122.98 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.376 2.051 . . . . 0.54000000000000004 112.941 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CD2' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -142.3 -176.87 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.252 -0.885 . . . . 0.40000000000000002 109.106 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 26.0 t -94.36 140.41 29.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.113 0.482 . . . . 1.3700000000000001 110.04 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.24 -12.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.582 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.88 9.68 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 1.25 110.406 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -94.82 161.81 14.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.34999999999999998 110.595 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.61 84.15 6.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.29 -0.633 . . . . 2.5899999999999999 109.29 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.7 mm -57.75 117.29 18.1 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.35999999999999999 110.697 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 77.9 Cg_exo -51.5 132.59 40.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.544 2.829 . . . . 0.37 112.742 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -60.63 -18.73 56.71 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.334 2.689 . . . . 0.23999999999999999 112.861 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 150.29 42.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.195 -0.298 . . . . 1.74 110.195 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.7 t-105 -149.86 155.4 39.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 1.3999999999999999 109.377 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.65 140.69 58.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.087 0.47 . . . . 0.67000000000000004 110.555 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 15.4 t -80.54 110.46 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.584 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.32 -2.98 30.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.681 -0.69 . . . . 0.81999999999999995 111.329 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 -60.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.113 0.412 . . . . 0.33000000000000002 112.113 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.0 t -105.6 -47.35 3.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.236 -0.586 . . . . 0.5 112.411 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 55.52 0.08 OUTLIER Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.942 -1.123 . . . . 0.58999999999999997 112.596 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -154.33 -170.94 3.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.314 -0.625 . . . . 0.33000000000000002 109.314 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -98.35 122.61 41.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 1.3400000000000001 109.842 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -98.68 139.58 34.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 0.22 110.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.73 135.44 34.1 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.885 0.374 . . . . 0.27000000000000002 110.163 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -68.99 117.37 10.56 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.913 -0.773 . . . . 0.34000000000000002 108.913 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.215 0.531 . . . . 0.91000000000000003 111.591 -174.605 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 110.338 -0.245 . . . . 0.55000000000000004 110.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 42' ' ' MET . 10.7 m -91.09 147.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.726 -0.472 . . . . 0.33000000000000002 109.726 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 46.8 mt-10 -118.27 124.04 46.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.051 0.453 . . . . 1.74 111.36 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CZ ' HD23 ' A' ' 65' ' ' LEU . 82.7 m-85 -113.06 138.13 50.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.23000000000000001 110.039 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.67 121.21 37.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 0.34999999999999998 110.191 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.1 p -83.24 166.23 18.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.085 -0.507 . . . . 1.55 110.888 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.63 3.03 10.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.471 -0.786 . . . . 1.99 110.595 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -99.28 -0.29 41.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.274 -0.421 . . . . 1.74 110.461 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.98 9.04 58.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.927 -0.654 . . . . 0.62 113.464 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -111.36 156.26 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.351 0.576 . . . . 2.52 110.764 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -122.9 147.82 46.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.879 -0.786 . . . . 1.99 108.879 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -146.86 153.99 40.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 0.17999999999999999 111.178 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.33 138.17 47.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.55 -0.75 . . . . 1.3799999999999999 110.371 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.655 ' O ' HG22 ' A' ' 30' ' ' VAL . 62.9 mtm -136.91 147.82 60.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.85 -0.426 . . . . 0.62 109.85 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.69 123.27 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.049 1.833 . . . . 0.54000000000000004 112.746 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -125.28 -175.74 3.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.913 -0.773 . . . . 0.40000000000000002 108.913 173.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 7.4 m -88.08 132.16 34.4 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.447 -0.575 . . . . 1.3700000000000001 109.447 171.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.41 -12.06 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.429 0.633 . . . . 1.0 110.225 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.5 6.31 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.809 . . . . 1.25 110.357 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.23 160.37 14.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.34999999999999998 110.777 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -77.45 95.67 4.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.845 -0.798 . . . . 2.5899999999999999 108.845 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.77 117.72 23.15 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.41 -0.359 . . . . 0.35999999999999999 110.763 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 54.4 Cg_exo -51.85 125.33 16.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.161 2.574 . . . . 0.37 112.179 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -62.3 -12.14 25.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.378 2.719 . . . . 0.23999999999999999 113.217 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.58 143.51 16.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.451 -0.341 . . . . 1.74 110.418 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.6 t-105 -142.79 159.01 43.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.561 -0.903 . . . . 1.3999999999999999 108.561 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.79 144.81 55.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.99 0.424 . . . . 0.67000000000000004 110.656 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 3.6 t -83.17 107.84 16.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.09 -0.505 . . . . 0.31 110.794 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -4.37 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.957 -0.565 . . . . 0.81999999999999995 111.249 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.46 -60.43 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 111.896 0.332 . . . . 0.33000000000000002 111.896 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 53.1 t -108.51 -44.64 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.608 -0.437 . . . . 0.5 112.162 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 55.21 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.131 -1.033 . . . . 0.58999999999999997 111.785 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -153.8 -165.46 2.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.282 -0.636 . . . . 0.33000000000000002 109.282 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -99.71 149.56 23.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.485 -0.561 . . . . 1.3400000000000001 109.485 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -123.99 147.0 48.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.994 0.426 . . . . 0.22 110.677 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.83 139.26 35.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.078 -0.51 . . . . 0.27000000000000002 110.244 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -75.94 123.81 26.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 0.34000000000000002 109.111 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.91000000000000003 111.321 -176.618 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 CA-C-O 120.599 0.238 . . . . 0.55000000000000004 111.011 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 42' ' ' MET . 11.5 m -102.69 157.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.709 -0.478 . . . . 0.33000000000000002 109.709 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 45.2 mt-10 -131.47 127.71 37.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.729 0.3 . . . . 1.74 111.218 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.98 144.08 46.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.454 -0.339 . . . . 0.23000000000000001 110.438 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.97 127.6 43.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.34999999999999998 110.449 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 30.9 p -90.34 168.32 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 1.55 110.978 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.97 -6.08 39.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.634 -0.712 . . . . 1.99 110.882 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 72.1 mmtt -84.57 -13.41 51.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 1.74 110.284 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.71 13.71 46.19 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.704 -0.68 . . . . 0.62 112.583 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -105.38 145.77 30.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 2.52 110.328 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -120.15 142.95 48.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.578 -0.527 . . . . 1.99 109.578 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -149.79 154.19 38.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.973 0.416 . . . . 0.17999999999999999 111.271 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.22 143.24 42.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.668 -0.696 . . . . 1.3799999999999999 109.955 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 30' ' ' VAL . 64.2 mtm -136.41 150.28 70.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.078 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.247 1.965 . . . . 0.54000000000000004 113.006 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.488 ' CD2' HG21 ' A' ' 30' ' ' VAL . 33.7 m-85 -141.69 -177.09 5.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.623 -0.717 . . . . 0.40000000000000002 109.604 177.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -104.17 144.55 31.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.232 0.539 . . . . 1.3700000000000001 110.334 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -76.81 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.645 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.42 22.54 15.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.067 -0.97 . . . . 1.25 110.034 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -119.51 146.07 45.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.005 -0.543 . . . . 0.34999999999999998 110.308 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.02 85.09 2.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.94 -0.763 . . . . 2.5899999999999999 108.94 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.0 mm -58.68 117.43 20.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.35999999999999999 110.45 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.8 Cg_exo -53.72 130.37 38.64 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.066 2.511 . . . . 0.37 112.291 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 37.8 Cg_exo -61.23 -11.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.151 2.567 . . . . 0.23999999999999999 112.929 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.08 137.4 14.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.531 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -137.21 158.74 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.939 -0.763 . . . . 1.3999999999999999 108.939 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.25 141.04 56.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.924 0.393 . . . . 0.67000000000000004 110.606 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.5 t -82.97 109.26 16.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.425 . . . . 0.31 110.842 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -14.05 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.792 -0.64 . . . . 0.81999999999999995 111.403 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.03 -60.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.016 0.376 . . . . 0.33000000000000002 112.016 -171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.518 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 42.5 t -110.91 -44.46 3.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.507 -0.477 . . . . 0.5 111.79 -172.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.67 55.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.215 -0.993 . . . . 0.58999999999999997 112.239 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.432 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -152.02 -162.9 1.61 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.986 -0.375 . . . . 0.33000000000000002 109.986 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -98.62 142.47 30.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.42 -0.585 . . . . 1.3400000000000001 109.42 170.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -117.2 138.97 51.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.939 0.4 . . . . 0.22 110.568 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.08 134.28 35.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.131 -0.486 . . . . 0.27000000000000002 110.192 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.4 tm? -68.69 118.59 11.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.667 -0.864 . . . . 0.34000000000000002 108.667 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 C--N 1.322 -0.609 0 CA-C-O 121.252 0.549 . . . . 0.91000000000000003 111.698 -175.24 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 41' ' ' GLU . . . . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.563 0.22 . . . . 0.55000000000000004 110.545 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 42' ' ' MET . 12.1 m -86.39 148.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.145 -0.687 . . . . 0.33000000000000002 109.145 175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 34.8 tt0 -118.68 130.53 55.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.376 0.608 . . . . 1.74 111.431 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 76.5 m-85 -118.76 141.28 48.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.23000000000000001 109.94 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -127.64 113.57 16.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 0.34999999999999998 110.586 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.7 t -85.44 164.02 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.082 -0.508 . . . . 1.55 110.235 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.8 -11.66 56.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.213 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -72.38 -6.66 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 1.74 110.946 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.15 78.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.869 -0.682 . . . . 0.62 112.111 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -105.98 129.99 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.903 0.382 . . . . 2.52 110.661 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 62.1 mtt180 -105.91 153.23 22.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 1.99 109.803 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -154.91 153.04 30.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.936 0.398 . . . . 0.17999999999999999 110.571 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.452 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 7.4 pt-20 -105.49 139.61 39.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.704 -0.68 . . . . 1.3799999999999999 110.332 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.3 mtm -131.68 151.57 78.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.268 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.82 122.68 4.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.54000000000000004 112.894 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.469 ' CD1' HG21 ' A' ' 30' ' ' VAL . 16.2 m-85 -131.76 -176.78 4.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.231 -0.895 . . . . 0.40000000000000002 108.862 172.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 15.0 m -87.07 137.52 32.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.723 -0.473 . . . . 1.3700000000000001 109.723 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -73.98 -7.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.681 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.42 20.49 9.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.25 111.052 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.05 160.21 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.34999999999999998 110.462 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.56 106.53 9.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.077 -0.712 . . . . 2.5899999999999999 109.077 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mm -76.02 117.56 64.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.085 -0.339 . . . . 0.35999999999999999 110.085 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 51.5 Cg_exo -54.71 127.94 28.26 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.159 2.573 . . . . 0.37 112.614 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -60.78 -14.22 30.8 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.467 2.778 . . . . 0.23999999999999999 113.217 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.56 140.95 25.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.116 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -147.76 159.16 44.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 1.3999999999999999 109.363 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.68 142.4 58.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.67000000000000004 110.996 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 12.7 t -83.53 112.4 19.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.31 110.944 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.15 -12.45 60.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 0.81999999999999995 111.294 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.3 -59.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.184 0.439 . . . . 0.33000000000000002 112.184 -172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.5 t -114.17 -45.48 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.5 112.266 -173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 68.62 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.163 -1.017 . . . . 0.58999999999999997 111.696 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -163.52 -170.58 2.27 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.635 -0.505 . . . . 0.33000000000000002 109.635 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -99.57 117.37 33.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.009 -0.367 . . . . 1.3400000000000001 110.009 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -92.85 141.15 28.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.245 -0.434 . . . . 0.22 110.336 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.2 136.63 38.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.009 0.433 . . . . 0.27000000000000002 110.268 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 3.3 tm? -69.93 120.01 15.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.375 -0.829 . . . . 0.34000000000000002 109.543 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.376 -0.375 . . . . 0.91000000000000003 111.303 -176.154 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.748 -0.093 . . . . 0.55000000000000004 110.748 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 42' ' ' MET . 13.1 m -81.34 140.75 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.539 -0.541 . . . . 0.33000000000000002 109.539 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -117.16 130.26 56.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 1.74 111.347 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 93.1 m-85 -116.61 142.1 47.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.757 -0.656 . . . . 0.23000000000000001 109.793 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.4 122.47 42.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.8 0.333 . . . . 0.34999999999999998 110.587 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 31.5 p -83.53 170.64 14.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 1.55 111.142 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.09 -5.71 43.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.743 -0.662 . . . . 1.99 110.808 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.654 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 66.0 mmtt -86.41 -13.4 46.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.117 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.85 34.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.98 -0.629 . . . . 0.62 112.463 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -113.17 131.6 55.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.919 0.39 . . . . 2.52 110.078 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -105.51 145.39 30.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.99 109.808 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.28 153.13 43.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.735 0.302 . . . . 0.17999999999999999 110.937 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 13.1 pt-20 -106.43 144.26 33.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.772 -0.649 . . . . 1.3799999999999999 110.188 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' VAL . 52.8 mtm -139.38 148.52 57.0 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.342 -0.39 . . . . 0.62 110.059 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' MET . 3.3 Cg_exo -75.5 122.24 6.85 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.441 2.094 . . . . 0.54000000000000004 112.943 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CD2' HG21 ' A' ' 30' ' ' VAL . 7.3 m-85 -137.35 -176.19 4.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.359 -0.837 . . . . 0.40000000000000002 109.025 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.27 146.77 23.46 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.392 -0.595 . . . . 1.3700000000000001 109.392 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.28 -6.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 1.0 110.621 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.47 20.35 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 1.25 110.057 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -108.67 152.43 24.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.849 -0.614 . . . . 0.34999999999999998 109.933 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -75.02 88.71 2.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.427 -0.583 . . . . 2.5899999999999999 109.427 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 30' ' ' VAL . 31.2 mm -58.81 116.08 14.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 0.35999999999999999 110.725 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 53.8 Cg_exo -52.8 131.42 41.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.42 2.747 . . . . 0.37 112.637 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 31.3 Cg_exo -61.43 -22.44 74.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.491 2.794 . . . . 0.23999999999999999 113.166 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.78 152.12 39.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.35 . . . . 1.74 110.16 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.4 t-105 -149.51 159.24 44.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.394 -0.595 . . . . 1.3999999999999999 109.394 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.37 143.79 56.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.67000000000000004 110.656 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.8 t -80.52 109.2 14.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.31 110.748 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.06 -10.16 59.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.81999999999999995 111.251 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.03 -60.27 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.127 0.417 . . . . 0.33000000000000002 112.127 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.6 t -112.47 -46.49 3.16 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.464 -0.495 . . . . 0.5 111.634 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 76.82 0.11 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.117 -1.039 . . . . 0.58999999999999997 112.315 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -171.61 -167.42 0.51 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.33000000000000002 109.347 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -98.56 140.34 32.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.142 -0.688 . . . . 1.3400000000000001 109.142 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -118.71 147.98 43.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.391 -0.368 . . . . 0.22 110.551 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.8 mt -99.57 136.63 39.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.107 -0.497 . . . . 0.27000000000000002 110.25 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 3.0 tm? -70.65 123.28 21.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.553 -0.749 . . . . 0.34000000000000002 109.872 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.91000000000000003 110.638 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.957 -0.386 . . . . 0.55000000000000004 109.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 42' ' ' MET . 10.6 m -96.26 142.62 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.781 -0.451 . . . . 0.33000000000000002 109.781 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.98 135.05 55.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.128 0.489 . . . . 1.74 111.069 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.718 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 79.9 m-85 -125.58 144.24 50.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.23000000000000001 110.442 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -131.22 117.74 19.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.151 -0.477 . . . . 0.34999999999999998 110.541 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.6 t -91.67 161.66 14.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.972 0.415 . . . . 1.55 110.258 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.29 -1.94 9.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 1.99 110.663 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HG2' ' SG ' ' A' ' 34' ' ' CYS . 74.7 mmtt -74.53 -15.18 60.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.598 . . . . 1.74 110.434 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.83 1.25 63.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.915 -0.66 . . . . 0.62 112.069 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -106.57 123.69 48.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.948 0.404 . . . . 2.52 110.766 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.427 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 61.4 mtt180 -99.12 155.15 17.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 1.99 109.67 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 34.0 p90 -156.02 156.23 34.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 0.17999999999999999 111.176 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.32 144.69 32.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.272 -0.876 . . . . 1.3799999999999999 109.506 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.606 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.7 mtm -137.66 148.93 63.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.637 0.256 . . . . 0.62 110.878 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.71 125.8 4.41 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.608 2.205 . . . . 0.54000000000000004 112.578 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HD2' HG21 ' A' ' 30' ' ' VAL . 4.9 m-85 -140.94 -177.11 4.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.64 . . . . 0.40000000000000002 110.236 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 6.4 m -89.06 140.5 29.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.859 -0.609 . . . . 1.3700000000000001 110.056 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.94 -6.21 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.557 0.694 . . . . 1.0 110.216 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.39 8.48 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 1.25 110.948 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -103.67 142.9 33.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.757 0.313 . . . . 0.34999999999999998 110.88 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.42 92.68 1.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.569 -0.53 . . . . 2.5899999999999999 109.569 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG11 ' A' ' 30' ' ' VAL . 27.9 mm -58.46 115.9 13.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.618 -0.719 . . . . 0.35999999999999999 110.519 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.9 Cg_exo -55.05 134.93 66.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.062 2.508 . . . . 0.37 112.48 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 21.8 Cg_exo -66.78 -5.15 12.55 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.457 2.771 . . . . 0.23999999999999999 112.836 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.67 137.22 16.83 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.365 -0.606 . . . . 1.74 109.365 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.718 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -148.4 159.84 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.755 0.312 . . . . 1.3999999999999999 110.87 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.09 135.12 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 0.67000000000000004 110.995 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.1 t -84.7 112.04 20.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.758 -0.655 . . . . 0.31 110.861 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.37 -14.37 60.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.81999999999999995 110.981 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.86 -59.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.705 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.2 t -112.11 -46.35 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.418 -0.513 . . . . 0.5 112.001 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.9 56.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.871 -1.157 . . . . 0.58999999999999997 112.662 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.513 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -150.67 -173.09 4.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.914 0.357 . . . . 0.33000000000000002 110.361 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.75 105.17 17.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.795 -0.446 . . . . 1.3400000000000001 109.795 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . . . -83.73 142.83 30.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.852 -0.613 . . . . 0.22 110.745 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.1 mt -90.72 136.44 33.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.276 0.56 . . . . 0.27000000000000002 110.249 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 2.5 tm? -66.89 130.0 41.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.11 -0.95 . . . . 0.34000000000000002 109.888 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.975 0.417 . . . . 0.91000000000000003 110.859 179.774 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.812 0.339 . . . . 1.7 110.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -141.4 140.87 33.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.82 -0.437 . . . . 0.55000000000000004 109.82 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 42' ' ' MET . 14.3 m -81.43 147.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.962 -0.384 . . . . 0.33000000000000002 109.962 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 57.6 tt0 -121.05 121.44 37.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.246 0.546 . . . . 1.74 110.937 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 80.4 m-85 -112.61 141.18 46.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.564 -0.743 . . . . 0.23000000000000001 110.075 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -122.97 118.74 28.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 0.34999999999999998 110.503 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 28.3 p -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.899 0.38 . . . . 1.55 110.498 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG3' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -74.36 0.14 15.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 1.99 110.894 178.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.717 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 69.5 mmtt -75.9 -21.85 56.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.227 -0.657 . . . . 1.74 109.227 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.08 5.05 41.23 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.282 -0.872 . . . . 0.62 112.303 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -103.79 143.8 32.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 2.52 110.701 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 55.5 mtt180 -113.61 144.51 42.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.288 -0.414 . . . . 1.99 109.914 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.95 153.41 41.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.244 -0.435 . . . . 0.17999999999999999 110.659 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 11.1 pt-20 -110.84 143.64 41.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 1.3799999999999999 110.351 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.639 ' O ' HG22 ' A' ' 30' ' ' VAL . 63.1 mtm -137.37 151.63 71.73 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.227 -0.442 . . . . 0.62 109.82 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.75 122.86 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.039 1.826 . . . . 0.54000000000000004 112.688 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 30' ' ' VAL . 11.3 m-85 -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.798 -0.637 . . . . 0.40000000000000002 109.33 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 21.9 t -84.36 137.87 33.18 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.29 -0.633 . . . . 1.3700000000000001 109.29 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 3.8 p -81.01 -5.75 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.285 0.564 . . . . 1.0 110.618 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.69 13.85 19.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.572 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -98.91 160.21 14.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.34999999999999998 110.767 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.65 91.83 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.734 -0.839 . . . . 2.5899999999999999 108.734 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.472 HG22 ' HG ' ' A' ' 65' ' ' LEU . 21.3 mm -58.3 120.89 47.83 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.35999999999999999 111.08 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 56.1 Cg_exo -52.51 129.05 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.385 2.723 . . . . 0.37 112.215 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 22.9 Cg_exo -64.56 -17.28 59.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.154 2.569 . . . . 0.23999999999999999 113.112 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.23 148.88 33.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.885 0.374 . . . . 1.74 110.353 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 32.4 t-105 -146.25 159.25 43.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.745 -0.835 . . . . 1.3999999999999999 108.745 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.58 142.43 56.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.82 0.343 . . . . 0.67000000000000004 110.194 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.7 t -77.79 109.04 11.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.31 110.645 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -14.4 60.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.854 -0.612 . . . . 0.81999999999999995 111.315 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.54 -60.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.096 0.406 . . . . 0.33000000000000002 112.096 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 43.6 t -125.15 -42.62 2.0 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.31 -0.556 . . . . 0.5 112.228 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.77 92.85 0.38 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.003 -1.094 . . . . 0.58999999999999997 112.266 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 35' ' ' GLU . . . -178.75 -177.7 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.847 -0.427 . . . . 0.33000000000000002 109.847 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -98.0 123.19 41.89 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.63 -0.878 . . . . 1.3400000000000001 108.63 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -102.33 129.21 48.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.138 -0.483 . . . . 0.22 110.819 -176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.52 136.61 33.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.991 -0.549 . . . . 0.27000000000000002 110.141 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.489 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.3 tm? -78.98 131.77 36.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.512 -0.767 . . . . 0.34000000000000002 109.123 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.95 145.39 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.496 -0.32 . . . . 0.91000000000000003 110.27 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' CG ' ' HG2' ' A' ' 75' ' ' LYS . 67.7 m-20 65.11 30.43 11.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.932 -0.576 . . . . 1.96 112.078 175.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.91 61.13 4.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.035 -0.602 . . . . 1.47 113.021 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.437 0.637 . . . . 3.25 110.301 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.17 -78.85 0.18 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.501 -1.04 . . . . 1.0600000000000001 110.501 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.55 145.61 95.39 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.322 2.014 . . . . 1.24 111.302 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 40.8 mt-10 -46.47 -60.65 2.22 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.699 0.624 . . . . 1.9199999999999999 112.654 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 30.9 tt0 -106.69 35.82 2.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 1.6499999999999999 109.904 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -59.14 -56.33 23.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 2.48 109.675 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 67' ' ' ASP . 61.9 mttm . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.128 0.892 . . . . 4.9199999999999999 111.415 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.018 0.437 . . . . 1.7 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.7 142.76 32.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.233 -0.439 . . . . 0.55000000000000004 109.903 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 42' ' ' MET . 3.2 m -87.86 144.65 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.167 -0.679 . . . . 0.33000000000000002 109.167 176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 37.8 tt0 -119.59 128.09 53.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.312 0.577 . . . . 1.74 110.673 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 61.1 m-85 -113.83 139.26 49.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.436 -0.802 . . . . 0.23000000000000001 109.844 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 119.54 35.48 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.315 -0.254 . . . . 0.34999999999999998 110.315 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 21.1 p -80.51 172.07 14.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.462 . . . . 1.55 111.967 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 41.6 mt-10 -64.81 -21.41 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.705 . . . . 1.99 110.994 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.15 0.03 54.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 1.74 111.037 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.31 31.1 43.1 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.862 -0.685 . . . . 0.62 112.589 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -113.42 127.46 56.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 2.52 109.545 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 49.5 mtt180 -99.51 141.34 32.43 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.661 -0.496 . . . . 1.99 109.661 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -142.51 153.4 43.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.868 -0.605 . . . . 0.17999999999999999 110.385 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.83 135.81 41.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 1.3799999999999999 110.057 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 30' ' ' VAL . 65.4 mmm -125.73 146.64 55.73 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.714 -0.675 . . . . 0.62 110.188 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.57 122.46 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.036 1.824 . . . . 0.54000000000000004 112.775 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -143.25 -177.42 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.656 -0.702 . . . . 0.40000000000000002 109.276 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 24.0 t -93.2 143.21 26.48 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.654 -0.498 . . . . 1.3700000000000001 109.654 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 4.4 p -79.24 -1.28 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.751 -178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -127.17 21.11 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.766 -0.652 . . . . 1.25 110.761 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -109.77 172.02 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.34999999999999998 110.078 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 33.8 tt0 -76.05 118.23 18.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 2.5899999999999999 109.181 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.8 mm -89.79 106.03 12.91 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.164 -0.68 . . . . 0.35999999999999999 109.164 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 49' ' ' GLU . 63.9 Cg_exo -51.99 124.95 15.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.232 2.621 . . . . 0.37 112.449 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 51.1 Cg_exo -55.22 -19.3 20.76 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.634 2.889 . . . . 0.23999999999999999 113.429 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.65 152.86 38.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.74 110.551 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 34.7 t-105 -149.05 160.72 43.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.949 -0.759 . . . . 1.3999999999999999 108.949 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -75.89 143.68 41.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.4 . . . . 0.67000000000000004 110.412 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.4 t -83.58 97.76 9.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.307 0.575 . . . . 0.31 110.357 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 9.8 mmpt? -77.07 11.0 1.99 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.347 -0.842 . . . . 0.81999999999999995 111.694 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.85 -60.71 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.623 0.249 . . . . 0.33000000000000002 111.102 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t -108.9 -45.76 3.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.913 -0.315 . . . . 0.5 111.282 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.72 55.67 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.445 -0.883 . . . . 0.58999999999999997 112.156 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -149.29 -167.21 2.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.985 -0.376 . . . . 0.33000000000000002 109.985 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 tt0 -99.55 148.4 24.33 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.493 -0.558 . . . . 1.3400000000000001 109.493 171.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -124.86 147.43 48.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.966 0.412 . . . . 0.22 111.293 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.0 mt -104.0 137.03 42.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.27000000000000002 109.976 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.4 tm? -73.18 132.08 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.513 -0.767 . . . . 0.34000000000000002 109.629 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 66' ' ' VAL . 33.9 m -112.15 110.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 0.91000000000000003 110.91 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 63.66 83.55 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.327 -0.851 . . . . 1.96 112.363 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -151.44 -92.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 1.47 112.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 69.71 -60.76 0.46 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.423 0.689 . . . . 3.25 111.668 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -129.81 -72.72 0.13 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.086 -0.578 . . . . 1.0600000000000001 111.691 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.16 127.8 11.61 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.181 1.92 . . . . 1.24 111.536 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 34.0 mt-10 -56.72 -49.93 73.72 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.221 -0.899 . . . . 1.9199999999999999 111.593 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -136.42 78.8 1.73 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.402 -0.817 . . . . 1.6499999999999999 109.659 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -149.99 -36.7 0.15 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.198 -0.455 . . . . 2.48 110.71 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.802 -0.618 . . . . 4.9199999999999999 110.403 -176.592 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.593 0.235 . . . . 1.7 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -142.24 136.86 30.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.3 -0.259 . . . . 0.55000000000000004 110.3 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 42' ' ' MET . 15.2 m -80.0 154.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.18 -0.304 . . . . 0.33000000000000002 110.18 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 6.7 tp10 -116.37 135.87 53.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 1.74 110.724 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.77 136.4 49.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.384 -0.371 . . . . 0.23000000000000001 110.028 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.38 121.98 35.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.272 -0.422 . . . . 0.34999999999999998 110.505 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.3 p -86.58 159.77 19.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.091 0.472 . . . . 1.55 110.219 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.86 4.74 5.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 1.99 110.515 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mmmt -91.71 -16.9 26.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 1.74 109.437 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.11 -3.66 22.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.672 -0.775 . . . . 0.62 113.711 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -100.54 143.33 30.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.408 0.604 . . . . 2.52 111.974 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -113.31 148.25 36.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.402 -0.817 . . . . 1.99 108.977 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.82 152.26 30.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.945 0.402 . . . . 0.17999999999999999 111.011 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 10.1 pt-20 -108.42 138.14 45.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.818 -0.628 . . . . 1.3799999999999999 110.158 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 37.5 mtm -130.7 152.64 80.83 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.601 -0.272 . . . . 0.62 110.572 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.52 122.91 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.198 1.932 . . . . 0.54000000000000004 113.069 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HG21 ' A' ' 30' ' ' VAL . 23.8 m-85 -137.54 -175.89 4.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.261 -0.881 . . . . 0.40000000000000002 109.368 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 33.9 t -86.95 144.05 27.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.41 -0.589 . . . . 1.3700000000000001 109.41 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 6.8 p -80.72 2.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.494 0.664 . . . . 1.0 110.426 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.8 5.89 7.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.101 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -97.03 147.33 24.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.805 0.336 . . . . 0.34999999999999998 110.959 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.73 89.5 1.35 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.386 0.612 . . . . 2.5899999999999999 109.814 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 68' ' ' GLY . 28.2 mm -58.65 124.26 71.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.182 -0.917 . . . . 0.35999999999999999 110.691 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 11.4 Cg_endo -55.58 129.64 36.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.056 2.504 . . . . 0.37 112.295 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -59.68 -16.28 36.1 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.509 2.806 . . . . 0.23999999999999999 113.626 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 151.04 36.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.995 -0.372 . . . . 1.74 109.995 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -146.52 159.66 43.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.31 -0.626 . . . . 1.3999999999999999 109.31 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 139.3 57.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.962 0.41 . . . . 0.67000000000000004 110.653 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.8 t -79.04 110.07 13.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.006 0.431 . . . . 0.31 111.098 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 1.1 mpmm? -76.68 -5.94 50.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.81999999999999995 111.642 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -83.82 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.09 -0.244 . . . . 0.33000000000000002 111.638 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.27 -44.45 2.58 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.589 -0.444 . . . . 0.5 112.081 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.12 75.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.252 -0.975 . . . . 0.58999999999999997 112.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -165.85 -168.69 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.409 -0.589 . . . . 0.33000000000000002 109.409 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -98.39 133.43 42.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 1.3400000000000001 109.903 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -110.66 132.82 53.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 0.22 110.426 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.74 137.5 32.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.234 -0.439 . . . . 0.27000000000000002 110.164 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 31' ' ' GLU . 2.7 tm? -71.23 121.9 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 0.34000000000000002 110.018 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 77.8 t -105.31 109.23 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.694 -0.685 . . . . 0.91000000000000003 109.892 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 75' ' ' LYS . 33.9 t70 59.07 102.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.383 -0.826 . . . . 1.96 112.053 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 175.99 62.56 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.317 -0.856 . . . . 1.47 111.374 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.03 4.68 44.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.246 0.546 . . . . 3.25 110.176 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 48' ' ' ALA . . . 160.55 -74.09 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.031 -0.828 . . . . 1.0600000000000001 111.031 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.93 128.83 16.42 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.329 2.02 . . . . 1.24 112.163 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 35.1 mt-10 -70.02 136.25 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 1.9199999999999999 110.31 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 49.4 tt0 59.11 43.14 17.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.934 0.873 . . . . 1.6499999999999999 110.467 175.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -74.51 -50.89 16.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.295 -0.866 . . . . 2.48 109.067 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HE2' ' HG3' ' A' ' 73' ' ' GLU . 61.4 mttm . . . . . 0 C--O 1.249 1.069 0 CA-C-N 114.614 -1.175 . . . . 4.9199999999999999 111.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.75 0.31 . . . . 1.7 110.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.56 143.8 32.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.325 -0.398 . . . . 0.55000000000000004 109.979 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 42' ' ' MET . 22.0 m -88.89 153.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 110.154 -0.313 . . . . 0.33000000000000002 110.154 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 37.5 mt-10 -114.68 120.11 39.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.425 -0.352 . . . . 1.74 111.207 -173.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.5 m-85 -112.94 141.05 47.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.474 -0.33 . . . . 0.23000000000000001 110.488 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -135.37 126.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.34999999999999998 110.446 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 19.5 p -89.39 -177.05 5.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.55 111.41 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.64 -14.18 62.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.668 . . . . 1.99 112.438 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HE3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -87.64 -25.51 23.5 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.43 0.633 . . . . 1.74 110.3 176.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.39 5.35 40.01 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.283 -0.872 . . . . 0.62 111.331 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 39.0 m80 -68.39 102.24 1.38 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.746 -0.464 . . . . 2.52 109.746 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mtt180 -98.22 141.95 30.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.034 -0.53 . . . . 1.99 110.491 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -151.0 153.4 35.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.603 -0.726 . . . . 0.17999999999999999 110.486 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.0 mt-10 -104.58 138.64 40.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 1.3799999999999999 110.097 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 30' ' ' VAL . 42.8 mtm -135.25 146.16 56.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.773 -0.454 . . . . 0.62 109.773 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.91 121.83 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.029 1.819 . . . . 0.54000000000000004 113.314 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.16 -175.87 3.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.221 -0.9 . . . . 0.40000000000000002 108.945 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 29.0 t -81.0 135.77 35.9 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.3 -0.63 . . . . 1.3700000000000001 109.3 171.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 72' ' ' GLU . 3.7 p -74.58 -4.15 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.43 0.633 . . . . 1.0 110.579 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.6 19.96 11.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 1.25 110.402 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -108.32 161.23 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.075 0.464 . . . . 0.34999999999999998 111.075 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.79 88.66 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 2.5899999999999999 109.533 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.1 mm -58.8 121.27 52.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.588 -0.733 . . . . 0.35999999999999999 110.909 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.47 127.38 25.21 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.939 2.426 . . . . 0.37 111.802 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 42.7 Cg_exo -58.9 -8.99 6.78 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.757 2.972 . . . . 0.23999999999999999 114.314 -176.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.48 148.22 27.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.711 0.291 . . . . 1.74 110.731 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 23.5 t-105 -151.7 158.18 43.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.716 -0.846 . . . . 1.3999999999999999 108.716 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.24 142.71 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.117 0.484 . . . . 0.67000000000000004 111.183 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 6.0 t -79.59 103.83 9.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.717 -0.674 . . . . 0.31 111.127 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 7.94 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.81999999999999995 111.636 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.83 -59.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.114 0.413 . . . . 0.33000000000000002 112.114 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -110.42 -45.28 3.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.203 0.446 . . . . 0.5 112.203 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.64 68.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.096 -1.05 . . . . 0.58999999999999997 112.18 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -172.99 -166.04 0.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.33000000000000002 109.139 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -99.43 146.77 25.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.66 -0.416 . . . . 1.3400000000000001 109.987 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -119.62 148.33 43.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.22 110.306 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -102.88 140.55 37.01 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.044 0.45 . . . . 0.27000000000000002 110.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.3 tm? -74.17 112.61 10.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.418 -0.81 . . . . 0.34000000000000002 109.059 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -100.61 114.99 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.301 0.572 . . . . 0.91000000000000003 112.041 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 75' ' ' LYS . 12.6 m-20 56.01 51.33 12.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.908 -1.042 . . . . 1.96 111.769 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.64 67.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.04 -0.824 . . . . 1.47 111.04 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 28.5 t70 -81.04 61.77 4.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.247 0.546 . . . . 3.25 110.456 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.13 -95.24 1.08 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.715 -0.675 . . . . 1.0600000000000001 112.448 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 69' ' ' ASP . 10.3 Cg_endo -54.23 126.59 22.65 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.941 2.427 . . . . 1.24 112.95 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' H ' HG23 ' A' ' 46' ' ' VAL . 39.9 mt-10 -68.69 151.42 46.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.295 -0.866 . . . . 1.9199999999999999 110.826 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 56.54 62.38 2.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.339 0.59 . . . . 1.6499999999999999 110.743 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -136.36 -54.74 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.876 -0.602 . . . . 2.48 110.675 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 66.5 tttm . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.059 -0.972 . . . . 4.9199999999999999 110.033 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 73' ' ' GLU . 87.9 mt-30 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.063 -0.347 . . . . 1.7 110.063 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.18 141.41 32.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.293 -0.412 . . . . 0.55000000000000004 111.02 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 42' ' ' MET . 19.6 m -96.65 141.63 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.295 -0.632 . . . . 0.33000000000000002 109.295 172.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 34.8 tt0 -119.23 126.58 51.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.365 0.602 . . . . 1.74 111.15 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 94.4 m-85 -115.52 136.66 52.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.387 -0.824 . . . . 0.23000000000000001 109.821 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.31 117.44 23.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.942 0.401 . . . . 0.34999999999999998 110.755 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 15.8 t -82.93 156.24 23.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.55 109.702 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.22 -3.32 19.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.783 -0.644 . . . . 1.99 110.875 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -75.82 -21.27 57.47 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.373 -0.602 . . . . 1.74 109.373 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.36 -16.42 17.27 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.62 112.358 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -73.92 128.01 34.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 2.52 111.762 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -110.8 153.07 25.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.144 -0.688 . . . . 1.99 109.144 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 32.3 p90 -161.59 153.3 19.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.522 -0.308 . . . . 0.17999999999999999 110.576 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 pt-20 -112.19 142.56 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.966 -0.561 . . . . 1.3799999999999999 110.527 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 30' ' ' VAL . 68.5 mtm -133.72 155.08 80.76 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.611 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.0 122.98 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.376 2.051 . . . . 0.54000000000000004 112.941 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CD2' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -142.3 -176.87 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.252 -0.885 . . . . 0.40000000000000002 109.106 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 26.0 t -94.36 140.41 29.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.113 0.482 . . . . 1.3700000000000001 110.04 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 72' ' ' GLU . 4.9 p -76.24 -12.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.582 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.88 9.68 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 1.25 110.406 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -94.82 161.81 14.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.34999999999999998 110.595 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.61 84.15 6.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.29 -0.633 . . . . 2.5899999999999999 109.29 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 70' ' ' GLY . 32.7 mm -57.75 117.29 18.1 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.35999999999999999 110.697 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 77.9 Cg_exo -51.5 132.59 40.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.544 2.829 . . . . 0.37 112.742 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -60.63 -18.73 56.71 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.334 2.689 . . . . 0.23999999999999999 112.861 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 150.29 42.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.195 -0.298 . . . . 1.74 110.195 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.7 t-105 -149.86 155.4 39.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 1.3999999999999999 109.377 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.65 140.69 58.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.087 0.47 . . . . 0.67000000000000004 110.555 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 15.4 t -80.54 110.46 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.584 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.32 -2.98 30.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.681 -0.69 . . . . 0.81999999999999995 111.329 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 -60.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.113 0.412 . . . . 0.33000000000000002 112.113 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.0 t -105.6 -47.35 3.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.236 -0.586 . . . . 0.5 112.411 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 55.52 0.08 OUTLIER Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.942 -1.123 . . . . 0.58999999999999997 112.596 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -154.33 -170.94 3.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.314 -0.625 . . . . 0.33000000000000002 109.314 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -98.35 122.61 41.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 1.3400000000000001 109.842 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -98.68 139.58 34.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 0.22 110.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.73 135.44 34.1 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.885 0.374 . . . . 0.27000000000000002 110.163 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -68.99 117.37 10.56 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.913 -0.773 . . . . 0.34000000000000002 108.913 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.47 111.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.215 0.531 . . . . 0.91000000000000003 111.591 -174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 5.5 m-20 67.97 90.11 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.159 -0.928 . . . . 1.96 111.928 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -82.88 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.124 -0.944 . . . . 1.47 111.209 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 48.24 44.07 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.864 0.84 . . . . 3.25 110.21 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.664 ' O ' HG12 ' A' ' 50' ' ' ILE . . . 153.61 -112.85 0.55 Allowed Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.006 -0.997 . . . . 1.0600000000000001 110.988 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.09 124.47 11.39 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.086 1.858 . . . . 1.24 112.11 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 46' ' ' VAL . 15.9 pt-20 -72.12 157.88 36.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.962 -0.563 . . . . 1.9199999999999999 110.015 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 28' ' ' GLN . 7.2 tp10 72.13 -41.03 0.49 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.747 0.654 . . . . 1.6499999999999999 111.728 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 72' ' ' GLU . 39.2 ttmt -59.87 -43.41 94.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.146 -0.479 . . . . 2.48 111.088 -177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 67' ' ' ASP . 99.3 mttt . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.596 0.56 . . . . 4.9199999999999999 111.132 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.454 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 50.0 mt-30 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.579 0.228 . . . . 1.7 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -142.74 137.17 29.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.338 -0.245 . . . . 0.55000000000000004 110.338 174.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 42' ' ' MET . 10.7 m -91.09 147.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.726 -0.472 . . . . 0.33000000000000002 109.726 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 46.8 mt-10 -118.27 124.04 46.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.051 0.453 . . . . 1.74 111.36 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CZ ' HD23 ' A' ' 65' ' ' LEU . 82.7 m-85 -113.06 138.13 50.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.23000000000000001 110.039 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.67 121.21 37.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 0.34999999999999998 110.191 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.1 p -83.24 166.23 18.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.085 -0.507 . . . . 1.55 110.888 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.63 3.03 10.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.471 -0.786 . . . . 1.99 110.595 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -99.28 -0.29 41.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.274 -0.421 . . . . 1.74 110.461 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.98 9.04 58.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.927 -0.654 . . . . 0.62 113.464 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -111.36 156.26 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.351 0.576 . . . . 2.52 110.764 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -122.9 147.82 46.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.879 -0.786 . . . . 1.99 108.879 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -146.86 153.99 40.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 0.17999999999999999 111.178 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.33 138.17 47.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.55 -0.75 . . . . 1.3799999999999999 110.371 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.655 ' O ' HG22 ' A' ' 30' ' ' VAL . 62.9 mtm -136.91 147.82 60.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.85 -0.426 . . . . 0.62 109.85 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.69 123.27 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.049 1.833 . . . . 0.54000000000000004 112.746 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -125.28 -175.74 3.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.913 -0.773 . . . . 0.40000000000000002 108.913 173.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 7.4 m -88.08 132.16 34.4 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.447 -0.575 . . . . 1.3700000000000001 109.447 171.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 2.7 p -76.41 -12.06 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.429 0.633 . . . . 1.0 110.225 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.5 6.31 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.809 . . . . 1.25 110.357 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.23 160.37 14.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.34999999999999998 110.777 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -77.45 95.67 4.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.845 -0.798 . . . . 2.5899999999999999 108.845 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.77 117.72 23.15 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.41 -0.359 . . . . 0.35999999999999999 110.763 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 54.4 Cg_exo -51.85 125.33 16.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.161 2.574 . . . . 0.37 112.179 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -62.3 -12.14 25.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.378 2.719 . . . . 0.23999999999999999 113.217 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.58 143.51 16.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.451 -0.341 . . . . 1.74 110.418 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.6 t-105 -142.79 159.01 43.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.561 -0.903 . . . . 1.3999999999999999 108.561 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.79 144.81 55.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.99 0.424 . . . . 0.67000000000000004 110.656 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 3.6 t -83.17 107.84 16.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.09 -0.505 . . . . 0.31 110.794 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -4.37 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.957 -0.565 . . . . 0.81999999999999995 111.249 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.46 -60.43 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 111.896 0.332 . . . . 0.33000000000000002 111.896 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 53.1 t -108.51 -44.64 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.608 -0.437 . . . . 0.5 112.162 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 55.21 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.131 -1.033 . . . . 0.58999999999999997 111.785 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -153.8 -165.46 2.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.282 -0.636 . . . . 0.33000000000000002 109.282 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -99.71 149.56 23.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.485 -0.561 . . . . 1.3400000000000001 109.485 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -123.99 147.0 48.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.994 0.426 . . . . 0.22 110.677 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.83 139.26 35.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.078 -0.51 . . . . 0.27000000000000002 110.244 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD11 ' HA3' ' A' ' 68' ' ' GLY . 3.5 tm? -75.94 123.81 26.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 0.34000000000000002 109.111 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.05 110.62 28.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.91000000000000003 111.321 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 64.06 80.9 0.22 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.224 -0.898 . . . . 1.96 112.114 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.525 ' O ' ' HD2' ' A' ' 71' ' ' PRO . . . -140.88 -106.39 0.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 1.47 112.391 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.12 26.17 12.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.942 0.401 . . . . 3.25 111.199 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.51 -66.61 0.44 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.501 -0.856 . . . . 1.0600000000000001 112.728 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 74.0 Cg_endo -76.12 147.06 29.45 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.412 2.075 . . . . 1.24 111.833 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 44.2 mt-10 -88.41 -57.15 3.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.678 -0.692 . . . . 1.9199999999999999 110.897 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 30.1 tt0 -115.87 18.98 15.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.272 -0.877 . . . . 1.6499999999999999 110.961 -166.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -79.81 -45.59 18.48 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.614 . . . . 2.48 109.704 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.0 tttp . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.953 -1.023 . . . . 4.9199999999999999 111.274 -179.213 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 109.75 -0.463 . . . . 1.7 109.75 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.91 157.82 44.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.55000000000000004 111.011 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 42' ' ' MET . 11.5 m -102.69 157.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.709 -0.478 . . . . 0.33000000000000002 109.709 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 45.2 mt-10 -131.47 127.71 37.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.729 0.3 . . . . 1.74 111.218 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.98 144.08 46.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.454 -0.339 . . . . 0.23000000000000001 110.438 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.97 127.6 43.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.34999999999999998 110.449 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 30.9 p -90.34 168.32 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 1.55 110.978 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.97 -6.08 39.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.634 -0.712 . . . . 1.99 110.882 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 72.1 mmtt -84.57 -13.41 51.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 1.74 110.284 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.71 13.71 46.19 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.704 -0.68 . . . . 0.62 112.583 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -105.38 145.77 30.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 2.52 110.328 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -120.15 142.95 48.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.578 -0.527 . . . . 1.99 109.578 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -149.79 154.19 38.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.973 0.416 . . . . 0.17999999999999999 111.271 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.22 143.24 42.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.668 -0.696 . . . . 1.3799999999999999 109.955 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 30' ' ' VAL . 64.2 mtm -136.41 150.28 70.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.078 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.247 1.965 . . . . 0.54000000000000004 113.006 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.488 ' CD2' HG21 ' A' ' 30' ' ' VAL . 33.7 m-85 -141.69 -177.09 5.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.623 -0.717 . . . . 0.40000000000000002 109.604 177.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -104.17 144.55 31.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.232 0.539 . . . . 1.3700000000000001 110.334 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 4.3 p -76.81 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.645 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.42 22.54 15.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.067 -0.97 . . . . 1.25 110.034 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -119.51 146.07 45.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.005 -0.543 . . . . 0.34999999999999998 110.308 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.02 85.09 2.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.94 -0.763 . . . . 2.5899999999999999 108.94 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.0 mm -58.68 117.43 20.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.35999999999999999 110.45 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.8 Cg_exo -53.72 130.37 38.64 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.066 2.511 . . . . 0.37 112.291 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 37.8 Cg_exo -61.23 -11.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.151 2.567 . . . . 0.23999999999999999 112.929 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.08 137.4 14.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.531 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -137.21 158.74 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.939 -0.763 . . . . 1.3999999999999999 108.939 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.25 141.04 56.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.924 0.393 . . . . 0.67000000000000004 110.606 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.5 t -82.97 109.26 16.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.425 . . . . 0.31 110.842 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -14.05 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.792 -0.64 . . . . 0.81999999999999995 111.403 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.03 -60.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.016 0.376 . . . . 0.33000000000000002 112.016 -171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.518 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 42.5 t -110.91 -44.46 3.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.507 -0.477 . . . . 0.5 111.79 -172.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.67 55.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.215 -0.993 . . . . 0.58999999999999997 112.239 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.432 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -152.02 -162.9 1.61 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.986 -0.375 . . . . 0.33000000000000002 109.986 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -98.62 142.47 30.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.42 -0.585 . . . . 1.3400000000000001 109.42 170.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -117.2 138.97 51.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.939 0.4 . . . . 0.22 110.568 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.08 134.28 35.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.131 -0.486 . . . . 0.27000000000000002 110.192 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.4 tm? -68.69 118.59 11.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.667 -0.864 . . . . 0.34000000000000002 108.667 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -107.17 118.75 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.252 0.549 . . . . 0.91000000000000003 111.698 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' OD2' ' HE2' ' A' ' 75' ' ' LYS . 6.2 m-20 57.19 61.09 2.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.023 -0.989 . . . . 1.96 112.31 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.473 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -143.73 64.57 0.47 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.835 -0.906 . . . . 1.47 110.835 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -66.94 85.28 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.221 0.534 . . . . 3.25 110.353 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.44 -110.28 3.04 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.291 -0.868 . . . . 1.0600000000000001 112.332 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.74 137.71 67.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.674 2.249 . . . . 1.24 112.028 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 46' ' ' VAL . 18.1 pt-20 -67.74 151.41 47.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.136 -0.484 . . . . 1.9199999999999999 110.027 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 65.74 15.89 10.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.134 0.492 . . . . 1.6499999999999999 110.851 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -90.79 -56.4 3.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 2.48 110.472 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HE2' ' OD2' ' A' ' 67' ' ' ASP . 62.8 tttm . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.047 -0.978 . . . . 4.9199999999999999 110.264 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.726 0.298 . . . . 1.7 110.431 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.512 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -141.7 140.27 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.55000000000000004 110.545 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 42' ' ' MET . 12.1 m -86.39 148.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.145 -0.687 . . . . 0.33000000000000002 109.145 175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 34.8 tt0 -118.68 130.53 55.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.376 0.608 . . . . 1.74 111.431 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 76.5 m-85 -118.76 141.28 48.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.23000000000000001 109.94 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -127.64 113.57 16.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 0.34999999999999998 110.586 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.7 t -85.44 164.02 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.082 -0.508 . . . . 1.55 110.235 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.8 -11.66 56.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.213 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -72.38 -6.66 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 1.74 110.946 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.15 78.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.869 -0.682 . . . . 0.62 112.111 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -105.98 129.99 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.903 0.382 . . . . 2.52 110.661 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 62.1 mtt180 -105.91 153.23 22.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 1.99 109.803 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -154.91 153.04 30.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.936 0.398 . . . . 0.17999999999999999 110.571 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.452 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 7.4 pt-20 -105.49 139.61 39.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.704 -0.68 . . . . 1.3799999999999999 110.332 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.3 mtm -131.68 151.57 78.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.268 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.82 122.68 4.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.54000000000000004 112.894 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.469 ' CD1' HG21 ' A' ' 30' ' ' VAL . 16.2 m-85 -131.76 -176.78 4.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.231 -0.895 . . . . 0.40000000000000002 108.862 172.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 15.0 m -87.07 137.52 32.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.723 -0.473 . . . . 1.3700000000000001 109.723 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 3.2 p -73.98 -7.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.681 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.42 20.49 9.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.25 111.052 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.05 160.21 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.34999999999999998 110.462 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.56 106.53 9.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.077 -0.712 . . . . 2.5899999999999999 109.077 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mm -76.02 117.56 64.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.085 -0.339 . . . . 0.35999999999999999 110.085 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 51.5 Cg_exo -54.71 127.94 28.26 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.159 2.573 . . . . 0.37 112.614 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -60.78 -14.22 30.8 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.467 2.778 . . . . 0.23999999999999999 113.217 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.56 140.95 25.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.116 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -147.76 159.16 44.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 1.3999999999999999 109.363 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.68 142.4 58.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.67000000000000004 110.996 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 12.7 t -83.53 112.4 19.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.31 110.944 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.15 -12.45 60.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 0.81999999999999995 111.294 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.3 -59.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.184 0.439 . . . . 0.33000000000000002 112.184 -172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.5 t -114.17 -45.48 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.5 112.266 -173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 68.62 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.163 -1.017 . . . . 0.58999999999999997 111.696 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -163.52 -170.58 2.27 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.635 -0.505 . . . . 0.33000000000000002 109.635 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -99.57 117.37 33.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.009 -0.367 . . . . 1.3400000000000001 110.009 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -92.85 141.15 28.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.245 -0.434 . . . . 0.22 110.336 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.2 136.63 38.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.009 0.433 . . . . 0.27000000000000002 110.268 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 3.3 tm? -69.93 120.01 15.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.375 -0.829 . . . . 0.34000000000000002 109.543 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.59 139.31 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.376 -0.375 . . . . 0.91000000000000003 111.303 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 6.2 m-20 51.74 48.29 23.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.593 -0.73 . . . . 1.96 112.332 176.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.62 -178.82 19.73 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.564 -0.827 . . . . 1.47 111.966 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -168.19 -61.04 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.305 -0.998 . . . . 3.25 108.305 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.07 -68.24 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.058 -0.974 . . . . 1.0600000000000001 112.126 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 18.5 Cg_endo -60.16 123.64 13.59 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.046 1.831 . . . . 1.24 111.729 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 36.5 mt-10 -64.39 134.46 54.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 1.9199999999999999 110.276 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 27.7 tt0 67.27 22.81 9.52 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.604 0.565 . . . . 1.6499999999999999 111.433 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.35 -36.03 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.3 0.572 . . . . 2.48 109.869 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 32.1 mmmt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.417 -0.802 . . . . 4.9199999999999999 109.331 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.529 0.681 . . . . 1.7 110.234 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.71 135.08 27.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.55000000000000004 110.748 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 42' ' ' MET . 13.1 m -81.34 140.75 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.539 -0.541 . . . . 0.33000000000000002 109.539 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -117.16 130.26 56.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 1.74 111.347 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 93.1 m-85 -116.61 142.1 47.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.757 -0.656 . . . . 0.23000000000000001 109.793 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.4 122.47 42.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.8 0.333 . . . . 0.34999999999999998 110.587 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 31.5 p -83.53 170.64 14.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 1.55 111.142 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.09 -5.71 43.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.743 -0.662 . . . . 1.99 110.808 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.654 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 66.0 mmtt -86.41 -13.4 46.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.117 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.85 34.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.98 -0.629 . . . . 0.62 112.463 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -113.17 131.6 55.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.919 0.39 . . . . 2.52 110.078 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -105.51 145.39 30.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.99 109.808 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.28 153.13 43.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.735 0.302 . . . . 0.17999999999999999 110.937 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 13.1 pt-20 -106.43 144.26 33.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.772 -0.649 . . . . 1.3799999999999999 110.188 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' VAL . 52.8 mtm -139.38 148.52 57.0 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.342 -0.39 . . . . 0.62 110.059 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' MET . 3.3 Cg_exo -75.5 122.24 6.85 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.441 2.094 . . . . 0.54000000000000004 112.943 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CD2' HG21 ' A' ' 30' ' ' VAL . 7.3 m-85 -137.35 -176.19 4.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.359 -0.837 . . . . 0.40000000000000002 109.025 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.27 146.77 23.46 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.392 -0.595 . . . . 1.3700000000000001 109.392 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.28 -6.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 1.0 110.621 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.47 20.35 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 1.25 110.057 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 70' ' ' GLY . . . -108.67 152.43 24.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.849 -0.614 . . . . 0.34999999999999998 109.933 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -75.02 88.71 2.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.427 -0.583 . . . . 2.5899999999999999 109.427 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 30' ' ' VAL . 31.2 mm -58.81 116.08 14.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 0.35999999999999999 110.725 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 53.8 Cg_exo -52.8 131.42 41.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.42 2.747 . . . . 0.37 112.637 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 31.3 Cg_exo -61.43 -22.44 74.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.491 2.794 . . . . 0.23999999999999999 113.166 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.78 152.12 39.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.35 . . . . 1.74 110.16 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.4 t-105 -149.51 159.24 44.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.394 -0.595 . . . . 1.3999999999999999 109.394 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.37 143.79 56.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.67000000000000004 110.656 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.8 t -80.52 109.2 14.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.31 110.748 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.06 -10.16 59.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.81999999999999995 111.251 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.03 -60.27 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.127 0.417 . . . . 0.33000000000000002 112.127 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.6 t -112.47 -46.49 3.16 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.464 -0.495 . . . . 0.5 111.634 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 76.82 0.11 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.117 -1.039 . . . . 0.58999999999999997 112.315 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -171.61 -167.42 0.51 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.33000000000000002 109.347 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -98.56 140.34 32.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.142 -0.688 . . . . 1.3400000000000001 109.142 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -118.71 147.98 43.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.391 -0.368 . . . . 0.22 110.551 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.8 mt -99.57 136.63 39.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.107 -0.497 . . . . 0.27000000000000002 110.25 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 68' ' ' GLY . 3.0 tm? -70.65 123.28 21.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.553 -0.749 . . . . 0.34000000000000002 109.872 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.09 110.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.91000000000000003 110.638 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 66.64 93.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.522 -0.763 . . . . 1.96 111.581 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -174.5 -112.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.669 . . . . 1.47 112.366 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 55.57 39.41 30.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.565 0.698 . . . . 3.25 110.659 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 48' ' ' ALA . . . 147.73 -83.85 0.18 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.596 -0.729 . . . . 1.0600000000000001 111.705 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 73.7 Cg_endo -77.02 138.37 18.28 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.371 2.047 . . . . 1.24 111.209 174.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.0 -47.82 41.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.842 -0.617 . . . . 1.9199999999999999 111.311 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -137.33 33.03 2.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.635 -0.711 . . . . 1.6499999999999999 110.655 -168.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 40.1 ttmt -100.96 -13.16 18.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.51 0.672 . . . . 2.48 110.161 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.541 -0.754 . . . . 4.9199999999999999 109.799 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.593 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 77.6 mt-30 . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.951 0.405 . . . . 1.7 110.853 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -142.64 141.44 31.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.55000000000000004 109.957 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 42' ' ' MET . 10.6 m -96.26 142.62 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.781 -0.451 . . . . 0.33000000000000002 109.781 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.98 135.05 55.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.128 0.489 . . . . 1.74 111.069 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.718 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 79.9 m-85 -125.58 144.24 50.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.23000000000000001 110.442 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -131.22 117.74 19.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.151 -0.477 . . . . 0.34999999999999998 110.541 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' ' HG2' ' A' ' 36' ' ' LYS . 42.6 t -91.67 161.66 14.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.972 0.415 . . . . 1.55 110.258 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.29 -1.94 9.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 1.99 110.663 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HG2' ' SG ' ' A' ' 34' ' ' CYS . 74.7 mmtt -74.53 -15.18 60.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.598 . . . . 1.74 110.434 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.83 1.25 63.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.915 -0.66 . . . . 0.62 112.069 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -106.57 123.69 48.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.948 0.404 . . . . 2.52 110.766 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.427 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 61.4 mtt180 -99.12 155.15 17.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 1.99 109.67 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 34.0 p90 -156.02 156.23 34.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 0.17999999999999999 111.176 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.32 144.69 32.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.272 -0.876 . . . . 1.3799999999999999 109.506 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.606 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.7 mtm -137.66 148.93 63.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.637 0.256 . . . . 0.62 110.878 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.71 125.8 4.41 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.608 2.205 . . . . 0.54000000000000004 112.578 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HD2' HG21 ' A' ' 30' ' ' VAL . 4.9 m-85 -140.94 -177.11 4.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.64 . . . . 0.40000000000000002 110.236 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 6.4 m -89.06 140.5 29.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.859 -0.609 . . . . 1.3700000000000001 110.056 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 6.2 p -78.94 -6.21 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.557 0.694 . . . . 1.0 110.216 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.39 8.48 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 1.25 110.948 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -103.67 142.9 33.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.757 0.313 . . . . 0.34999999999999998 110.88 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.42 92.68 1.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.569 -0.53 . . . . 2.5899999999999999 109.569 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG11 ' A' ' 30' ' ' VAL . 27.9 mm -58.46 115.9 13.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.618 -0.719 . . . . 0.35999999999999999 110.519 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.9 Cg_exo -55.05 134.93 66.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.062 2.508 . . . . 0.37 112.48 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 21.8 Cg_exo -66.78 -5.15 12.55 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.457 2.771 . . . . 0.23999999999999999 112.836 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.67 137.22 16.83 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.365 -0.606 . . . . 1.74 109.365 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.718 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -148.4 159.84 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.755 0.312 . . . . 1.3999999999999999 110.87 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.09 135.12 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 0.67000000000000004 110.995 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.1 t -84.7 112.04 20.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.758 -0.655 . . . . 0.31 110.861 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.37 -14.37 60.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.81999999999999995 110.981 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.86 -59.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.705 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.2 t -112.11 -46.35 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.418 -0.513 . . . . 0.5 112.001 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.9 56.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.871 -1.157 . . . . 0.58999999999999997 112.662 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -150.67 -173.09 4.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.914 0.357 . . . . 0.33000000000000002 110.361 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.75 105.17 17.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.795 -0.446 . . . . 1.3400000000000001 109.795 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . . . -83.73 142.83 30.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.852 -0.613 . . . . 0.22 110.745 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.1 mt -90.72 136.44 33.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.276 0.56 . . . . 0.27000000000000002 110.249 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 2.5 tm? -66.89 130.0 41.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.11 -0.95 . . . . 0.34000000000000002 109.888 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.3 113.23 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.975 0.417 . . . . 0.91000000000000003 110.859 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 63.2 73.41 0.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.457 -0.792 . . . . 1.96 111.422 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' CA ' HD11 ' A' ' 65' ' ' LEU . . . -157.69 -103.52 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.679 -0.691 . . . . 1.47 111.52 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 71.54 -41.65 0.51 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.697 0.799 . . . . 3.25 111.894 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.56 -67.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.488 -0.645 . . . . 1.0600000000000001 111.488 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.24 152.9 45.41 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.218 1.945 . . . . 1.24 112.466 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' OE2' ' HB3' ' A' ' 28' ' ' GLN . 19.5 pt-20 -112.83 117.16 31.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 1.9199999999999999 109.906 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 7.5 tp10 61.92 82.19 0.18 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.445 0.64 . . . . 1.6499999999999999 110.264 -176.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.91 -26.17 0.35 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 2.48 110.577 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.544 . . . . 4.9199999999999999 110.357 179.192 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.55 109.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 42' ' ' MET . 14.3 m -81.43 147.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.962 -0.384 . . . . 0.33 109.962 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 57.6 tt0 -121.05 121.44 37.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.246 0.546 . . . . 1.74 110.937 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 80.4 m-85 -112.61 141.18 46.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.564 -0.743 . . . . 0.23 110.075 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -122.97 118.74 28.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 0.35 110.503 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 28.3 p -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.899 0.38 . . . . 1.55 110.498 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG3' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -74.36 0.14 15.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 1.99 110.894 178.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.717 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 69.5 mmtt -75.9 -21.85 56.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.227 -0.657 . . . . 1.74 109.227 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.08 5.05 41.23 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.282 -0.872 . . . . 0.62 112.303 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -103.79 143.8 32.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 2.52 110.701 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 55.5 mtt180 -113.61 144.51 42.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.288 -0.414 . . . . 1.99 109.914 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.95 153.41 41.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.244 -0.435 . . . . 0.18 110.659 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 11.1 pt-20 -110.84 143.64 41.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 1.38 110.351 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.639 ' O ' HG22 ' A' ' 30' ' ' VAL . 63.1 mtm -137.37 151.63 71.73 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.227 -0.442 . . . . 0.62 109.82 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.75 122.86 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.039 1.826 . . . . 0.54 112.688 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 30' ' ' VAL . 11.3 m-85 -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.798 -0.637 . . . . 0.4 109.33 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 21.9 t -84.36 137.87 33.18 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.29 -0.633 . . . . 1.37 109.29 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.01 -5.75 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.285 0.564 . . . . 1.0 110.618 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.69 13.85 19.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.572 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -98.91 160.21 14.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.35 110.767 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.65 91.83 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.734 -0.839 . . . . 2.59 108.734 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.472 HG22 ' HG ' ' A' ' 65' ' ' LEU . 21.3 mm -58.3 120.89 47.83 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.36 111.08 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 56.1 Cg_exo -52.51 129.05 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.385 2.723 . . . . 0.37 112.215 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 22.9 Cg_exo -64.56 -17.28 59.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.154 2.569 . . . . 0.24 113.112 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.23 148.88 33.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.885 0.374 . . . . 1.74 110.353 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 32.4 t-105 -146.25 159.25 43.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.745 -0.835 . . . . 1.4 108.745 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.58 142.43 56.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.82 0.343 . . . . 0.67 110.194 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.7 t -77.79 109.04 11.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.31 110.645 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -14.4 60.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.854 -0.612 . . . . 0.82 111.315 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.54 -60.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.096 0.406 . . . . 0.33 112.096 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 43.6 t -125.15 -42.62 2.0 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.31 -0.556 . . . . 0.5 112.228 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.77 92.85 0.38 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.003 -1.094 . . . . 0.59 112.266 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 35' ' ' GLU . . . -178.75 -177.7 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.847 -0.427 . . . . 0.33 109.847 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -98.0 123.19 41.89 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.63 -0.878 . . . . 1.34 108.63 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -102.33 129.21 48.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.138 -0.483 . . . . 0.22 110.819 -176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.52 136.61 33.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.991 -0.549 . . . . 0.27 110.141 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.489 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.3 tm? -78.98 131.77 36.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.512 -0.767 . . . . 0.34 109.123 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 116.496 -0.32 . . . . 0.91 110.27 -179.511 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.903 -0.406 . . . . 0.55 109.903 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 42' ' ' MET . 3.2 m -87.86 144.65 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.167 -0.679 . . . . 0.33 109.167 176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 37.8 tt0 -119.59 128.09 53.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.312 0.577 . . . . 1.74 110.673 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 61.1 m-85 -113.83 139.26 49.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.436 -0.802 . . . . 0.23 109.844 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 119.54 35.48 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.315 -0.254 . . . . 0.35 110.315 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 21.1 p -80.51 172.07 14.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.462 . . . . 1.55 111.967 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 41.6 mt-10 -64.81 -21.41 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.705 . . . . 1.99 110.994 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.15 0.03 54.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 1.74 111.037 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.31 31.1 43.1 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.862 -0.685 . . . . 0.62 112.589 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -113.42 127.46 56.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 2.52 109.545 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 49.5 mtt180 -99.51 141.34 32.43 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.661 -0.496 . . . . 1.99 109.661 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -142.51 153.4 43.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.868 -0.605 . . . . 0.18 110.385 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.83 135.81 41.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 1.38 110.057 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 30' ' ' VAL . 65.4 mmm -125.73 146.64 55.73 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.714 -0.675 . . . . 0.62 110.188 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.57 122.46 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.036 1.824 . . . . 0.54 112.775 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -143.25 -177.42 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.656 -0.702 . . . . 0.4 109.276 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 24.0 t -93.2 143.21 26.48 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.654 -0.498 . . . . 1.37 109.654 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.24 -1.28 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.751 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -127.17 21.11 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.766 -0.652 . . . . 1.25 110.761 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -109.77 172.02 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.35 110.078 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 33.8 tt0 -76.05 118.23 18.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 2.59 109.181 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.8 mm -89.79 106.03 12.91 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.164 -0.68 . . . . 0.36 109.164 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 49' ' ' GLU . 63.9 Cg_exo -51.99 124.95 15.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.232 2.621 . . . . 0.37 112.449 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 51.1 Cg_exo -55.22 -19.3 20.76 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.634 2.889 . . . . 0.24 113.429 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.65 152.86 38.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.74 110.551 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 34.7 t-105 -149.05 160.72 43.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.949 -0.759 . . . . 1.4 108.949 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -75.89 143.68 41.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.4 . . . . 0.67 110.412 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.4 t -83.58 97.76 9.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.307 0.575 . . . . 0.31 110.357 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 9.8 mmpt? -77.07 11.0 1.99 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.347 -0.842 . . . . 0.82 111.694 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.85 -60.71 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.623 0.249 . . . . 0.33 111.102 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t -108.9 -45.76 3.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.913 -0.315 . . . . 0.5 111.282 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.72 55.67 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.445 -0.883 . . . . 0.59 112.156 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -149.29 -167.21 2.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.985 -0.376 . . . . 0.33 109.985 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 tt0 -99.55 148.4 24.33 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.493 -0.558 . . . . 1.34 109.493 171.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -124.86 147.43 48.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.966 0.412 . . . . 0.22 111.293 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.0 mt -104.0 137.03 42.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.27 109.976 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.4 tm? -73.18 132.08 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.513 -0.767 . . . . 0.34 109.629 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 66' ' ' VAL . 33.9 m . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 0.91 110.91 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.3 -0.259 . . . . 0.55 110.3 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 42' ' ' MET . 15.2 m -80.0 154.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.18 -0.304 . . . . 0.33 110.18 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 6.7 tp10 -116.37 135.87 53.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 1.74 110.724 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.77 136.4 49.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.384 -0.371 . . . . 0.23 110.028 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.38 121.98 35.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.272 -0.422 . . . . 0.35 110.505 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.3 p -86.58 159.77 19.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.091 0.472 . . . . 1.55 110.219 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.86 4.74 5.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 1.99 110.515 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mmmt -91.71 -16.9 26.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 1.74 109.437 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.11 -3.66 22.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.672 -0.775 . . . . 0.62 113.711 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -100.54 143.33 30.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.408 0.604 . . . . 2.52 111.974 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -113.31 148.25 36.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.402 -0.817 . . . . 1.99 108.977 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.82 152.26 30.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.945 0.402 . . . . 0.18 111.011 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 10.1 pt-20 -108.42 138.14 45.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.818 -0.628 . . . . 1.38 110.158 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 37.5 mtm -130.7 152.64 80.83 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.601 -0.272 . . . . 0.62 110.572 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.52 122.91 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.198 1.932 . . . . 0.54 113.069 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HG21 ' A' ' 30' ' ' VAL . 23.8 m-85 -137.54 -175.89 4.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.261 -0.881 . . . . 0.4 109.368 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 33.9 t -86.95 144.05 27.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.41 -0.589 . . . . 1.37 109.41 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.72 2.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.494 0.664 . . . . 1.0 110.426 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.8 5.89 7.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.101 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -97.03 147.33 24.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.805 0.336 . . . . 0.35 110.959 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.73 89.5 1.35 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.386 0.612 . . . . 2.59 109.814 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 mm -58.65 124.26 71.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.182 -0.917 . . . . 0.36 110.691 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 11.4 Cg_endo -55.58 129.64 36.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.056 2.504 . . . . 0.37 112.295 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -59.68 -16.28 36.1 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.509 2.806 . . . . 0.24 113.626 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 151.04 36.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.995 -0.372 . . . . 1.74 109.995 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -146.52 159.66 43.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.31 -0.626 . . . . 1.4 109.31 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 139.3 57.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.962 0.41 . . . . 0.67 110.653 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.8 t -79.04 110.07 13.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.006 0.431 . . . . 0.31 111.098 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 1.1 mpmm? -76.68 -5.94 50.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.82 111.642 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -83.82 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.09 -0.244 . . . . 0.33 111.638 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.27 -44.45 2.58 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.589 -0.444 . . . . 0.5 112.081 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.12 75.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.252 -0.975 . . . . 0.59 112.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -165.85 -168.69 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.409 -0.589 . . . . 0.33 109.409 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -98.39 133.43 42.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 1.34 109.903 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -110.66 132.82 53.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 0.22 110.426 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.74 137.5 32.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.234 -0.439 . . . . 0.27 110.164 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 31' ' ' GLU . 2.7 tm? -71.23 121.9 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 0.34 110.018 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 77.8 t . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.694 -0.685 . . . . 0.91 109.892 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.979 -0.378 . . . . 0.55 109.979 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 42' ' ' MET . 22.0 m -88.89 153.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 110.154 -0.313 . . . . 0.33 110.154 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 37.5 mt-10 -114.68 120.11 39.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.425 -0.352 . . . . 1.74 111.207 -173.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.5 m-85 -112.94 141.05 47.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.474 -0.33 . . . . 0.23 110.488 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -135.37 126.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.35 110.446 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 19.5 p -89.39 -177.05 5.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.55 111.41 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.64 -14.18 62.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.668 . . . . 1.99 112.438 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HE3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -87.64 -25.51 23.5 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.43 0.633 . . . . 1.74 110.3 176.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.39 5.35 40.01 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.283 -0.872 . . . . 0.62 111.331 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 39.0 m80 -68.39 102.24 1.38 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.746 -0.464 . . . . 2.52 109.746 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mtt180 -98.22 141.95 30.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.034 -0.53 . . . . 1.99 110.491 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -151.0 153.4 35.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.603 -0.726 . . . . 0.18 110.486 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.0 mt-10 -104.58 138.64 40.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 1.38 110.097 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 30' ' ' VAL . 42.8 mtm -135.25 146.16 56.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.773 -0.454 . . . . 0.62 109.773 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.91 121.83 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.029 1.819 . . . . 0.54 113.314 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.16 -175.87 3.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.221 -0.9 . . . . 0.4 108.945 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 29.0 t -81.0 135.77 35.9 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.3 -0.63 . . . . 1.37 109.3 171.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.58 -4.15 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.43 0.633 . . . . 1.0 110.579 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.6 19.96 11.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 1.25 110.402 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -108.32 161.23 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.075 0.464 . . . . 0.35 111.075 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.79 88.66 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 2.59 109.533 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.1 mm -58.8 121.27 52.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.588 -0.733 . . . . 0.36 110.909 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.47 127.38 25.21 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.939 2.426 . . . . 0.37 111.802 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 42.7 Cg_exo -58.9 -8.99 6.78 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.757 2.972 . . . . 0.24 114.314 -176.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.48 148.22 27.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.711 0.291 . . . . 1.74 110.731 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 23.5 t-105 -151.7 158.18 43.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.716 -0.846 . . . . 1.4 108.716 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.24 142.71 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.117 0.484 . . . . 0.67 111.183 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 6.0 t -79.59 103.83 9.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.717 -0.674 . . . . 0.31 111.127 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 7.94 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.82 111.636 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.83 -59.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.114 0.413 . . . . 0.33 112.114 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -110.42 -45.28 3.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.203 0.446 . . . . 0.5 112.203 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.64 68.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.096 -1.05 . . . . 0.59 112.18 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -172.99 -166.04 0.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.33 109.139 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -99.43 146.77 25.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.66 -0.416 . . . . 1.34 109.987 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -119.62 148.33 43.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.22 110.306 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -102.88 140.55 37.01 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.044 0.45 . . . . 0.27 110.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.3 tm? -74.17 112.61 10.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.418 -0.81 . . . . 0.34 109.059 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 121.301 0.572 . . . . 0.91 112.041 -173.075 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.566 0.222 . . . . 0.55 111.02 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 42' ' ' MET . 19.6 m -96.65 141.63 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.295 -0.632 . . . . 0.33 109.295 172.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 34.8 tt0 -119.23 126.58 51.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.365 0.602 . . . . 1.74 111.15 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 94.4 m-85 -115.52 136.66 52.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.387 -0.824 . . . . 0.23 109.821 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.31 117.44 23.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.942 0.401 . . . . 0.35 110.755 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 15.8 t -82.93 156.24 23.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.55 109.702 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.22 -3.32 19.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.783 -0.644 . . . . 1.99 110.875 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -75.82 -21.27 57.47 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.373 -0.602 . . . . 1.74 109.373 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.36 -16.42 17.27 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.62 112.358 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -73.92 128.01 34.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 2.52 111.762 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -110.8 153.07 25.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.144 -0.688 . . . . 1.99 109.144 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 32.3 p90 -161.59 153.3 19.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.522 -0.308 . . . . 0.18 110.576 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 pt-20 -112.19 142.56 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.966 -0.561 . . . . 1.38 110.527 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 30' ' ' VAL . 68.5 mtm -133.72 155.08 80.76 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.611 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.0 122.98 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.376 2.051 . . . . 0.54 112.941 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CD2' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -142.3 -176.87 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.252 -0.885 . . . . 0.4 109.106 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 26.0 t -94.36 140.41 29.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.113 0.482 . . . . 1.37 110.04 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.24 -12.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.582 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.88 9.68 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 1.25 110.406 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -94.82 161.81 14.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.35 110.595 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.61 84.15 6.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.29 -0.633 . . . . 2.59 109.29 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.7 mm -57.75 117.29 18.1 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.36 110.697 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 77.9 Cg_exo -51.5 132.59 40.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.544 2.829 . . . . 0.37 112.742 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -60.63 -18.73 56.71 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.334 2.689 . . . . 0.24 112.861 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 150.29 42.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.195 -0.298 . . . . 1.74 110.195 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.7 t-105 -149.86 155.4 39.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 1.4 109.377 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.65 140.69 58.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.087 0.47 . . . . 0.67 110.555 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 15.4 t -80.54 110.46 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.584 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.32 -2.98 30.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.681 -0.69 . . . . 0.82 111.329 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 -60.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.113 0.412 . . . . 0.33 112.113 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.0 t -105.6 -47.35 3.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.236 -0.586 . . . . 0.5 112.411 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 55.52 0.08 OUTLIER Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.942 -1.123 . . . . 0.59 112.596 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -154.33 -170.94 3.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.314 -0.625 . . . . 0.33 109.314 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -98.35 122.61 41.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 1.34 109.842 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -98.68 139.58 34.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 0.22 110.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.73 135.44 34.1 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.885 0.374 . . . . 0.27 110.163 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -68.99 117.37 10.56 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.913 -0.773 . . . . 0.34 108.913 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.215 0.531 . . . . 0.91 111.591 -174.605 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 110.338 -0.245 . . . . 0.55 110.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 42' ' ' MET . 10.7 m -91.09 147.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.726 -0.472 . . . . 0.33 109.726 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 46.8 mt-10 -118.27 124.04 46.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.051 0.453 . . . . 1.74 111.36 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CZ ' HD23 ' A' ' 65' ' ' LEU . 82.7 m-85 -113.06 138.13 50.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.23 110.039 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.67 121.21 37.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 0.35 110.191 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.1 p -83.24 166.23 18.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.085 -0.507 . . . . 1.55 110.888 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.63 3.03 10.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.471 -0.786 . . . . 1.99 110.595 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -99.28 -0.29 41.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.274 -0.421 . . . . 1.74 110.461 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.98 9.04 58.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.927 -0.654 . . . . 0.62 113.464 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -111.36 156.26 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.351 0.576 . . . . 2.52 110.764 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -122.9 147.82 46.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.879 -0.786 . . . . 1.99 108.879 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -146.86 153.99 40.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 0.18 111.178 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.33 138.17 47.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.55 -0.75 . . . . 1.38 110.371 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.655 ' O ' HG22 ' A' ' 30' ' ' VAL . 62.9 mtm -136.91 147.82 60.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.85 -0.426 . . . . 0.62 109.85 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.69 123.27 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.049 1.833 . . . . 0.54 112.746 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -125.28 -175.74 3.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.913 -0.773 . . . . 0.4 108.913 173.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 7.4 m -88.08 132.16 34.4 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.447 -0.575 . . . . 1.37 109.447 171.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -76.41 -12.06 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.429 0.633 . . . . 1.0 110.225 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.5 6.31 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.809 . . . . 1.25 110.357 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.23 160.37 14.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.35 110.777 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -77.45 95.67 4.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.845 -0.798 . . . . 2.59 108.845 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.77 117.72 23.15 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.41 -0.359 . . . . 0.36 110.763 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 54.4 Cg_exo -51.85 125.33 16.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.161 2.574 . . . . 0.37 112.179 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -62.3 -12.14 25.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.378 2.719 . . . . 0.24 113.217 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.58 143.51 16.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.451 -0.341 . . . . 1.74 110.418 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.6 t-105 -142.79 159.01 43.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.561 -0.903 . . . . 1.4 108.561 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.79 144.81 55.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.99 0.424 . . . . 0.67 110.656 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 3.6 t -83.17 107.84 16.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.09 -0.505 . . . . 0.31 110.794 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -4.37 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.957 -0.565 . . . . 0.82 111.249 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.46 -60.43 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 111.896 0.332 . . . . 0.33 111.896 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 53.1 t -108.51 -44.64 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.608 -0.437 . . . . 0.5 112.162 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 55.21 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.131 -1.033 . . . . 0.59 111.785 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -153.8 -165.46 2.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.282 -0.636 . . . . 0.33 109.282 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -99.71 149.56 23.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.485 -0.561 . . . . 1.34 109.485 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -123.99 147.0 48.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.994 0.426 . . . . 0.22 110.677 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.83 139.26 35.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.078 -0.51 . . . . 0.27 110.244 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -75.94 123.81 26.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 0.34 109.111 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.91 111.321 -176.618 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.32 0 CA-C-O 120.599 0.238 . . . . 0.55 111.011 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 42' ' ' MET . 11.5 m -102.69 157.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.709 -0.478 . . . . 0.33 109.709 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 45.2 mt-10 -131.47 127.71 37.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.729 0.3 . . . . 1.74 111.218 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.98 144.08 46.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.454 -0.339 . . . . 0.23 110.438 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.97 127.6 43.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.35 110.449 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 30.9 p -90.34 168.32 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 1.55 110.978 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.97 -6.08 39.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.634 -0.712 . . . . 1.99 110.882 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 72.1 mmtt -84.57 -13.41 51.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 1.74 110.284 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.71 13.71 46.19 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.704 -0.68 . . . . 0.62 112.583 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -105.38 145.77 30.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 2.52 110.328 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -120.15 142.95 48.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.578 -0.527 . . . . 1.99 109.578 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -149.79 154.19 38.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.973 0.416 . . . . 0.18 111.271 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.22 143.24 42.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.668 -0.696 . . . . 1.38 109.955 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 30' ' ' VAL . 64.2 mtm -136.41 150.28 70.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.078 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.247 1.965 . . . . 0.54 113.006 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.488 ' CD2' HG21 ' A' ' 30' ' ' VAL . 33.7 m-85 -141.69 -177.09 5.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.623 -0.717 . . . . 0.4 109.604 177.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -104.17 144.55 31.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.232 0.539 . . . . 1.37 110.334 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -76.81 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.645 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.42 22.54 15.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.067 -0.97 . . . . 1.25 110.034 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -119.51 146.07 45.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.005 -0.543 . . . . 0.35 110.308 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.02 85.09 2.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.94 -0.763 . . . . 2.59 108.94 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.0 mm -58.68 117.43 20.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.36 110.45 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.8 Cg_exo -53.72 130.37 38.64 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.066 2.511 . . . . 0.37 112.291 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 37.8 Cg_exo -61.23 -11.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.151 2.567 . . . . 0.24 112.929 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.08 137.4 14.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.531 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -137.21 158.74 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.939 -0.763 . . . . 1.4 108.939 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.25 141.04 56.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.924 0.393 . . . . 0.67 110.606 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.5 t -82.97 109.26 16.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.425 . . . . 0.31 110.842 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -14.05 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.792 -0.64 . . . . 0.82 111.403 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.03 -60.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.016 0.376 . . . . 0.33 112.016 -171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.518 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 42.5 t -110.91 -44.46 3.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.507 -0.477 . . . . 0.5 111.79 -172.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.67 55.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.215 -0.993 . . . . 0.59 112.239 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.432 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -152.02 -162.9 1.61 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.986 -0.375 . . . . 0.33 109.986 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -98.62 142.47 30.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.42 -0.585 . . . . 1.34 109.42 170.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -117.2 138.97 51.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.939 0.4 . . . . 0.22 110.568 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.08 134.28 35.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.131 -0.486 . . . . 0.27 110.192 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.4 tm? -68.69 118.59 11.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.667 -0.864 . . . . 0.34 108.667 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 C--N 1.322 -0.609 0 CA-C-O 121.252 0.549 . . . . 0.91 111.698 -175.24 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 41' ' ' GLU . . . . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.563 0.22 . . . . 0.55 110.545 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 42' ' ' MET . 12.1 m -86.39 148.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.145 -0.687 . . . . 0.33 109.145 175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 34.8 tt0 -118.68 130.53 55.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.376 0.608 . . . . 1.74 111.431 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 76.5 m-85 -118.76 141.28 48.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.23 109.94 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -127.64 113.57 16.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 0.35 110.586 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.7 t -85.44 164.02 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.082 -0.508 . . . . 1.55 110.235 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.8 -11.66 56.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.213 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -72.38 -6.66 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 1.74 110.946 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.15 78.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.869 -0.682 . . . . 0.62 112.111 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -105.98 129.99 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.903 0.382 . . . . 2.52 110.661 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 62.1 mtt180 -105.91 153.23 22.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 1.99 109.803 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -154.91 153.04 30.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.936 0.398 . . . . 0.18 110.571 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.452 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 7.4 pt-20 -105.49 139.61 39.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.704 -0.68 . . . . 1.38 110.332 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.3 mtm -131.68 151.57 78.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.268 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.82 122.68 4.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.54 112.894 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.469 ' CD1' HG21 ' A' ' 30' ' ' VAL . 16.2 m-85 -131.76 -176.78 4.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.231 -0.895 . . . . 0.4 108.862 172.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 15.0 m -87.07 137.52 32.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.723 -0.473 . . . . 1.37 109.723 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -73.98 -7.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.681 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.42 20.49 9.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.25 111.052 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.05 160.21 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.35 110.462 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.56 106.53 9.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.077 -0.712 . . . . 2.59 109.077 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mm -76.02 117.56 64.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.085 -0.339 . . . . 0.36 110.085 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 51.5 Cg_exo -54.71 127.94 28.26 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.159 2.573 . . . . 0.37 112.614 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -60.78 -14.22 30.8 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.467 2.778 . . . . 0.24 113.217 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.56 140.95 25.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.116 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -147.76 159.16 44.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 1.4 109.363 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.68 142.4 58.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.67 110.996 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 12.7 t -83.53 112.4 19.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.31 110.944 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.15 -12.45 60.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 0.82 111.294 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.3 -59.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.184 0.439 . . . . 0.33 112.184 -172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.5 t -114.17 -45.48 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.5 112.266 -173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 68.62 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.163 -1.017 . . . . 0.59 111.696 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -163.52 -170.58 2.27 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.635 -0.505 . . . . 0.33 109.635 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -99.57 117.37 33.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.009 -0.367 . . . . 1.34 110.009 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -92.85 141.15 28.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.245 -0.434 . . . . 0.22 110.336 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.2 136.63 38.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.009 0.433 . . . . 0.27 110.268 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 3.3 tm? -69.93 120.01 15.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.375 -0.829 . . . . 0.34 109.543 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.376 -0.375 . . . . 0.91 111.303 -176.154 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.748 -0.093 . . . . 0.55 110.748 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 42' ' ' MET . 13.1 m -81.34 140.75 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.539 -0.541 . . . . 0.33 109.539 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -117.16 130.26 56.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 1.74 111.347 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 93.1 m-85 -116.61 142.1 47.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.757 -0.656 . . . . 0.23 109.793 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.4 122.47 42.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.8 0.333 . . . . 0.35 110.587 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 31.5 p -83.53 170.64 14.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 1.55 111.142 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.09 -5.71 43.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.743 -0.662 . . . . 1.99 110.808 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.654 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 66.0 mmtt -86.41 -13.4 46.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.117 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.85 34.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.98 -0.629 . . . . 0.62 112.463 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -113.17 131.6 55.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.919 0.39 . . . . 2.52 110.078 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -105.51 145.39 30.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.99 109.808 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.28 153.13 43.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.735 0.302 . . . . 0.18 110.937 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 13.1 pt-20 -106.43 144.26 33.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.772 -0.649 . . . . 1.38 110.188 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' VAL . 52.8 mtm -139.38 148.52 57.0 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.342 -0.39 . . . . 0.62 110.059 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' MET . 3.3 Cg_exo -75.5 122.24 6.85 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.441 2.094 . . . . 0.54 112.943 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CD2' HG21 ' A' ' 30' ' ' VAL . 7.3 m-85 -137.35 -176.19 4.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.359 -0.837 . . . . 0.4 109.025 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.27 146.77 23.46 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.392 -0.595 . . . . 1.37 109.392 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.28 -6.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 1.0 110.621 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.47 20.35 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 1.25 110.057 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -108.67 152.43 24.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.849 -0.614 . . . . 0.35 109.933 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -75.02 88.71 2.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.427 -0.583 . . . . 2.59 109.427 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 30' ' ' VAL . 31.2 mm -58.81 116.08 14.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 0.36 110.725 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 53.8 Cg_exo -52.8 131.42 41.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.42 2.747 . . . . 0.37 112.637 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 31.3 Cg_exo -61.43 -22.44 74.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.491 2.794 . . . . 0.24 113.166 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.78 152.12 39.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.35 . . . . 1.74 110.16 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.4 t-105 -149.51 159.24 44.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.394 -0.595 . . . . 1.4 109.394 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.37 143.79 56.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.67 110.656 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.8 t -80.52 109.2 14.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.31 110.748 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.06 -10.16 59.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.82 111.251 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.03 -60.27 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.127 0.417 . . . . 0.33 112.127 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.6 t -112.47 -46.49 3.16 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.464 -0.495 . . . . 0.5 111.634 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 76.82 0.11 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.117 -1.039 . . . . 0.59 112.315 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -171.61 -167.42 0.51 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.33 109.347 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -98.56 140.34 32.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.142 -0.688 . . . . 1.34 109.142 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -118.71 147.98 43.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.391 -0.368 . . . . 0.22 110.551 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.8 mt -99.57 136.63 39.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.107 -0.497 . . . . 0.27 110.25 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 3.0 tm? -70.65 123.28 21.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.553 -0.749 . . . . 0.34 109.872 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.91 110.638 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.957 -0.386 . . . . 0.55 109.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 42' ' ' MET . 10.6 m -96.26 142.62 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.781 -0.451 . . . . 0.33 109.781 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.98 135.05 55.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.128 0.489 . . . . 1.74 111.069 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.718 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 79.9 m-85 -125.58 144.24 50.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.23 110.442 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -131.22 117.74 19.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.151 -0.477 . . . . 0.35 110.541 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' ' HG2' ' A' ' 36' ' ' LYS . 42.6 t -91.67 161.66 14.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.972 0.415 . . . . 1.55 110.258 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.29 -1.94 9.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 1.99 110.663 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HG2' ' SG ' ' A' ' 34' ' ' CYS . 74.7 mmtt -74.53 -15.18 60.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.598 . . . . 1.74 110.434 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.83 1.25 63.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.915 -0.66 . . . . 0.62 112.069 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -106.57 123.69 48.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.948 0.404 . . . . 2.52 110.766 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.427 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 61.4 mtt180 -99.12 155.15 17.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 1.99 109.67 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 34.0 p90 -156.02 156.23 34.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 0.18 111.176 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.32 144.69 32.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.272 -0.876 . . . . 1.38 109.506 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.606 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.7 mtm -137.66 148.93 63.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.637 0.256 . . . . 0.62 110.878 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.71 125.8 4.41 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.608 2.205 . . . . 0.54 112.578 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HD2' HG21 ' A' ' 30' ' ' VAL . 4.9 m-85 -140.94 -177.11 4.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.64 . . . . 0.4 110.236 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 6.4 m -89.06 140.5 29.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.859 -0.609 . . . . 1.37 110.056 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.94 -6.21 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.557 0.694 . . . . 1.0 110.216 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.39 8.48 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 1.25 110.948 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -103.67 142.9 33.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.757 0.313 . . . . 0.35 110.88 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.42 92.68 1.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.569 -0.53 . . . . 2.59 109.569 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG11 ' A' ' 30' ' ' VAL . 27.9 mm -58.46 115.9 13.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.618 -0.719 . . . . 0.36 110.519 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.9 Cg_exo -55.05 134.93 66.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.062 2.508 . . . . 0.37 112.48 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 21.8 Cg_exo -66.78 -5.15 12.55 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.457 2.771 . . . . 0.24 112.836 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.67 137.22 16.83 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.365 -0.606 . . . . 1.74 109.365 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.718 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -148.4 159.84 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.755 0.312 . . . . 1.4 110.87 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.09 135.12 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 0.67 110.995 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.1 t -84.7 112.04 20.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.758 -0.655 . . . . 0.31 110.861 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.37 -14.37 60.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.82 110.981 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.86 -59.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.346 -0.388 . . . . 0.33 111.705 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.2 t -112.11 -46.35 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.418 -0.513 . . . . 0.5 112.001 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.9 56.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.871 -1.157 . . . . 0.59 112.662 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.513 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -150.67 -173.09 4.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.914 0.357 . . . . 0.33 110.361 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.75 105.17 17.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.795 -0.446 . . . . 1.34 109.795 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . . . -83.73 142.83 30.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.852 -0.613 . . . . 0.22 110.745 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.1 mt -90.72 136.44 33.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.276 0.56 . . . . 0.27 110.249 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 2.5 tm? -66.89 130.0 41.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.11 -0.95 . . . . 0.34 109.888 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.975 0.417 . . . . 0.91 110.859 179.774 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.812 0.339 . . . . 1.7 110.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -141.4 140.87 33.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.82 -0.437 . . . . 0.55 109.82 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 42' ' ' MET . 14.3 m -81.43 147.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.962 -0.384 . . . . 0.33 109.962 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 57.6 tt0 -121.05 121.44 37.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.246 0.546 . . . . 1.74 110.937 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 80.4 m-85 -112.61 141.18 46.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.564 -0.743 . . . . 0.23 110.075 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -122.97 118.74 28.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 0.35 110.503 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 28.3 p -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.899 0.38 . . . . 1.55 110.498 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG3' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -74.36 0.14 15.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 1.99 110.894 178.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.717 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 69.5 mmtt -75.9 -21.85 56.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.227 -0.657 . . . . 1.74 109.227 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.08 5.05 41.23 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.282 -0.872 . . . . 0.62 112.303 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -103.79 143.8 32.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 2.52 110.701 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.531 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 55.5 mtt180 -113.61 144.51 42.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.288 -0.414 . . . . 1.99 109.914 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.95 153.41 41.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.244 -0.435 . . . . 0.18 110.659 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 11.1 pt-20 -110.84 143.64 41.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 1.38 110.351 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.639 ' O ' HG22 ' A' ' 30' ' ' VAL . 63.1 mtm -137.37 151.63 71.73 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.227 -0.442 . . . . 0.62 109.82 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.75 122.86 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.039 1.826 . . . . 0.54 112.688 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 30' ' ' VAL . 11.3 m-85 -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.798 -0.637 . . . . 0.4 109.33 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 21.9 t -84.36 137.87 33.18 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.29 -0.633 . . . . 1.37 109.29 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 3.8 p -81.01 -5.75 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.285 0.564 . . . . 1.0 110.618 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.69 13.85 19.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.572 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -98.91 160.21 14.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.35 110.767 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.65 91.83 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.734 -0.839 . . . . 2.59 108.734 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.472 HG22 ' HG ' ' A' ' 65' ' ' LEU . 21.3 mm -58.3 120.89 47.83 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.36 111.08 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 56.1 Cg_exo -52.51 129.05 30.29 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.385 2.723 . . . . 0.37 112.215 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 22.9 Cg_exo -64.56 -17.28 59.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.154 2.569 . . . . 0.24 113.112 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.23 148.88 33.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.885 0.374 . . . . 1.74 110.353 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.508 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 32.4 t-105 -146.25 159.25 43.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.745 -0.835 . . . . 1.4 108.745 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.58 142.43 56.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.82 0.343 . . . . 0.67 110.194 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.7 t -77.79 109.04 11.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.965 0.412 . . . . 0.31 110.645 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -14.4 60.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.854 -0.612 . . . . 0.82 111.315 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.54 -60.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.096 0.406 . . . . 0.33 112.096 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 43.6 t -125.15 -42.62 2.0 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.31 -0.556 . . . . 0.5 112.228 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.77 92.85 0.38 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.003 -1.094 . . . . 0.59 112.266 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 35' ' ' GLU . . . -178.75 -177.7 0.53 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.847 -0.427 . . . . 0.33 109.847 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -98.0 123.19 41.89 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.63 -0.878 . . . . 1.34 108.63 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -102.33 129.21 48.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.138 -0.483 . . . . 0.22 110.819 -176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.52 136.61 33.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.991 -0.549 . . . . 0.27 110.141 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.489 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.3 tm? -78.98 131.77 36.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.512 -0.767 . . . . 0.34 109.123 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.95 145.39 16.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.496 -0.32 . . . . 0.91 110.27 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' CG ' ' HG2' ' A' ' 75' ' ' LYS . 67.7 m-20 65.11 30.43 11.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.932 -0.576 . . . . 1.96 112.078 175.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.91 61.13 4.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.035 -0.602 . . . . 1.47 113.021 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.437 0.637 . . . . 3.25 110.301 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.17 -78.85 0.18 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.501 -1.04 . . . . 1.06 110.501 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.55 145.61 95.39 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.322 2.014 . . . . 1.24 111.302 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 40.8 mt-10 -46.47 -60.65 2.22 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.699 0.624 . . . . 1.92 112.654 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 30.9 tt0 -106.69 35.82 2.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.079 -0.509 . . . . 1.65 109.904 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -59.14 -56.33 23.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 2.48 109.675 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 67' ' ' ASP . 61.9 mttm . . . . . 0 C--O 1.25 1.129 0 O-C-N 124.128 0.892 . . . . 4.92 111.415 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.018 0.437 . . . . 1.7 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.7 142.76 32.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.233 -0.439 . . . . 0.55 109.903 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 42' ' ' MET . 3.2 m -87.86 144.65 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.167 -0.679 . . . . 0.33 109.167 176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.522 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 37.8 tt0 -119.59 128.09 53.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.312 0.577 . . . . 1.74 110.673 -177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 61.1 m-85 -113.83 139.26 49.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.436 -0.802 . . . . 0.23 109.844 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.25 119.54 35.48 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.315 -0.254 . . . . 0.35 110.315 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 21.1 p -80.51 172.07 14.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.462 . . . . 1.55 111.967 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 41.6 mt-10 -64.81 -21.41 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.705 . . . . 1.99 110.994 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.15 0.03 54.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 1.74 111.037 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.31 31.1 43.1 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.862 -0.685 . . . . 0.62 112.589 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -113.42 127.46 56.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 2.52 109.545 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 49.5 mtt180 -99.51 141.34 32.43 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.661 -0.496 . . . . 1.99 109.661 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -142.51 153.4 43.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.868 -0.605 . . . . 0.18 110.385 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.83 135.81 41.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.05 -0.523 . . . . 1.38 110.057 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.554 ' O ' HG22 ' A' ' 30' ' ' VAL . 65.4 mmm -125.73 146.64 55.73 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.714 -0.675 . . . . 0.62 110.188 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -82.57 122.46 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.036 1.824 . . . . 0.54 112.775 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -143.25 -177.42 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.656 -0.702 . . . . 0.4 109.276 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 24.0 t -93.2 143.21 26.48 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.654 -0.498 . . . . 1.37 109.654 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 4.4 p -79.24 -1.28 4.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.751 -178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -127.17 21.11 6.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.766 -0.652 . . . . 1.25 110.761 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -109.77 172.02 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.228 -0.442 . . . . 0.35 110.078 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 33.8 tt0 -76.05 118.23 18.59 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 2.59 109.181 173.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.8 mm -89.79 106.03 12.91 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.164 -0.68 . . . . 0.36 109.164 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 49' ' ' GLU . 63.9 Cg_exo -51.99 124.95 15.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.232 2.621 . . . . 0.37 112.449 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 51.1 Cg_exo -55.22 -19.3 20.76 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.634 2.889 . . . . 0.24 113.429 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -147.65 152.86 38.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.74 110.551 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 34.7 t-105 -149.05 160.72 43.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.949 -0.759 . . . . 1.4 108.949 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -75.89 143.68 41.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.4 . . . . 0.67 110.412 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.4 t -83.58 97.76 9.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.307 0.575 . . . . 0.31 110.357 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 9.8 mmpt? -77.07 11.0 1.99 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.347 -0.842 . . . . 0.82 111.694 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -98.85 -60.71 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.623 0.249 . . . . 0.33 111.102 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t -108.9 -45.76 3.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.913 -0.315 . . . . 0.5 111.282 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.72 55.67 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.445 -0.883 . . . . 0.59 112.156 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -149.29 -167.21 2.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.985 -0.376 . . . . 0.33 109.985 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 tt0 -99.55 148.4 24.33 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.493 -0.558 . . . . 1.34 109.493 171.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -124.86 147.43 48.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.966 0.412 . . . . 0.22 111.293 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 79.0 mt -104.0 137.03 42.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.27 109.976 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.4 tm? -73.18 132.08 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.513 -0.767 . . . . 0.34 109.629 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 33.9 m -112.15 110.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.413 0.625 . . . . 0.91 110.91 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 63.66 83.55 0.16 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.327 -0.851 . . . . 1.96 112.363 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -151.44 -92.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 1.47 112.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 69.71 -60.76 0.46 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.423 0.689 . . . . 3.25 111.668 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -129.81 -72.72 0.13 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.086 -0.578 . . . . 1.06 111.691 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.16 127.8 11.61 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.181 1.92 . . . . 1.24 111.536 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 34.0 mt-10 -56.72 -49.93 73.72 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.221 -0.899 . . . . 1.92 111.593 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -136.42 78.8 1.73 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.402 -0.817 . . . . 1.65 109.659 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -149.99 -36.7 0.15 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.198 -0.455 . . . . 2.48 110.71 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.802 -0.618 . . . . 4.92 110.403 -176.592 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.593 0.235 . . . . 1.7 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -142.24 136.86 30.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.3 -0.259 . . . . 0.55 110.3 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 42' ' ' MET . 15.2 m -80.0 154.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.18 -0.304 . . . . 0.33 110.18 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 6.7 tp10 -116.37 135.87 53.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 1.74 110.724 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.77 136.4 49.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.384 -0.371 . . . . 0.23 110.028 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.38 121.98 35.46 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.272 -0.422 . . . . 0.35 110.505 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.3 p -86.58 159.77 19.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.091 0.472 . . . . 1.55 110.219 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.86 4.74 5.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 1.99 110.515 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mmmt -91.71 -16.9 26.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 1.74 109.437 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.11 -3.66 22.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.672 -0.775 . . . . 0.62 113.711 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -100.54 143.33 30.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.408 0.604 . . . . 2.52 111.974 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -113.31 148.25 36.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.402 -0.817 . . . . 1.99 108.977 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -153.82 152.26 30.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.945 0.402 . . . . 0.18 111.011 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 10.1 pt-20 -108.42 138.14 45.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.818 -0.628 . . . . 1.38 110.158 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 37.5 mtm -130.7 152.64 80.83 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.601 -0.272 . . . . 0.62 110.572 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.52 122.91 5.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.198 1.932 . . . . 0.54 113.069 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HG21 ' A' ' 30' ' ' VAL . 23.8 m-85 -137.54 -175.89 4.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.261 -0.881 . . . . 0.4 109.368 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 33.9 t -86.95 144.05 27.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.41 -0.589 . . . . 1.37 109.41 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 6.8 p -80.72 2.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.494 0.664 . . . . 1.0 110.426 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.8 5.89 7.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.63 -0.714 . . . . 1.25 111.101 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -97.03 147.33 24.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.805 0.336 . . . . 0.35 110.959 -175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -72.73 89.5 1.35 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.386 0.612 . . . . 2.59 109.814 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 68' ' ' GLY . 28.2 mm -58.65 124.26 71.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.182 -0.917 . . . . 0.36 110.691 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 11.4 Cg_endo -55.58 129.64 36.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.056 2.504 . . . . 0.37 112.295 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -59.68 -16.28 36.1 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.509 2.806 . . . . 0.24 113.626 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 151.04 36.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.995 -0.372 . . . . 1.74 109.995 174.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -146.52 159.66 43.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.31 -0.626 . . . . 1.4 109.31 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 139.3 57.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.962 0.41 . . . . 0.67 110.653 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 3.8 t -79.04 110.07 13.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.006 0.431 . . . . 0.31 111.098 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 1.1 mpmm? -76.68 -5.94 50.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.82 111.642 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.4 t -83.82 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.09 -0.244 . . . . 0.33 111.638 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.27 -44.45 2.58 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.589 -0.444 . . . . 0.5 112.081 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.12 75.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.252 -0.975 . . . . 0.59 112.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -165.85 -168.69 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.409 -0.589 . . . . 0.33 109.409 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -98.39 133.43 42.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.995 0.426 . . . . 1.34 109.903 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -110.66 132.82 53.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 0.22 110.426 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.74 137.5 32.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.234 -0.439 . . . . 0.27 110.164 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.423 HD22 ' O ' ' A' ' 31' ' ' GLU . 2.7 tm? -71.23 121.9 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.486 -0.779 . . . . 0.34 110.018 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 77.8 t -105.31 109.23 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.694 -0.685 . . . . 0.91 109.892 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 75' ' ' LYS . 33.9 t70 59.07 102.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.383 -0.826 . . . . 1.96 112.053 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 175.99 62.56 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.317 -0.856 . . . . 1.47 111.374 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.03 4.68 44.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.246 0.546 . . . . 3.25 110.176 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 48' ' ' ALA . . . 160.55 -74.09 0.2 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.031 -0.828 . . . . 1.06 111.031 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.93 128.83 16.42 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.329 2.02 . . . . 1.24 112.163 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 35.1 mt-10 -70.02 136.25 50.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 1.92 110.31 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 49.4 tt0 59.11 43.14 17.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.934 0.873 . . . . 1.65 110.467 175.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -74.51 -50.89 16.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.295 -0.866 . . . . 2.48 109.067 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HE2' ' HG3' ' A' ' 73' ' ' GLU . 61.4 mttm . . . . . 0 C--O 1.249 1.069 0 CA-C-N 114.614 -1.175 . . . . 4.92 111.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.75 0.31 . . . . 1.7 110.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.56 143.8 32.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.325 -0.398 . . . . 0.55 109.979 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 42' ' ' MET . 22.0 m -88.89 153.84 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 110.154 -0.313 . . . . 0.33 110.154 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 37.5 mt-10 -114.68 120.11 39.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.425 -0.352 . . . . 1.74 111.207 -173.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 39' ' ' ARG . 71.5 m-85 -112.94 141.05 47.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.474 -0.33 . . . . 0.23 110.488 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -135.37 126.16 27.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.35 110.446 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 19.5 p -89.39 -177.05 5.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.55 111.41 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -66.64 -14.18 62.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.668 . . . . 1.99 112.438 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HE3' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -87.64 -25.51 23.5 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.43 0.633 . . . . 1.74 110.3 176.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.39 5.35 40.01 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.283 -0.872 . . . . 0.62 111.331 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 39.0 m80 -68.39 102.24 1.38 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.746 -0.464 . . . . 2.52 109.746 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mtt180 -98.22 141.95 30.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.034 -0.53 . . . . 1.99 110.491 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -151.0 153.4 35.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.603 -0.726 . . . . 0.18 110.486 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.0 mt-10 -104.58 138.64 40.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.676 -0.693 . . . . 1.38 110.097 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 30' ' ' VAL . 42.8 mtm -135.25 146.16 56.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.773 -0.454 . . . . 0.62 109.773 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.91 121.83 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.029 1.819 . . . . 0.54 113.314 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.16 -175.87 3.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.221 -0.9 . . . . 0.4 108.945 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 29.0 t -81.0 135.77 35.9 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.3 -0.63 . . . . 1.37 109.3 171.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 72' ' ' GLU . 3.7 p -74.58 -4.15 5.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.43 0.633 . . . . 1.0 110.579 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.6 19.96 11.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 1.25 110.402 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.633 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -108.32 161.23 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.075 0.464 . . . . 0.35 111.075 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.79 88.66 7.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.491 -0.777 . . . . 2.59 109.533 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 65' ' ' LEU . 23.1 mm -58.8 121.27 52.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.588 -0.733 . . . . 0.36 110.909 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.47 127.38 25.21 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.939 2.426 . . . . 0.37 111.802 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 42.7 Cg_exo -58.9 -8.99 6.78 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.757 2.972 . . . . 0.24 114.314 -176.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.48 148.22 27.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.711 0.291 . . . . 1.74 110.731 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.406 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 23.5 t-105 -151.7 158.18 43.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.716 -0.846 . . . . 1.4 108.716 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.24 142.71 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.117 0.484 . . . . 0.67 111.183 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 6.0 t -79.59 103.83 9.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.717 -0.674 . . . . 0.31 111.127 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.9 7.94 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.622 . . . . 0.82 111.636 174.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.83 -59.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.114 0.413 . . . . 0.33 112.114 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -110.42 -45.28 3.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.203 0.446 . . . . 0.5 112.203 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.64 68.8 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.096 -1.05 . . . . 0.59 112.18 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -172.99 -166.04 0.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.33 109.139 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -99.43 146.77 25.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.66 -0.416 . . . . 1.34 109.987 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -119.62 148.33 43.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.209 -0.451 . . . . 0.22 110.306 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -102.88 140.55 37.01 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.044 0.45 . . . . 0.27 110.385 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 3.3 tm? -74.17 112.61 10.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.418 -0.81 . . . . 0.34 109.059 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -100.61 114.99 41.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.301 0.572 . . . . 0.91 112.041 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 75' ' ' LYS . 12.6 m-20 56.01 51.33 12.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.908 -1.042 . . . . 1.96 111.769 173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.64 67.19 0.56 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.04 -0.824 . . . . 1.47 111.04 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.592 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 28.5 t70 -81.04 61.77 4.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.247 0.546 . . . . 3.25 110.456 -177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.13 -95.24 1.08 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.715 -0.675 . . . . 1.06 112.448 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 69' ' ' ASP . 10.3 Cg_endo -54.23 126.59 22.65 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.941 2.427 . . . . 1.24 112.95 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' H ' HG23 ' A' ' 46' ' ' VAL . 39.9 mt-10 -68.69 151.42 46.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.295 -0.866 . . . . 1.92 110.826 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 56.54 62.38 2.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.339 0.59 . . . . 1.65 110.743 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -136.36 -54.74 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.876 -0.602 . . . . 2.48 110.675 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 66.5 tttm . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.059 -0.972 . . . . 4.92 110.033 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 73' ' ' GLU . 26.1 mt-30 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.063 -0.347 . . . . 1.7 110.063 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.18 141.41 32.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.293 -0.412 . . . . 0.55 111.02 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 42' ' ' MET . 19.6 m -96.65 141.63 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.295 -0.632 . . . . 0.33 109.295 172.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 34.8 tt0 -119.23 126.58 51.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.365 0.602 . . . . 1.74 111.15 -177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 94.4 m-85 -115.52 136.66 52.85 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.387 -0.824 . . . . 0.23 109.821 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.31 117.44 23.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.942 0.401 . . . . 0.35 110.755 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 15.8 t -82.93 156.24 23.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 1.55 109.702 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.22 -3.32 19.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.783 -0.644 . . . . 1.99 110.875 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -75.82 -21.27 57.47 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.373 -0.602 . . . . 1.74 109.373 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.36 -16.42 17.27 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.62 112.358 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -73.92 128.01 34.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.914 0.388 . . . . 2.52 111.762 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -110.8 153.07 25.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.144 -0.688 . . . . 1.99 109.144 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 32.3 p90 -161.59 153.3 19.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.522 -0.308 . . . . 0.18 110.576 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 pt-20 -112.19 142.56 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.966 -0.561 . . . . 1.38 110.527 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.551 ' O ' HG22 ' A' ' 30' ' ' VAL . 68.5 mtm -133.72 155.08 80.76 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.157 -0.474 . . . . 0.62 110.611 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.0 122.98 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.376 2.051 . . . . 0.54 112.941 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CD2' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -142.3 -176.87 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.252 -0.885 . . . . 0.4 109.106 175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 26.0 t -94.36 140.41 29.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.113 0.482 . . . . 1.37 110.04 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 72' ' ' GLU . 4.9 p -76.24 -12.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.582 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.88 9.68 30.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 1.25 110.406 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -94.82 161.81 14.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.35 110.595 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.61 84.15 6.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.29 -0.633 . . . . 2.59 109.29 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 70' ' ' GLY . 32.7 mm -57.75 117.29 18.1 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.36 110.697 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 77.9 Cg_exo -51.5 132.59 40.93 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.544 2.829 . . . . 0.37 112.742 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.5 Cg_exo -60.63 -18.73 56.71 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.334 2.689 . . . . 0.24 112.861 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.31 150.29 42.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.195 -0.298 . . . . 1.74 110.195 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 31.7 t-105 -149.86 155.4 39.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 1.4 109.377 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.65 140.69 58.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.087 0.47 . . . . 0.67 110.555 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 15.4 t -80.54 110.46 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.584 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.32 -2.98 30.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.681 -0.69 . . . . 0.82 111.329 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 -60.37 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.113 0.412 . . . . 0.33 112.113 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.0 t -105.6 -47.35 3.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.236 -0.586 . . . . 0.5 112.411 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 55.52 0.08 OUTLIER Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.942 -1.123 . . . . 0.59 112.596 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -154.33 -170.94 3.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.314 -0.625 . . . . 0.33 109.314 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -98.35 122.61 41.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 1.34 109.842 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -98.68 139.58 34.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.938 -0.574 . . . . 0.22 110.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.73 135.44 34.1 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.885 0.374 . . . . 0.27 110.163 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.5 tm? -68.99 117.37 10.56 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.913 -0.773 . . . . 0.34 108.913 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.47 111.02 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.215 0.531 . . . . 0.91 111.591 -174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 5.5 m-20 67.97 90.11 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.159 -0.928 . . . . 1.96 111.928 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -82.88 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.124 -0.944 . . . . 1.47 111.209 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.6 t70 48.24 44.07 19.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.864 0.84 . . . . 3.25 110.21 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.664 ' O ' HG12 ' A' ' 50' ' ' ILE . . . 153.61 -112.85 0.55 Allowed Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.006 -0.997 . . . . 1.06 110.988 -175.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.09 124.47 11.39 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.086 1.858 . . . . 1.24 112.11 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 46' ' ' VAL . 15.9 pt-20 -72.12 157.88 36.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.962 -0.563 . . . . 1.92 110.015 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 28' ' ' GLN . 7.2 tp10 72.13 -41.03 0.49 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.747 0.654 . . . . 1.65 111.728 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 72' ' ' GLU . 39.2 ttmt -59.87 -43.41 94.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.146 -0.479 . . . . 2.48 111.088 -177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 67' ' ' ASP . 99.3 mttt . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.596 0.56 . . . . 4.92 111.132 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.471 HE21 ' HB ' ' A' ' 46' ' ' VAL . 52.8 mt-30 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.579 0.228 . . . . 1.7 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -142.74 137.17 29.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.338 -0.245 . . . . 0.55 110.338 174.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 42' ' ' MET . 10.7 m -91.09 147.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.726 -0.472 . . . . 0.33 109.726 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 65' ' ' LEU . 46.8 mt-10 -118.27 124.04 46.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.051 0.453 . . . . 1.74 111.36 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CZ ' HD23 ' A' ' 65' ' ' LEU . 82.7 m-85 -113.06 138.13 50.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.037 -0.529 . . . . 0.23 110.039 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.67 121.21 37.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 0.35 110.191 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 31.1 p -83.24 166.23 18.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.085 -0.507 . . . . 1.55 110.888 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.63 3.03 10.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.471 -0.786 . . . . 1.99 110.595 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -99.28 -0.29 41.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.274 -0.421 . . . . 1.74 110.461 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.98 9.04 58.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.927 -0.654 . . . . 0.62 113.464 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -111.36 156.26 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.351 0.576 . . . . 2.52 110.764 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -122.9 147.82 46.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.879 -0.786 . . . . 1.99 108.879 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -146.86 153.99 40.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.957 0.408 . . . . 0.18 111.178 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.33 138.17 47.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.55 -0.75 . . . . 1.38 110.371 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.655 ' O ' HG22 ' A' ' 30' ' ' VAL . 62.9 mtm -136.91 147.82 60.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.85 -0.426 . . . . 0.62 109.85 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.69 123.27 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.049 1.833 . . . . 0.54 112.746 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.2 m-85 -125.28 -175.74 3.39 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.913 -0.773 . . . . 0.4 108.913 173.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 7.4 m -88.08 132.16 34.4 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.447 -0.575 . . . . 1.37 109.447 171.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 72' ' ' GLU . 2.7 p -76.41 -12.06 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.429 0.633 . . . . 1.0 110.225 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.5 6.31 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.809 . . . . 1.25 110.357 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.23 160.37 14.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.35 110.777 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -77.45 95.67 4.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.845 -0.798 . . . . 2.59 108.845 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.77 117.72 23.15 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.41 -0.359 . . . . 0.36 110.763 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 54.4 Cg_exo -51.85 125.33 16.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.161 2.574 . . . . 0.37 112.179 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -62.3 -12.14 25.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.378 2.719 . . . . 0.24 113.217 -177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.58 143.51 16.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.451 -0.341 . . . . 1.74 110.418 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.6 t-105 -142.79 159.01 43.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.561 -0.903 . . . . 1.4 108.561 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.79 144.81 55.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.99 0.424 . . . . 0.67 110.656 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 61' ' ' ALA . 3.6 t -83.17 107.84 16.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.09 -0.505 . . . . 0.31 110.794 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -4.37 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.957 -0.565 . . . . 0.82 111.249 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.46 -60.43 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 111.896 0.332 . . . . 0.33 111.896 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 53.1 t -108.51 -44.64 4.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.608 -0.437 . . . . 0.5 112.162 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.86 55.21 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.131 -1.033 . . . . 0.59 111.785 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 56' ' ' CYS . . . -153.8 -165.46 2.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.282 -0.636 . . . . 0.33 109.282 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -99.71 149.56 23.2 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.485 -0.561 . . . . 1.34 109.485 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -123.99 147.0 48.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.994 0.426 . . . . 0.22 110.677 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.83 139.26 35.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.078 -0.51 . . . . 0.27 110.244 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD11 ' HA3' ' A' ' 68' ' ' GLY . 3.5 tm? -75.94 123.81 26.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 0.34 109.111 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.05 110.62 28.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.222 0.534 . . . . 0.91 111.321 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 64.06 80.9 0.22 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.224 -0.898 . . . . 1.96 112.114 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.525 ' O ' ' HD2' ' A' ' 71' ' ' PRO . . . -140.88 -106.39 0.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.73 -0.748 . . . . 1.47 112.391 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.12 26.17 12.47 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.942 0.401 . . . . 3.25 111.199 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.51 -66.61 0.44 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.501 -0.856 . . . . 1.06 112.728 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 74.0 Cg_endo -76.12 147.06 29.45 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.412 2.075 . . . . 1.24 111.833 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 44.2 mt-10 -88.41 -57.15 3.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.678 -0.692 . . . . 1.92 110.897 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 30.1 tt0 -115.87 18.98 15.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.272 -0.877 . . . . 1.65 110.961 -166.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -79.81 -45.59 18.48 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.614 . . . . 2.48 109.704 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.0 tttp . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.953 -1.023 . . . . 4.92 111.274 -179.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 109.75 -0.463 . . . . 1.7 109.75 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.91 157.82 44.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.55 111.011 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 42' ' ' MET . 11.5 m -102.69 157.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.709 -0.478 . . . . 0.33 109.709 175.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HD22 ' A' ' 65' ' ' LEU . 45.2 mt-10 -131.47 127.71 37.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.729 0.3 . . . . 1.74 111.218 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -118.98 144.08 46.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.454 -0.339 . . . . 0.23 110.438 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.97 127.6 43.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.331 -0.395 . . . . 0.35 110.449 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 30.9 p -90.34 168.32 11.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 1.55 110.978 -176.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.97 -6.08 39.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.634 -0.712 . . . . 1.99 110.882 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 72.1 mmtt -84.57 -13.41 51.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 1.74 110.284 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.71 13.71 46.19 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.704 -0.68 . . . . 0.62 112.583 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -105.38 145.77 30.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 2.52 110.328 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -120.15 142.95 48.47 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.578 -0.527 . . . . 1.99 109.578 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -149.79 154.19 38.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.973 0.416 . . . . 0.18 111.271 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.22 143.24 42.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.668 -0.696 . . . . 1.38 109.955 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 30' ' ' VAL . 64.2 mtm -136.41 150.28 70.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.078 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.247 1.965 . . . . 0.54 113.006 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.488 ' CD2' HG21 ' A' ' 30' ' ' VAL . 33.7 m-85 -141.69 -177.09 5.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.623 -0.717 . . . . 0.4 109.604 177.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 25.5 t -104.17 144.55 31.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.232 0.539 . . . . 1.37 110.334 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 4.3 p -76.81 -7.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.481 -0.781 . . . . 1.0 109.645 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.42 22.54 15.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.067 -0.97 . . . . 1.25 110.034 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 45' ' ' SER . . . -119.51 146.07 45.77 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.005 -0.543 . . . . 0.35 110.308 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.02 85.09 2.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.94 -0.763 . . . . 2.59 108.94 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.0 mm -58.68 117.43 20.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.36 110.45 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.8 Cg_exo -53.72 130.37 38.64 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.066 2.511 . . . . 0.37 112.291 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 37.8 Cg_exo -61.23 -11.94 21.27 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.151 2.567 . . . . 0.24 112.929 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -155.08 137.4 14.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.531 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -137.21 158.74 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.939 -0.763 . . . . 1.4 108.939 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.25 141.04 56.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.924 0.393 . . . . 0.67 110.606 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 4.5 t -82.97 109.26 16.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.425 . . . . 0.31 110.842 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.27 -14.05 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.792 -0.64 . . . . 0.82 111.403 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.03 -60.53 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.016 0.376 . . . . 0.33 112.016 -171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.518 ' SG ' ' HE3' ' A' ' 36' ' ' LYS . 42.5 t -110.91 -44.46 3.61 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.507 -0.477 . . . . 0.5 111.79 -172.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.67 55.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.215 -0.993 . . . . 0.59 112.239 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.432 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -152.02 -162.9 1.61 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.986 -0.375 . . . . 0.33 109.986 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -98.62 142.47 30.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.42 -0.585 . . . . 1.34 109.42 170.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -117.2 138.97 51.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.939 0.4 . . . . 0.22 110.568 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.08 134.28 35.39 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.131 -0.486 . . . . 0.27 110.192 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 31' ' ' GLU . 3.4 tm? -68.69 118.59 11.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.667 -0.864 . . . . 0.34 108.667 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -107.17 118.75 55.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.252 0.549 . . . . 0.91 111.698 -175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' OD2' ' HE2' ' A' ' 75' ' ' LYS . 6.2 m-20 57.19 61.09 2.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.023 -0.989 . . . . 1.96 112.31 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.473 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -143.73 64.57 0.47 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.835 -0.906 . . . . 1.47 110.835 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -66.94 85.28 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.221 0.534 . . . . 3.25 110.353 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.44 -110.28 3.04 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.291 -0.868 . . . . 1.06 112.332 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.74 137.71 67.49 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.674 2.249 . . . . 1.24 112.028 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 46' ' ' VAL . 18.1 pt-20 -67.74 151.41 47.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.136 -0.484 . . . . 1.92 110.027 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 65.74 15.89 10.25 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.134 0.492 . . . . 1.65 110.851 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -90.79 -56.4 3.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.424 -0.353 . . . . 2.48 110.472 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HE2' ' OD2' ' A' ' 67' ' ' ASP . 62.8 tttm . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.047 -0.978 . . . . 4.92 110.264 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.726 0.298 . . . . 1.7 110.431 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.512 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -141.7 140.27 33.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.55 110.545 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 42' ' ' MET . 12.1 m -86.39 148.73 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.145 -0.687 . . . . 0.33 109.145 175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' OE2' ' HD3' ' A' ' 39' ' ' ARG . 34.8 tt0 -118.68 130.53 55.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.376 0.608 . . . . 1.74 111.431 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 76.5 m-85 -118.76 141.28 48.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.23 109.94 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . . . -127.64 113.57 16.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 0.35 110.586 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 61' ' ' ALA . 42.7 t -85.44 164.02 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.082 -0.508 . . . . 1.55 110.235 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.8 -11.66 56.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 1.99 111.213 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -72.38 -6.66 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 1.74 110.946 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.15 78.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.869 -0.682 . . . . 0.62 112.111 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -105.98 129.99 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.903 0.382 . . . . 2.52 110.661 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 62.1 mtt180 -105.91 153.23 22.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 1.99 109.803 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -154.91 153.04 30.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.936 0.398 . . . . 0.18 110.571 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.452 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 7.4 pt-20 -105.49 139.61 39.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.704 -0.68 . . . . 1.38 110.332 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.568 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.3 mtm -131.68 151.57 78.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.166 -0.47 . . . . 0.62 110.268 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.82 122.68 4.97 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.54 112.894 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.469 ' CD1' HG21 ' A' ' 30' ' ' VAL . 16.2 m-85 -131.76 -176.78 4.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.231 -0.895 . . . . 0.4 108.862 172.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 15.0 m -87.07 137.52 32.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.723 -0.473 . . . . 1.37 109.723 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 71' ' ' PRO . 3.2 p -73.98 -7.46 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.681 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.42 20.49 9.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.011 0.434 . . . . 1.25 111.052 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -102.05 160.21 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.132 -0.486 . . . . 0.35 110.462 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.56 106.53 9.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.077 -0.712 . . . . 2.59 109.077 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.6 mm -76.02 117.56 64.87 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.085 -0.339 . . . . 0.36 110.085 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 51.5 Cg_exo -54.71 127.94 28.26 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.159 2.573 . . . . 0.37 112.614 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 32.2 Cg_exo -60.78 -14.22 30.8 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.467 2.778 . . . . 0.24 113.217 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.56 140.95 25.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.116 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -147.76 159.16 44.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 1.4 109.363 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.68 142.4 58.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.807 0.337 . . . . 0.67 110.996 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 12.7 t -83.53 112.4 19.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.31 110.944 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.15 -12.45 60.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 0.82 111.294 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.3 t -81.3 -59.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.184 0.439 . . . . 0.33 112.184 -172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.5 t -114.17 -45.48 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.5 112.266 -173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 68.62 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.163 -1.017 . . . . 0.59 111.696 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -163.52 -170.58 2.27 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.635 -0.505 . . . . 0.33 109.635 -176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -99.57 117.37 33.81 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.009 -0.367 . . . . 1.34 110.009 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -92.85 141.15 28.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.245 -0.434 . . . . 0.22 110.336 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.2 136.63 38.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.009 0.433 . . . . 0.27 110.268 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 3.3 tm? -69.93 120.01 15.01 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.375 -0.829 . . . . 0.34 109.543 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.59 139.31 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.376 -0.375 . . . . 0.91 111.303 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 75' ' ' LYS . 6.2 m-20 51.74 48.29 23.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.593 -0.73 . . . . 1.96 112.332 176.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.62 -178.82 19.73 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.564 -0.827 . . . . 1.47 111.966 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -168.19 -61.04 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.305 -0.998 . . . . 3.25 108.305 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -143.07 -68.24 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.058 -0.974 . . . . 1.06 112.126 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 18.5 Cg_endo -60.16 123.64 13.59 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.046 1.831 . . . . 1.24 111.729 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 46' ' ' VAL . 36.5 mt-10 -64.39 134.46 54.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 1.92 110.276 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 27.7 tt0 67.27 22.81 9.52 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.604 0.565 . . . . 1.65 111.433 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -65.35 -36.03 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.3 0.572 . . . . 2.48 109.869 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 32.1 mmmt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.417 -0.802 . . . . 4.92 109.331 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.529 0.681 . . . . 1.7 110.234 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.71 135.08 27.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.55 110.748 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 42' ' ' MET . 13.1 m -81.34 140.75 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.539 -0.541 . . . . 0.33 109.539 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -117.16 130.26 56.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 1.74 111.347 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 65' ' ' LEU . 93.1 m-85 -116.61 142.1 47.33 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.757 -0.656 . . . . 0.23 109.793 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.4 122.47 42.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.8 0.333 . . . . 0.35 110.587 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' ' 36' ' ' LYS . 31.5 p -83.53 170.64 14.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.031 0.443 . . . . 1.55 111.142 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.09 -5.71 43.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.743 -0.662 . . . . 1.99 110.808 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.654 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 66.0 mmtt -86.41 -13.4 46.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.74 110.117 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.85 34.76 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.98 -0.629 . . . . 0.62 112.463 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -113.17 131.6 55.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.919 0.39 . . . . 2.52 110.078 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -105.51 145.39 30.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.808 -0.441 . . . . 1.99 109.808 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.28 153.13 43.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.735 0.302 . . . . 0.18 110.937 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 13.1 pt-20 -106.43 144.26 33.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.772 -0.649 . . . . 1.38 110.188 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.515 ' O ' HG22 ' A' ' 30' ' ' VAL . 52.8 mtm -139.38 148.52 57.0 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.342 -0.39 . . . . 0.62 110.059 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' MET . 3.3 Cg_exo -75.5 122.24 6.85 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.441 2.094 . . . . 0.54 112.943 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CD2' HG21 ' A' ' 30' ' ' VAL . 7.3 m-85 -137.35 -176.19 4.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.359 -0.837 . . . . 0.4 109.025 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.27 146.77 23.46 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.392 -0.595 . . . . 1.37 109.392 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.28 -6.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 1.0 110.621 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.47 20.35 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 1.25 110.057 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 70' ' ' GLY . . . -108.67 152.43 24.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.849 -0.614 . . . . 0.35 109.933 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -75.02 88.71 2.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.427 -0.583 . . . . 2.59 109.427 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 30' ' ' VAL . 31.2 mm -58.81 116.08 14.14 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.12 -0.491 . . . . 0.36 110.725 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 53.8 Cg_exo -52.8 131.42 41.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.42 2.747 . . . . 0.37 112.637 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 31.3 Cg_exo -61.43 -22.44 74.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.491 2.794 . . . . 0.24 113.166 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.78 152.12 39.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.35 . . . . 1.74 110.16 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.426 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 30.4 t-105 -149.51 159.24 44.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.394 -0.595 . . . . 1.4 109.394 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.37 143.79 56.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.072 0.463 . . . . 0.67 110.656 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.8 t -80.52 109.2 14.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.827 -0.624 . . . . 0.31 110.748 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.06 -10.16 59.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.731 -0.668 . . . . 0.82 111.251 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.03 -60.27 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.127 0.417 . . . . 0.33 112.127 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.6 t -112.47 -46.49 3.16 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.464 -0.495 . . . . 0.5 111.634 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.05 76.82 0.11 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.117 -1.039 . . . . 0.59 112.315 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -171.61 -167.42 0.51 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.347 -0.612 . . . . 0.33 109.347 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -98.56 140.34 32.94 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.142 -0.688 . . . . 1.34 109.142 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . . . -118.71 147.98 43.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.391 -0.368 . . . . 0.22 110.551 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.8 mt -99.57 136.63 39.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.107 -0.497 . . . . 0.27 110.25 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 68' ' ' GLY . 3.0 tm? -70.65 123.28 21.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.553 -0.749 . . . . 0.34 109.872 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.09 110.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.91 110.638 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 66.64 93.61 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.522 -0.763 . . . . 1.96 111.581 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -174.5 -112.52 0.29 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.669 . . . . 1.47 112.366 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 55.57 39.41 30.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.565 0.698 . . . . 3.25 110.659 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 48' ' ' ALA . . . 147.73 -83.85 0.18 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.596 -0.729 . . . . 1.06 111.705 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 73.7 Cg_endo -77.02 138.37 18.28 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.371 2.047 . . . . 1.24 111.209 174.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.0 -47.82 41.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.842 -0.617 . . . . 1.92 111.311 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -137.33 33.03 2.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.635 -0.711 . . . . 1.65 110.655 -168.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 40.1 ttmt -100.96 -13.16 18.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.51 0.672 . . . . 2.48 110.161 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.541 -0.754 . . . . 4.92 109.799 179.625 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.593 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 26.0 mt-30 . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.951 0.405 . . . . 1.7 110.853 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' H ' ' HB2' ' A' ' 73' ' ' GLU . . . -142.64 141.44 31.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.55 109.957 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 42' ' ' MET . 10.6 m -96.26 142.62 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.781 -0.451 . . . . 0.33 109.781 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.98 135.05 55.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.128 0.489 . . . . 1.74 111.069 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.718 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 79.9 m-85 -125.58 144.24 50.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.23 110.442 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' HG2' ' A' ' 39' ' ' ARG . . . -131.22 117.74 19.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.151 -0.477 . . . . 0.35 110.541 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' SG ' ' HG2' ' A' ' 36' ' ' LYS . 42.6 t -91.67 161.66 14.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.972 0.415 . . . . 1.55 110.258 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.29 -1.94 9.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.506 -0.77 . . . . 1.99 110.663 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HG2' ' SG ' ' A' ' 34' ' ' CYS . 74.7 mmtt -74.53 -15.18 60.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.598 . . . . 1.74 110.434 173.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.83 1.25 63.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.915 -0.66 . . . . 0.62 112.069 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -106.57 123.69 48.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.948 0.404 . . . . 2.52 110.766 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.427 ' HG2' ' CB ' ' A' ' 33' ' ' ALA . 61.4 mtt180 -99.12 155.15 17.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 1.99 109.67 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 56' ' ' CYS . 34.0 p90 -156.02 156.23 34.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 0.18 111.176 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.32 144.69 32.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.272 -0.876 . . . . 1.38 109.506 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.606 ' O ' HG22 ' A' ' 30' ' ' VAL . 60.7 mtm -137.66 148.93 63.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.637 0.256 . . . . 0.62 110.878 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.71 125.8 4.41 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.608 2.205 . . . . 0.54 112.578 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.415 ' HD2' HG21 ' A' ' 30' ' ' VAL . 4.9 m-85 -140.94 -177.11 4.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.64 . . . . 0.4 110.236 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 6.4 m -89.06 140.5 29.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.859 -0.609 . . . . 1.37 110.056 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 6.2 p -78.94 -6.21 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.557 0.694 . . . . 1.0 110.216 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.39 8.48 27.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.403 -0.817 . . . . 1.25 110.948 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 45' ' ' SER . . . -103.67 142.9 33.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.757 0.313 . . . . 0.35 110.88 -176.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.42 92.68 1.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.569 -0.53 . . . . 2.59 109.569 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.404 HD12 HG11 ' A' ' 30' ' ' VAL . 27.9 mm -58.46 115.9 13.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.618 -0.719 . . . . 0.36 110.519 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 52.9 Cg_exo -55.05 134.93 66.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.062 2.508 . . . . 0.37 112.48 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 21.8 Cg_exo -66.78 -5.15 12.55 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.457 2.771 . . . . 0.24 112.836 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -152.67 137.22 16.83 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.365 -0.606 . . . . 1.74 109.365 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.718 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -148.4 159.84 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.755 0.312 . . . . 1.4 110.87 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.09 135.12 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.216 0.532 . . . . 0.67 110.995 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 7.1 t -84.7 112.04 20.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.758 -0.655 . . . . 0.31 110.861 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.37 -14.37 60.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.82 110.981 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.86 -59.45 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.346 -0.388 . . . . 0.33 111.705 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.2 t -112.11 -46.35 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.418 -0.513 . . . . 0.5 112.001 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.9 56.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.871 -1.157 . . . . 0.59 112.662 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' H ' ' HB3' ' A' ' 56' ' ' CYS . . . -150.67 -173.09 4.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.914 0.357 . . . . 0.33 110.361 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -98.75 105.17 17.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.795 -0.446 . . . . 1.34 109.795 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . . . -83.73 142.83 30.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.852 -0.613 . . . . 0.22 110.745 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.1 mt -90.72 136.44 33.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.276 0.56 . . . . 0.27 110.249 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' PRO . 2.5 tm? -66.89 130.0 41.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.11 -0.95 . . . . 0.34 109.888 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.3 113.23 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.975 0.417 . . . . 0.91 110.859 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 63.2 73.41 0.45 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.457 -0.792 . . . . 1.96 111.422 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.484 ' CA ' HD11 ' A' ' 65' ' ' LEU . . . -157.69 -103.52 0.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.679 -0.691 . . . . 1.47 111.52 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 71.54 -41.65 0.51 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.697 0.799 . . . . 3.25 111.894 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.56 -67.55 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.488 -0.645 . . . . 1.06 111.488 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.24 152.9 45.41 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.218 1.945 . . . . 1.24 112.466 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' OE2' ' HB3' ' A' ' 28' ' ' GLN . 19.5 pt-20 -112.83 117.16 31.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 1.92 109.906 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 7.5 tp10 61.92 82.19 0.18 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.445 0.64 . . . . 1.65 110.264 -176.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -147.91 -26.17 0.35 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 2.48 110.577 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.958 -0.544 . . . . 4.92 110.357 179.192 . . . . . . . . 0 0 . 1 stop_ save_